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Dissertation can be summarized as following.
1. Chapter 1 deals with the cyclization of -ketosulfone, -ketonitrile and -
ketophosphonate dianions with 1, 1-diacetylcyclopropane. These reactions afford 1-
hydroxyspiro[5.2]cyclooct-4-en-3-ones which were transformed, by reaction with 
tetrabutylammonium halides, into functionalized phenols. 
2. Chapter 2 includes the cyclization of the dianions of diethyl 2-oxopropylphosphonate 
and of acetone with 1, 1-diacylopropanes. These reactions afforded 
hydroxyspiro[5.2]cyclooctenones which were transformed, by homo-Michael reactions 
with tetrabutylammonium halides, into various functionalized phenols or their dimmers. 
3. In chapter 3 we have described the chemo- and regioselective synthesis of  -bromo-3-
ketosulfones, -bromo-3-ketonitriles and various functionalized 2-(-
bromoalkyl)benzofurans by application of a ′ring-closing/ring-opening′ strategy. The 
cyclization of 3-ketosulfone and 3-ketonitrile dianions with 1-bromo-2-chloroethane or 
1,4-dibromobut-2-ene afforded functionalized 2-alkylidenetetrahydrofurans which were 
subsequently cleaved by reaction with boron tribromide or boron trichloride.
4. In chapter 4 we have reported sterically encumbered diaryl ethers which are prepared 
based on formal [3+3] cyclizations of novel 4-aryloxy-1,3-bis(trimethylsilyloxy)-1,3-
dienes. 
5. In chapter 5 we have studied fuctionalized 1-azaxanthones (5-oxo-5H-[1]-
benzopyrano[2,3-b]pyridines) which were prepared by TMSOTf-mediated reaction of 
1,3-bis(trimethylsilyloxy)-1,3-butadienes with cyanochromones and subsequent base-
mediated domino retro-Michael / nitrile-addition / heterocyclization reactions.
6. In chapter 6 we have reported sterically encumbered biaryls which are regioselectively 
prepared based on formal [3+3] cyclizations of novel 4-aryl-1,3-bis(trimethylsilyloxy)-
1,3-dienes. 
7. Chapter 7 deals with the regioselective synthesis of functionalized 
thiophenoxybenzoates by domino [3+3] cycllization / homo Michael reactions of 1-
trimethylsilyloxy-3-thiophenoxy-1, 3-butadienes with 1,1-diacylcyclopropanes. 
8. In chapter 8 we studied the synthesis of various tetraarylthiophenes based on Suzuki 
reactions of tetrabromothiophene. 
99. In chapters 9 to 12 our studies were focused on the isolation and characterization of 
new chemical constituents from Pulicaria undulata. During these studies we have 
isolated and structurally elucidated different chemical constituents that belong to 
flavonoid and ent-kaurane-type diterpenes, to two new flavonoid glycosides, 
pulicaroside, undulatoside and one new flavonoid undulol. In addition, four known 
flavonones – one new ent-kaurane-type diterpene glycoside, pulicaroside-B together with 
three known compounds paniculosides-IV, roseoside and corchionol C  which  are 
derivatives of -ionol – were isolated. The structures of the new and known compounds 
were elucidated by 1D- and 2D-NMR techniques, along with other spectral evidences and 
comparison of the spectral data with those of closely related compounds. All the 
flavonoids (1-6) that are discussed in chapter 11 exibited superoxide anion scavenging 
activity. 
10
                    
                          PART- A 
Synthesis of Pharmacologically Relevant 
Arenes by [3+3] Cyclizations 
11
General Introduction 
Methods in Organic Synthesis are an alerting service covering the most important current 
developments in organic synthesis. It is designed with the synthetic organic chemist in 
mind, providing informative reaction schemes and covering new reactions and new 
methods. At the beginning, organic chemistry was considered a branch of natural 
sciences dealing with a specific type of compounds mainly isolated from living 
organisms. Even today natural products continue to play an important role in discovery 
and development of new pharmaceuticals.1 Since the discoveries of penicillin, a large 
number of antibiotics have been isolated from scores of micro-organisms.2 Natural 
products also provide a great help ic chemotherapy of cancer. They are integral part of 
anticancer drugs e.g. bleomycin, doxorubicin, mitomycine, and paclitaxel.3 All this 
pharmacologically and biologically important stuff designed by Mother Nature was not 
available in bulk quantities which man demanded. This forced scientists to look for 
alternate way to get it in bulk amounts while following to foot step of nature. That 
gradually resulted in the form of modern synthetic organic chemistry. The 
spirocycloprapane moiety is present in many cytotoxic compounds which play an 
important role an therapeutic agent in the treatment of cancer and systemic 
chemotherapy.4 Most of the chemotherapeutic agents used today belong to alkylating 
compounds, such as chlorambucil, melphalan, thiotepa and busulfan.5 New cytotoxic 
compounds are an important target in medicinal chemistry, as many  natural products 
with cytotoxic properties were identified as poisonous components in fungi. The isolation 
of the illudins S and M as cytotoxic constituents of O. illudens was reported in 1950.6
The synthesis of illudin analogs is of considerable pharamacological relevance, due to 
their cytotoxic and cancerostatic activity. Padwa and coworkers reported an interesting 
and efficient synthesis of illudin based on cyclization reactions of diazo compounds.7 In 
addition, spirocyclopropanes are present in a number of pharmacologically interesting 
natural products, such as CC-1065 and duocarmycin SA8, which exhibit a considerable
antiproliferative activity against human leukaemia HL60 cells.9 Benzofurans represent   
important synthetic bulding blocks and occur in a variety of pharmacologically relevant 
natural products, such as diazonamide A, anigopreissinA, euparin, coumestrol, 
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dehydrotremetone,or cicerfuran.10 Synthetic amiodarine represents a potent antiarrthmic 
and antianginal drug that is used in the clinic.11 Functionalized diaryl ethers occur in a 
variety of natural products which show strong pharmacological activties.12 This includes, 
for example, geodinhydrate methylester, methyl chloroasterrate,13a,b 1-
desgalloylsanguiin,13c dehydrotrigallic acid,13d epiphorellic acid,13e jolkianin,13f remurin 
A,13g  and micareic acid. Azaxanthones are also of considerable pharmacological 
relevance. For example, they show antiinflammatory activity and represent inhibitors of 
the passive cutaneous anaphylaxis.14 Biaryls containing a 3-arylsalicylate substructure 
occur in a variety of pharmacologically relevant natural products. The simple biaryls 
cynandione A-C have been isolated from many plant sources and show a considerable in 
vitro activity against hepatocytes, human bladder carcinoma T-24 cells, epidermoid 
carcinoma KB cells, and human hepatoma PLC/PRF/5 cells.15 A number of natural 
products, such as knipholone, 6'-O-methylknipholone or (+)-asphodelin, contain an 
anthraquinone moiety.16
My own studies were focussed on the synthesis of different spirocyclopropanes and their 
reactions. I synthesized different types of benzofurans which are versatile synthetic 
bulding block in organic chemistry. I also contributed to the development of a new 
methodology for the synthesis of diaryl ethers, azaxanthones, and biaryls which are all 
important parts or analogues of different natural products.  
Note: The text of the individual chapters were generally directly taken from the 
publications without change. 
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                                                                                           Chapter 1 
Synthesis and Reactions of Functionalized Spirocyclo-propanes by 
Cyclization of Dilithiated -Ketosulfones, α-Cyanoacetone and Diethyl 
2-Oxopropylphosphonate with 1,1-Diacetylcyclopropane 
                                                                                    Tetrahedron 2008, accepted 
 1.1 Introduction 
1.1. Cytotoxic natural products are important lead structures for the synthesis of new 
anticancer agents.1 Notably, the search for new cytotoxic compounds is of ongoing 
importance since tumours, similar to bacteria, may become resistant to known 
chemotherapeutics.2 In addition, several types of tumours have not yet been efficiently 
addressed by chemotherapeutic methods. Spiro [2.5] cycloocta-4, 7-dien-6-ones and 
related spirocyclopropanes constitute an important structural motif of cytotoxic and 
cancerostatic natural and non-natural products. This includes, for example, the illudins S 
and M (Figure 1) which possess a 1-hydroxyspiro [5.2] cyclooct-4-en-2-one skeleton.3
The cytotoxic natural products CC-1065 and duocarmycin SA contain a 
spiro[2.5]cycloocta-4,7-dien-6-one moiety containing aromatic rings fused to a 
heterocyclic ring system.4 Most of the chemotherapeutic agents used today belong to 
alkylating compounds (chlorambucil, melphalan, thiotepa and busulfan), platinum 
derivatives (cisplatin,carboplatin), inhibitors of topoisomerases (camptothecin, etoposide, 
doxorubicin), antimetabolic compounds (5-fluoruracil, methotrexate, hydroxyurea) or 
inhibitors of mitosis (taxol, vinblastine). The illudins belong to the group of alkylating 
agents: The reaction of a nucleophile (such as glutathione) with the unsaturated ketone 
moiety results in formation of a cyclohexadiene which rapidly undergoes an 
aromatization with concurrent ring opening of the cyclopropane moiety and alkylation of 
the DNA.3
15
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Chart 1. Natural cancerostatic spirocyclopropanes 
In their pioneering work, Baird and Winstein studied the synthesis of spiro[2.5]cycloocta-
4,7-dien-6-ones and their reaction with various nucleophiles.5 Padwa and coworkers 
reported interesting cyclization reactions of diazo compounds which allow a convenient 
synthesis of illudins.6 We reported7 the synthesis of ester-substituted 1-
hydroxyspiro[5.2]cyclooct-4-en-3-ones based on cyclization reactions of 1,3-dicarbonyl 
dianions. Noteworthy, the products showed a considerable antiproliferative activity 
against human leukemia HL60cells. Herein, we report the synthesis and reactions of 
novel spirocyclopropanes based on cyclizations of -ketosulfone, -ketonitrile and -
ketophosphonate dianions with 1,1-diacetylcyclopropane. These reactions provide a 
convenient access to functionalized phenols, which are not readily available by other 
methods.
1.2 Results and Discussion 
 1.2.1 -Ketosulfones 
1.2. Dianions of -ketosulfones are useful synthetic building blocks, which have been 
previously used in cyclization reactions. This includes, for example, the synthesis of 2-
(sulfonylmethylidene) tetrahydrofurans8 and 7-sulfonyl-2, 3,3a, 4,5,6-hexahydro 
benzofurans9 by cyclization of -ketosulfone dianions with cyclic sulfates and 1,4-
dibromobut-2-ene, respectively. The cyclization of the dianions of -ketosulfones 1a,b, 
generated by means of LDA (2.0 equiv.), with 1,1-diacetylcyclopropane (2) afforded the 
1-hydroxyspiro [5.2] cyclooct-4-en-3-ones 3a,b (Scheme 1, Table 1). The relatively low 
16
isolated yields can be explained by the fact that the products are, due to their high 
reactivity, rather unstable and readily decompose during the chromatographic 
purification. However, it proved possible to directly use the crude spirocyclopropane for 
the next synthetic step (vide infra) without chromatographic purification.  
Me Me
O O
SO2Ar
O
SO2Ar
O
Me
HO
Me
1a,b
i
3a,b2
+
Scheme 1. Synthesis of 3a,b; i: 1) LDA (2.0 equiv), 1a,b (1.0 equiv), THF, 1 h 0 °C, 2) 2
(1.0 equiv), −78 → 20 °C, 14 h 
                              Table 1. Synthesis of 3a,b  
3 Ar  % a
a Ph 30 
b 4-MeC6H4 32 
                                          a Yields of isolated products 
Despite its unstable nature, it proved to be possible to grow a single crystal of 
spirocyclopropane 3b and to independently confirm its structure by X-ray crystal 
structure analysis (Figure 1).10
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1.3.  Figure 1. Ortep plot of 3b 
The BF3⋅OEt2-mediated reaction of pure 3a,b with tetrabutylammonium halides afforded 
the sulfonyl-substituted phenols 4a-f containing a remote chloride, bromide, and iodide 
group (Scheme 2, Table 2). Alternatively, the crude material could be successfully 
employed (vide supra). Products 4a-f were presumably formed by Lewis acid mediated 
elimination of water to give a highly reactive spiro[2.5]cycloocta-4,7-dien-6-one 
(intermediate A). The cyclopropane moiety is subsequently cleaved by Lewis acid 
mediated attack of the halide ion to give a phenolate (intermediate B), which is 
protonated upon addition of water (aqueous work-up). The structure of 4f was 
independently confirmed by X-ray crystal structure analysis (Figure 2). 
18
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SO2Ar
O
MeMe
A
SO2Ar
O
MeMe
X
B
_
N(nBu)4+
X
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_
N(nBu)4+
BF3 OEt2.
H2O
Scheme 2. Synthesis of 4a-f; i: BF3⋅OEt2, CH2Cl2, −78 → 20 °C, 6 h, then 20 °C, 6 h 
                               Table 2. Reaction of 3a,b with N(nBu)4
4 Ar X % a
a Ph Cl 80 
b Ph Br 75 
c Ph I 81 
d 4-MeC6H4 Cl 78 
e 4-MeC6H4 Br 68 
f 4-MeC6H4 I 84 
                                                 a Yields of isolated products 
19
                  
               Figure 2. Ortep plot of 4f
1.2.2  α-Cyanoacetone 
The cyclization of 2 with the dianion of α-cyanoacetone, generated by treatment of 5-
methylisoxazole (5) with LDA,11 afforded 1-hydroxyspiro[5.2]cyclooct-4-en-3-one 6
(Scheme 3). The BF3⋅OEt2-mediated reaction of 6 with tetrabutylammonium halides gave 
the 2-cyanophenols 7a-c containing a remote halide group (Scheme 3, Table 3). The 
formation of 7a-c can be explained by a similar mechanism as discussed for 4a-f. The 
structure of 7b was independently confirmed by X-ray crystal structure analysis (Figure 
3).10
20
             
Me Me
O O
CN
O
Me
HO
Me
N
OH3C
CN
OH
MeMe
X
5 i
6 (41%)2
+
7a-c
ii
N(nBu)4X
Scheme 3. Synthesis of 7a-c; i: 1) LDA (2.0 equiv), 5 (1.0 equiv), THF, 1 h, 0 °C, 2) 2
(1.0 equiv), −78 → 20 °C, 14 h; ii: nBu4NX (1.0 equiv), BF3⋅OEt2  (0.5 equiv.), –78 → 20 
°C, 12 h 
                                   Table 3. Products and yields  
7 X  % a
a Cl 64 
b Br 67 
c I 75 
                                                  a Yields of isolated product 
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1.4. Figure 3. Ortep plot of 7b
1.2.3  Diethyl 2-Oxopropylphosphonate 
The cyclization of 2 with the dianion of diethyl 2-oxopropylphosphonate (8), generated 
by means of LDA, afforded the novel unsubstituted 1-hydroxyspiro[5.2]cyclooct-4-en-3-
one 9 (Scheme 4). The formation of 9 can be explained by cyclization (intermediate C), 
elimination of lithium diethylphosphate (intermediate D) and subsequent protonation 
upon addition of water. Alternatively, the reaction can be regarded as a domino ′aldol / 
Horner-Wadsworth-Emmons (HWE)′ reaction. The BF3⋅OEt2-mediated reaction of 9 with 
tetrabutylammonium halides afforded the functionalized phenols 10a-c (Scheme 5, Table 
4).  
22
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PO(OEt)2
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i
Me Me
O O
O
Me
HO
Me
9 (30%)2
+
PO(OEt)2
O
Me
LiO
Me
OLi
O
Me
LiO
Me
H2O
_ LiOPO(OEt)2C D
Scheme 4. Synthesis of spirocyclopropane 9; i: 1) LDA (2.0 equiv), 8 (1.0 equiv), THF, 1 
h 0 °C, 2) 2 (1.0 equiv), −78 → 20 °C, 14 h 
                      
i
O
Me
HO
Me
10a-c
OH
MeMe
X
N(nBu)4X
9
Scheme 5. Reaction of 9 with nBu4NX; ii: nBu4NX (1.0 equiv), BF3⋅OEt2  (0.5 equiv.), –
78 → 20 °C, 12 h 
                              Table 4. Products and yields 
10 X % a
a Cl 73 
b Br 68 
c I 63 
                                                 a Yields of isolated product 
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In conclusion, 1-hydroxyspiro[5.2]cyclooct-4-en-3-ones were prepared by cyclization of  
-ketosulfone, -ketonitrile and -ketophosphonate dianions with 1,1-
diacetylcyclopropane. These products were transformed into functionalized phenols by 
Lewis acid mediated reaction with tetrabutylammonium halides. The reactions reported 
provide a convenient two-step approach to functionalized phenols, which are not readily 
available by other methods.  
1.3 Experimental Section 
General Comments. All solvents were dried by standard methods and all reactions were 
carried out under an inert atmosphere. For 1H and 13C NMR spectra the deuterated 
solvents indicated were used. Mass spectrometric data (MS) were obtained by electron 
ionization (EI, 70 eV), chemical ionization (CI, H2O) or electrospray ionization (ESI). 
For preparative scale chromatography, silica gel (60-200 mesh) was used. Melting points 
are uncorrected.  
Typical procedure for the cyclization of 1,3-dicarbonyl dianions with 1,1 
diacetylcyclopropane.  A THF solution (8.5 mL) of LDA was prepared by addition of 
nBuLi (3.10 mL, 7.7 mmol, 2.5 M solution in hexane) to a THF solution of 
diisopropylamine (1.0 mL, 7.76 mmol) at 0 °C. After stirring for 1 h, β-ketosulfone 1
(768 mg, 3.88 mmol) was added at –78 °C and the solution was stirred for 1 h. To the 
solution was added 1,1-diacetylcyclopropane (2) (490 mg, 3.88 mmol) at –78 °C and the 
solution was allowed to warm to 20 °C during 14 h. To the reaction mixture was added 
an aqueous solution of HCl (1 M) and the organic and aqueous layers were extracted with 
CH2Cl2 and the combined organic layers were washed with brine, dried (Na2SO4), 
filtered, and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (silica gel, hexane/EtOAc) to give 3a as a yellow solid (230 mg, 30%). 
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8-Hydroxy-4,8-dimethyl-5-(phenylsulfonyl)spiro[2.5]oct-4-en-6-one (3a): Mp = 
165−167 °C. 1H NMR (300 MHz, CDCl3): δ = 0.93−0.97 (m, 1 H, CH2), 1.13 (s, 3 H, 
CH3), 1.28−1.32 (m, 1 H, CH2), 1.50−1.54 (m, 1 H, CH2), 2.22 (s, 3 H, CH3), 2.45 (d, 1 
H, J = 15.8 Hz, CH2), 2.55 (d, 1 H, J = 15.8 Hz, CH2), 7.40−7.49 (m, 3 H, ArH), 
7.83−7.87 (dd, 2 H, J = 8.4, 3.6 Hz, ArH);  13C NMR (75 MHz, CDCl3): δ = 11.5, 13.6 
(CH2), 16.5, 25.8 (CH3), 38.8 (C), 52.4 (CH2), 69.7 (C), 128.0 (2C CH), 128.9 (2C CH), 
133.3 (CH),  136.5, 149.0, 173.8, 191.4 (C); IR (KBr): ~ν  = 3407 (S), 2967 (w), 2924 (w), 
1664 (m), 1544 (s), 1447 (m), 1375 (m), 1334 (s), 1301 (s), 1088 (s), 732 (s) cm−1; MS 
(CI): m/z (%): 307 ([M+1]+), 100), 289 (11.21), 247 (6.07), 199 (2.82); HRMS (CI): 
calcd. for C16H19SO4 ([M+1]+) 307.0996, found 307.1001. 
8-Hydroxy-4,8-dimethyl-5-(4-methylphenylsulfonyl)spiro[2.5]oct-4-en-6-one (3b):
Starting with n-BuLi (31mL, 78.4 mmol, 2.5 M solution in hexane), diisopropylamine 
(11 mL, 78.4 mmol), 1,1-diacetylcyclopropane (2) (5.00 g, 39.7 mmol), and p-
tolylsulfonylacetone (8.41 g, 39.7 mmol) in THF (86 mL), 3b was isolated as a colourless 
solid, mp = 160−163 °C; 1H NMR (300 MHz, CDCl3): δ = 1.06−1.10 (m, 1 H, CH2), 1.29 
(s, 3 H, CH3), 1.32−1.36 (m, 1 H, CH2), 1.42−1.46 (m, 1 H, CH2), 1.66−1.70 (m, 1 H, 
CH2), 2.37 (s, 3 H, CH3), 2.49 (s, 3 H, CH3), 2.66 (d, 1 H, J = 13.4 Hz, CH2), 2.72 (d, 1 
H, J = 16.4 Hz, CH2), 7.38 (d, 2 H, J = 8.0 Hz, ArH), 7.94 (d, 2 H, J = 8.0 Hz, ArH); 13C 
NMR (75 MHz, CDCl3): δ = 11.3, 13.5 (CH2), 16.6, 22.0, 25.8 (CH3), 37.1 (C), 52.5 
(CH2), 71.6 (C), 128.2 (2C CH), 129.6 (2C CH), 136.8, 140.0, 144.2, 173.8, 191.5 (C); 
IR (KBr): ~ν  =  3489 (m), 2974 (m), 2929 (m), 1718 (m), 1679 (s), 1597 (m), 1373 (m), 
1301 (s), 1186 (s), 1086 (s), 981 (s), 815 (m), 543 (s) cm−1; MS (CI, 70 eV): m/z (%): 321 
([M+1]+ )100), 303 (10.21), 253 (11), 213 (9); HRMS (CI): calcd. for C17H21SO4
([M+1]+ ): 321.11521, found: 321.11551.  
Typical procedure for the reaction of 8-hydroxy-4,8-dimethyl-5-
(phenylsulfonyl)spiro[2.5]oct-4-en-6-ones with tetraalkylammonium halides. To a 
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CH2Cl2 solution (12.4 mL) of 3a (500 mg, 1.63 mmol) and of n-Bu4NCl (526 mg, 1.6 
mmol) was dropwise added BF3.OEt2  (0.10 mL, 0.8 mmol) at –78 °C under Argon 
atmosphere. The solution was allowed to warm to 20 °C over 6 h and was stirred for 
additional 6 h at 20 °C. The solution was filtered and the filtrate was poured into an 
aqueous solution of HCl (1.0 M). The organic and the aqueous layers were separated and 
the latter was extracted with CH2Cl2. The combined organic layers were washed with 
brine, dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue 
was purified by chromatography (silica gel, hexane/EtOAc) to give 4a as a yellow solid 
(435 mg, 75%). 
4-(2-Chloroethyl)-3,5-dimethyl-2-(phenylsulfonyl)phenol (4a): Starting with 3a (300 
mg, 1.0 mmol), n-Bu4NCl (272 mg, 1.0 mmol), CH2Cl2 (7.4 mL) and BF3⋅OEt2 (0.06 mL, 
0.5 mmol), 4a was isolated (355 mg, 80%) as a colourless solid, mp = 192−196 °C; 1H 
NMR (300 MHz, CDCl3): δ = 2.27(s, 3 H, CH3), 2.33 (s, 3 H, CH3), 2.89 (t, 2 H, J = 7.6 
Hz, CH2),  3.40 (t, 2 H, J = 6.9 Hz, CH2), 6.79 (s, 1 H, CH), 7.50−7.54 (m, 2 H, ArH), 
7.60−7.65 (m, 1 H, ArH), 7.83−7.87 (m, 1 H, ArH), 10.45 (s, 1 H, OH); 13C NMR (62 
MHz, CDCl3): δ = 16.5, 20.8 (CH3), 32.6, 41.7 (CH2), 118.6 (C), 119.1 (CH), 126.4 (2C 
CH), 128.3 (C), 129.2 (2C CH), 133.5 (CH),  137.2, 142.1, 145.6, 157.1 (C); IR (KBr): ~ν
= 3265 (s), 2957 (w), 2920 (w), 1601 (s), 1445 (s), 1342 (s), 1295 (m), 1109 (s), 1157 
(m), 762 (m), 691 (s), 649 (s), 568 (s), cm−1; GC-MS (EI, 70 eV): m/z (%): 326 (M+, 37Cl, 
10), 324 (M+, 35Cl, 22),  275 (100), 133(19), 91 (12), 77 (15); HRMS  (EI): calcd.for 
C16H17O3ClS [M+, 35Cl]: 324.05814, found: 324.057851. 
1.5.
1.6. 4-(2-Bromoethyl)-3,5-dimethyl-2-(phenylsulfonyl)phenol (4b): Starting with 3a
(500 mg, 1.6 mmol), n-Bu4NBr (526 mg, 1.63 mmol), CH2Cl2 (12.4 mL) and BF3⋅OEt2
(0.1 mL, 0.8 mmol), 4b was isolated (435 mg, 75%) as a colourless solid, mp = 144−146 
°C; 1H NMR (300 MHz, CDCl3): δ = 2.31 (s, 3 H, CH3), 2.52 (s, 3 H, CH3), 3.05 (t, 2 H, 
J = 7.7 Hz, CH2), 3.23 (t, 2 H, J = 6.9 Hz, CH2), 6.79 (s, 1 H, CH), 7.50−7.55 (m, 2 H, 
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ArH), 7.60−7.65 (m, 1 H, ArH), 7.83−7.87 (m, 1 H, ArH), 10.62 (s, 1 H, OH); 13C NMR 
(75 MHz, CDCl3): δ = 16.9, 21.2 (CH3), 29.5, 33.4 (CH2), 119.1 (C), 119.7 (CH), 127.1 
(2C CH), 129.6 (2C, CH), 129.9 (C), 133.9 (CH),  137.5, 142.5, 146.1, 157.5 (C); IR 
(KBr): ~ν  = 3264 (s), 2955 (w), 1601 (s), 1558 (s), 1445 (s), 1342 (s), 1278 (m), 1126 (s), 
1083 (s), 865 (w), 761 (m), 730 (s), 642 (m), cm−1; GC-MS (EI, 70 eV): m/z (%): 370 
(M+, 81Br, 21), 368 (M+, 79Br, 22), 289 (22), 275 (100), 133 (19), 91 (10), 77 (17); HRMS 
(EI): calcd. for C16H17O3BrS [M+ , 79Br]: 368.00763, found: 368.007146. 
4-(2-Iodoethyl)-3,5-dimethyl-2-(phenylsulfonyl)phenol (4c): Starting with 3a (500 mg, 
1.6 mmol), n-Bu4NI (603 mg, 1.6 mmol), CH2Cl2 (12.4 mL) and BF3⋅OEt2 (0.1 mL, 0.8 
mmol), 4c was isolated (425 mg, 81%) as a colourless solid, mp = 170−171 °C; 1H NMR 
(300 MHz, CDCl3): δ = 2.24 (s, 3 H, CH3), 2.30 (s, 3 H, CH3), 2.94−2.98 (m, 2 H, CH2), 
3.05−3.10 (m, 2 H, CH2), 6.78 (s, 1 H, CH), 7.50−7.54 (m, 2 H, ArH), 7.58−7.62 (m, 1 H, 
ArH), 7.83−7.87 (m, 1 H, ArH), 10.54 (s, 1 H, OH); 13C NMR (62 MHz, CDCl3): δ = 0.0 
(CH2), 15.8, 20.0 (CH3), 33.5 (CH2), 117.9 (C), 118.4 (CH), 125.7 (2C CH), 128.4 (2C 
CH), 131.0 (C), 132.7 (CH),  136.0, 141.3, 144.5, 156.2 (C); IR (KBr): ~ν  =  3262 (s), 
2950 (w), 1598 (s), 1559 (s), 1445 (s), 1341 (s), 1291 (s), 1207 (m), 1125 (s), 1082 (s), 
866 (m), 727 (s), 690 (s), 667 (m), 548 (s), cm−1; GC-MS (EI, 70 eV): m/z (%): 416 (M+, 
6), 289 (100), 275 (7), 196 (5), 148 (11), 91 (10), 77 (15); HRMS (EI): calcd. for 
C16H17O3IS [M+]: 415.99376, found: 415.99368. 
4-(2-Chloroethyl)-3,5-dimethyl-2-[(4-methylphenyl)sulfonyl]phenol (4d): Starting 
with 3b (300 mg, 0.9 mmol), n-Bu4NCl (260 mg, 0.9 mmol), CH2Cl2 (7.0 mL) and 
BF3⋅OEt2 (0.06 mL, 0.5 mmol), 4d was isolated (248 mg, 78%) as a colourless solid, mp 
= 118−121 °C; 1H NMR (300 MHz, CDCl3): δ = 2.40 (s, 3 H, CH3), 2.46 (s, 3 H, CH3), 
2.55 (s, 3 H, CH3), 3.11 (t, 2 H, J = 8.0 Hz, CH2), 3.53 (t, 2 H, J = 6.6 Hz, CH2), 6.96 (s, 1 
H, CH), 7.43 (d, 2 H, J = 8.0 Hz, ArH), 8.37 (d, 2 H, J = 8.0 Hz,  ArH), 10.74 (s, 1 H, 
OH); 13C NMR (75 MHz, CDCl3): δ = 16.9, 21.3, 22.0 (CH3), 33.0, 42.1 (CH2), 119.4 
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(C), 119.5 (CH), 126.5, (2C CH), 129.7 (C), 130.2 (2C CH), 137.7, 139.4, 144.9, 145.8, 
157.8 (C); IR (KBr): ~ν  =  3193 (m), 2960 (w), 2854 (w), 1605 (m), 1566 (m), 1463 (m), 
1240 (s), 1124 (s), 1085 (s), 811 (w), 684 (s), 548 (m), 555 (s), cm−1; GC-MS (EI, 70 
eV): m/z (%): 340 (M+, 37Cl, 26), 338 (M+, 35Cl, 28), 289 (100), 197 (11), 133 (23), 91 
(14), 77 (10); HRMS (EI): calcd. for C17H19O3ClS [M+, 35Cl]: 338.07379, found: 
338.07326. 
4-(2-Bromoethyl)-3,5-dimethyl-2-[(4-methylphenyl)sulfonyl]phenol (4e): Starting 
with 3b (500 mg, 1.5 mmol), n-Bu4NBr (503 mg, 1.5 mmol), CH2Cl2 (11.8 mL) and 
BF3⋅OEt2 (0.10 mL, 0.8 mmol), 4e was isolated (395 mg, 68%) as a colourless solid, mp 
= 135−137 °C;  1H NMR (300 MHz, CDCl3): δ = 2.46 (s, 3 H, CH3), 2.51 (s, 3 H, CH3), 
2.61 (s, 3 H, CH3), 3.24 (t, 2 H, J = 7.8 Hz, CH2), 3.66 (t, 2 H, J = 6.1 Hz, CH2), 6.97 (s, 1 
H, CH), 7.49 (d, 2 H, J = 8.0 Hz, ArH), 8.37 (d, 2 H, J = 8.4 Hz, ArH), 10.76 (s, 1 H, 
OH); 13C NMR (75 MHz, CDCl3): δ = 16.5, 18.9, 20.8 (CH3), 34.2, 41.8 (CH2), 119.1 
(C), 119.7 (CH), 126.5, (2C CH), 128.2 (C), 129.8, (2C CH), 139.2, 141.3,144.5, 145.5, 
160.0 (C); IR (KBr): ~ν  = 3194 (m), 2955 (w), 2853 (w), 1605 (m), 1565 (m), 1462 (m), 
1239 (s), 1124 (s), 1085 (s), 811 (m), 685 (s), 548 (m), 555 (s), cm−1; GC-MS (EI, 70 
eV): m/z (%): 384 (M+, 81Br, 20) 382 (M+, 79Br, 29),, 303 (25), 289 (100), 197 (12), 
133(27), 91 (13), 65 (10); HRMS (EI): calcd. for C17H19O3BrS [M+, 79Br]: 382.02328, 
found: 382.02340. 
4-(2-Iodoethyl)-3,5-dimethyl-2-[(4-methylphenyl)sulfonyl]phenol (4f): Starting with 
3b (400 mg, 1.3 mmol), n-Bu4NI (461 mg, 1.3 mmol), CH2Cl2 (9.5 mL) and BF3⋅OEt2
(0.08 mL, 0.6 mmol), 4f was isolated (520 mg, 84%) as a colourless solid, mp = 136−139 
°C; 1H NMR (300 MHz, CDCl3): δ = 2.23 (s, 3 H, CH3), 2.29 (s, 3 H, CH3), 2.40 (s, 3 H, 
CH3), 2.94−2.98 (m, 2H, CH2), 3.03−3.07 (m, 2 H, CH2), 6.75 (s, 1 H, CH), 7.30 (d, 2 H, 
J = 7.8 Hz, ArH), 7.70 (d, 2 H, J = 8.4 Hz, ArH), 10.47 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 0.0 (CH2I), 15.6, 19.9, 20.7 (CH3), 33.4 (CH2), 118.1 (C), 118.4 (CH), 126.7 
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(2C CH), 128.9 (2C CH), 130.8, 135.9, 138.3, 143.7, 144.2. 155.0 (C); IR (KBr): ~ν  = 
3206 (m), 2900 (s), 1597 (s), 1562 (s), 1493 (m), 1348 (m), 1259 (m), 1166 (w), 1125 (s), 
709 (s), 696 (s), 648 (w), 523 (m), cm−1; GC-MS (EI, 70 eV): m/z (%): 430 (M+, 7), 303 
(100), 289 (10), 209 (7), 133(10), 91 (18), 77 (8); HRMS (EI): calcd. for C17H19O3IS 
[M+]: 430.00872, found 430.00864.  
8-Hydroxy-4,8-dimethyl-5-cyanospiro[2.5]oct-4-en-6-one (6): Starting with n-BuLi 
(48.8 mL, 122.0 mmol, 2.5 M solution in hexane), diisopropylamine (17.2 mL, 122.0 
mmol), 1,1-diacetylcyclopropane (2) (7.70 g, 61.4 mmol), and 5-methylisoxazole (5) 
(5.00 g, 61.4 mmol) in THF (134 mL), 6 was isolated as yellow oil  (4.80 g, 41%);  1H 
NMR (300 MHz, CDCl3): δ = 0.94−1.07 (m, 2 H, CH2), 1.25−1.32 (m, 1 H, CH2), 1.22 
(s, 3 H, CH3), 1.61−1.68 (m, 1 H, CH2), 2.03 (s, 3 H, CH2), 2.69 (d, 2 H, J = 5.7 Hz, 
CH2); 13C NMR (62 MHz, CDCl3): δ = 12.1, 13.7 (CH2), 19.6, 25.4 (CH3), 34.2 (C), 51.0 
(CH2), 70.1 (C), 114.1 (CN), 128.7, 171.9, 191 (C); IR (neat): ~ν  = 3488 (m), 2969 (w), 
2931 (w), 2228 (m), 1678 (s), 1573 (m), 1383 (s), 1295 (s), 1164 (w), 1089 (m), 965 (w), 
740 (w) cm−1; -MS (CI, 70 eV): m/z (%) 191 ( [M+1]+),100), 148 (11.21), 125 (7), 74 (6); 
HRMS (CI): calcd. for C11H13O2N ([M+1]+ ): 191.09408, found: 191.093758.  
4-(2-Chloroethyl)-3,5-dimethyl-2-cyanophenol (7a): Starting with 6 (300 mg, 1.6 
mmol), n-Bu4NCl (436 mg, 1.6 mmol), CH2Cl2 (11.9 mL) and BF3⋅OEt2 (0.10 mL, 0.8 
mmol), 7a was isolated (205 mg, 64%) as a colourless solid, mp = 124−126 °C; 1H NMR 
(300 MHz, acetone-d6): δ = 2.40 (s, 3 H, CH3), 2.54 (s, 3 H, CH3), 3.20−3.25 (m, 2 H,
CH2), 3.64−3.68 (m, 2 H, CH2), 6.92 (s, 1 H, CH), 9.90 (s, 1 H, OH); 13C NMR (62 MHz, 
CDCl3): δ = 18.2, 20.7 (CH3), 29.7, 43.1 (CH2), 100.0 (C), 116.2 (CH), 116.6, 129.0, 
142.1, 146.6, 159.3 (C); IR (KBr): ~ν  = 3194 (s), 2961 (w), 1605 (s), 1566 (m), 1463 (s), 
1350 (m), 1240 (m), 1224 (s), 684 (s), 555 (m), cm−1; GC-MS (EI, 70 eV): m/z (%): 211 
(M+, 37Cl, 5), 209 (M+, 35Cl, 13),  160 (100), 77 (5); HRMS (EI): calcd.for C11H12ONCl 
[M+ , 35Cl]: 209.06019, found: 209.06040. 
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4-(2-Bromoethyl)-3,5-dimethyl-2-cyanophenol (7b): Starting with 6 (400 mg, 2.0 
mmol), n-Bu4NBr (674 mg, 2.0 mmol), CH2Cl2 (15.2 mL) and BF3⋅OEt2 (0.13 mL, 1.0 
mmol), 7b was isolated (142 mg, 67%) as a colourless solid; 1H NMR (300 MHz, 
acetone-d6): δ = 2.57 (s, 3 H, CH3), 2.71 (s, 3 H, CH3), 3.40 (t, 2 H, J = 7.6 Hz, CH2), 
3.72 (t, 2 H, J = 7.4 Hz, CH2), 6.98 (s, 1 H, CH), 9.82 (s, 1 H, OH); 13C NMR (62 MHz, 
CDCl3): δ = 18.1, 20.6 (CH2), 30.7, 33.4 (CH3), 100.4 (C), 116.2 (CH), 116.6, 129.0, 
142.0, 144.6, 159.3 (C); IR (KBr): ~ν  = 2958 (m), 2928 (m), 2858 (m), 1728 (s), 1464 
(m), 1286 (s), 1124 (m), 1073 (w), 742 (m), 704 (w), cm−1; GC-MS (EI, 70 eV): m/z (%): 
255 (M+, 81Br, 15), 253 (M+, 79Br, 16), 174 (49), 160 (100), 77 (6); HRMS (EI): calcd. for 
C11H12ONBr [M+, 79Br]: 253.00968, found: 253.00949.  
4-(2-Iodoethyl)-3,5-dimethyl-2-cyanophenol (7c): Starting with 6 (400 mg, 2.0 mmol), 
n-Bu4NI (738 mg, 2.0 mmol), CH2Cl2 (15.2 mL) and BF3⋅OEt2 (0.13 mL, 1.0 mmol), 7c
was isolated (475 mg, 75%) as a colourless solid, mp = 185−188 °C; 1H NMR (300 MHz, 
acetone-d6): δ = 2.50 (s, 3 H, CH3), 2.64 (s, 3 H, CH3), 3.34−3.38 (m, 2H, CH2), 
3.43−3.47 (m, 2 H, CH2), 6.89 (s, 1 H, CH), 9.85 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 2.7 (CH2), 18.5, 20.9 (CH3), 35.1 (CH2), 100.0 (C), 116.6 (CH), 117.6, 
131.6, 141.9, 144.5, 159.6 (C); IR (KBr): ~ν  = 3223 (s), 2923 (w), 2232 (s), 1598 (s), 
1443 (m), 1312 (m), 1168 (m), 1090 (w), 867 (m), 705 (w), cm−1; GC-MS (EI, 70 eV): 
m/z (%): 300 (M+, 5), 174 (100), 160 (18), 77 (5); HRMS (EI): calcd. for C11H12ONI 
[M+]: 300.99581, found: 300.995296. 
8-Hydroxy-4,8-dimethylspiro[2.5]oct-4-en-6-one (9): Starting with n-BuLi (28.6 mL, 
57.2 mmol, 2.5 M solution in hexane), diisopropylamine (8.6 mL, 57.2 mmol), 1,1-
diacetylcyclopropane (2) (7.70 g, 61.4 mmol), and diethyl 2-oxophosphonate 8 (5.55 g, 
28.6 mmol) in THF (62ml), 9 was isolated as gummy compound (2.20 g, 29%); 1H NMR 
(300 MHz, CDCl3): δ = 0.76−0.80 (m, 1 H, CH2), 0.97−1.02 (m, 2 H, CH2), 1.22 (s, 3 H, 
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CH3), 1.34−1.38 (m, 1 H, CH2), 1.68 (s, 3 H, CH3), 2.54 (d, 2 H, J = 15.8 Hz, CH2), 2.65 
(d, 2 H, J = 15.8 Hz, CH2); 13C NMR (62 MHz, CDCl3): δ = 9.0, 10.2 (CH2), 19.9, 25.3 
(CH3), 32.1 (C), 51.8 (CH2), 72.5 (C), 126.5 (CH), 161.5, 198.4 (C); IR (neat): ~ν  = 3403 
(s), 2975 (m), 1648 (s), 1604 (s), 1444 (m), 1387 (m), 1286 (m), 1144 (m), 1028 (m), 963 
(m), 860 (m), 641 (w) cm−1; GC-MS (EI, 70 eV): m/z (%): 166 (M+, 41), 148 (50), 138 
(40), 123 (38), 107 (85), 79 (100), 43 (85); HRMS (EI): calcd. for C10H14O2 [M+]: 
166.09883, found: 166.09916. 
4-(2-Chloroethyl)-3,5-dimethylphenol (10a): Starting with 9 (334 mg, 2.0 mmol), n-
Bu4NCl (554 mg, 2.0 mmol), CH2Cl2 (16 mL) and BF3⋅OEt2 (0.25 mL, 2.0 mmol), 10a
was isolated (170 mg, 68%) as a colourless solid; 1H NMR (300 MHz, CDCl3): δ = 2.22 
(s, 6 H, CH3), 2.98−3.02 (m, 2 H, CH2), 3.38−3.43 (m, 2 H, CH2), 6.43 (s, 2 H, CH); 13C 
NMR (75 MHz, CDCl3): δ = 19.2 (2C, CH3), 30.1, 42.4 (CH2), 115.0 (2C, CH), 126.9 
(C), 138.2 (2C, C), 153.8 (C); IR (KBr): ~ν  = 3355 (m), 3423 (s), 2920 (m), 1712 (m), 
1621 (s), 1582 (m), 1449 (s), 1315 (m), 1180 (m), 1161 (s), 1112 (w), 834 (m), cm−1; GC-
MS (EI, 70 eV): m/z (%):186 (M+, 37Cl, 17), 184 (M+, 35Cl, 13) 148 (6), 135 (100), 105 
(10), 91 (14), 77 (9); HRMS (EI): calcd. for C10H13OCl [M+,35Cl]: 184.05432, found: 
184.05631. 
4-(2-bromoethyl)-3,5-dimethylphenol (10b): Starting with 8-hydroxy-4,8-
dimethylspiro[2.5]oct-4-en-6-one (9) (180 mg, 1.0 mmol), n-Bu4NBr (322 mg, 1.0 
mmol), CH2Cl2 (7.6 mL) and BF3⋅OEt2 (0.074 mL, 1.0 mmol), 10b was isolated (170 mg, 
68%) as a colourless solid, mp = 76−79 °C;1H NMR (300 MHz, CDCl3): δ = 2.21 (s, 6 H, 
CH3), 3.12 (t, 2H, J = 6.3 Hz, CH2), 3.34 (t, 2 H, J = 6.5 Hz, CH2), 6.40 (s, 2 ×1 H, CH); 
13C NMR (62 MHz, CDCl3): δ = 19.2 (2C, CH3), 30.0, 32.7 (CH2), 115.2 (2C, CH), 
126.9 (C), 138.2 (2C, C), 153.8 (C); IR (KBr): ~ν  = 3314 (s), 2966 (S), 2855 (w), 1596 
(s), 1475 (s), 1318 (m), 1213 (w), 1191 (m), 1138 (s), 1025 (s), 852 (m), 633 (s), cm−1; 
GC-MS (EI, 70 eV): m/z (%): 230 (M+, 81Br, 18), 228 (M+, 79Br, 19), 149 (60), 135 (100), 
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105 (10), 91 (16), 77 (10); HRMS (EI): calcd. for C10H13OBr [M+ 79Br]: 228.01444, 
found: 228.01429. 
4-(2-Iodoethyl)-3,5-dimethylphenol (10c): Starting with 9 (135 mg, 0.8 mmol), n-
Bu4NI (298 mg, 0.8 mmol), CH2Cl2 (6.1 mL) and BF3⋅OEt2 (0.10 mL, 0.8 mmol), 10c
was isolated (170 mg, 68%) as a colourless solid, mp = 69−72 °C; 1H NMR (250 MHz, 
CDCl3): δ = 2.23 (s, 6 H, CH3), 3.01 (t, 2 H, J = 4.7 Hz, CH2), 3.06 (t, 2 H, J = 4.7 Hz, 
CH2), 6.40 (s, 2 H, CH); 13C NMR (62 MHz, CDCl3): δ = 0.00 (CH2) 17.7 (2C, CH3), 
32.1 (CH2), 112.6 (2C, CH), 128,1 (C), 135.8 (2C, C), 151.1 (C); IR (KBr): ~ν  = 3362 (s), 
3402 (S), 2960 (w), 1705 (m), 1606 (s), 1595 (m), 1460 (s), 1312 (s), 1190 (m), 1166 (s), 
1133 (s), 1024 (s), 850 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 276 (M+, 8), 149 (100), 
135 (21), 105 (10), 91 (13), 77 (9); HRMS (EI): calcd. for C1oH13OI [M+]: 276.00056, 
found: 276.07548. 
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                                                                                          Chapter  2 
Synthesis and Reactions of Hydroxyspiro[5.2]cyclo-octenones based on 
the Cyclization of the Dianions of Acetone and of Diethyl 2-
Oxopropylphosphonate with 1,1-Diacylcyclopropanes. 
                                                                         Tetrahedron Lett. 2008, submitted 
2.1 Introduction  
Spirocyclopropanes are present in a number of pharmacologically interesting natural 
products, such as the cytotoxic illudins (Figure 1)1 CC-1065 and duocarmycin SA.2 The 
illudins belong to the group of alkylating anticancer agents. The reaction of a nucleophile 
(such as glutathione) with the unsaturated ketone moiety results in formation of a 
cyclohexadiene which rapidly undergoes an aromatization with concurrent ring opening 
of the cyclopropane moiety and alkylation of the DNA.1 Recently, we have reported the 
TiCl4-mediated domino [3+3]-cyclization-homo-Michael reaction of 1,3-bis(silyl enol 
ethers) with 1,1-diacylcyclopropanes.3 These reactions proceed by in situ formation of a 
spiro[2.5]cycloocta-4,7-dien-6-one which is subsequently cleaved by the action of TiCl4.  
2.2 Results and Discussion 
In their pioneering work, Baird and Winstein studied the synthesis of spiro[2.5]cycloocta-
4,7-dien-6-ones and their reaction with various nucleophiles.4 Padwa and coworkers 
reported interesting cyclization reactions of diazo compounds which allow a convenient 
synthesis of illudins.5 We reported6 the synthesis of ester-substituted 1-
hydroxyspiro[5.2]cyclooct-4-en-3-ones, precursors of spiro[2.5]cycloocta-4,7-dien-6-
ones, based on cyclization reactions of 1,3-dicarbonyl dianions. The homo-Michael 
reaction of these highly activated7 spirocyclopropanes, which exhibit a considerable
antiproliferative activity against human leukemia HL60 cells, with various nucleophiles 
results in the formation of functionalized phenols. This transformation is related to the 
biosynthesis of the carcinogenic pterosins (Figure 1) which were isolated from the 
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bracken fern Pteridium aquilinium.9 It was shown earlier that the pterosins are formed 
from their direct biogenetic precursor, the spirocyclopropane ptaquilosin, by treatment 
with acid. It was proposed that the pterosins, ptaquilosin and illudin M are all formed 
from farnesyl phosphate via a common biosynthetic intermediate.1,9 Herein, we report 
what are, to the best of our knowledge, the first cyclizations of the dianions of diethyl 2-
oxopropylphosphonate and of acetone with 1,1-diacylopropanes. These reactions provide 
a convenient access to regioisomeric hydroxyspiro[5.2]cyclooctenones. Homo-Michael 
reactions of these products with tetrabutylammonium halides allow for a convenient 
synthesis of functionalized phenols which are not readily available by other methods. 
OH
Me
Me
Me
HO
Me
O
Illudin M
Me
Me
X
O
OH
Me
R
Pterosins
X = OH, OMe, Cl
R = H, Me
Figure 1 
The cyclization of the dianion10 of diethyl 2-oxopropylphosphonate (1), generated by 
means of LDA, with 1-acetyl-1-benzoylcyclopropane (2b) afforded the novel 1-
hydroxyspiro[5.2]cyclooct-4-en-3-ones and 3, respectively (Scheme 1). The formation of 
3 can be explained by cyclization (intermediate A), elimination of lithium 
diethylphosphate (intermediate B) and subsequent protonation upon addition of water. 
The reaction can be regarded as a domino ′aldol / Horner-Wadsworth-Emmons (HWE)′
reaction.  
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Scheme 1. Synthesis of spirocyclopropanes 3; i: 1) LDA (2.0 equiv), 1 (1.0 equiv), THF, 
1 h 0 °C, 2) 2,b (1.0 equiv), −78 → 20 °C, 14 h 
The BF3⋅OEt2-mediated reaction of 3 with tetrabutylammonium halides afforded the 
phenols 4a-c containing a halogenated side chain (Scheme 2, Table 1). Products 4a-c
were presumably formed by BF3⋅OEt2-mediated elimination of water to give a highly 
reactive spiro[2.5]cycloocta-4,7-dien-6-one (intermediate C). The cyclopropane moiety is 
subsequently cleaved by BF3⋅OEt2-mediated attack of the halide ion to give a phenolate 
(intermediate D), which is protonated upon addition of water (aqueous work-up). 
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Scheme 2. Reaction of 3 with nBu4NX; i: nBu4NX (1.0 equiv), BF3⋅OEt2  (0.5 equiv.), –78 → 20 
°C, 12 h 
                                         Table 1. Synthesis of phenols 4a-f  
4 R X  % a
a Ph Cl 70 
b Ph Br 75 
c Ph I 81 
                                                                a Yields of isolated products 
The cyclization of 1,1-diacylcyclopropanes 2a-d with the dianion11 of acetone (5), 
generated by addition of 5 to a THF-suspension of potassium hydride and subsequent 
addition of TMEDA and nBuLi, afforded the 1-hydroxyspiro[5.2]cyclooct-3-en-5-ones 
6a-d (Scheme 3).14 The unexpected formation 6a-d, which are regioisomers of products 
3a,b, can be explained as follows: the reaction of dianion E with  2a-d afforded 
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intermediate F which was transformed, by protonation and deprotonation, into 
intermediate G. The latter underwent a cyclization to give H which afforded 6a-d upon 
aqueous work-up. Products 6b-d were formed by regioselective attack of dianion E onto 
the aroyl rather than the acetyl group of 2b-d.  
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Me
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Me
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O
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O R
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O MeK+
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H2O
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Me
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K+, Li+
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_
_
_
_
i
_ _
6a-d
Scheme 3. Synthesis of 6a-d; i: 1) KH, THF, 0 °C; 2) nBuLi, TMEDA, -20 °C; 3) 2a-d –30 → 15 
°C, 15  
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                                     Table 2. Synthesis of spirocyclopropanes 6a-d 
6 R   % a
a Me 41 
b Ph 33 
c 4-ClC6H4 31 
d 4-FC6H4 30 
                                                       a Yields of isolated products 
The BF3⋅OEt2-mediated reaction of 6a with tetrabutylammonium halides afforded the 
phenols 7a-c (Scheme 4, Table 3). 12 Their formation can be explained by a mechanism 
related to the one discussed for 4a-f (vide supra). The structure of 7a was independently 
confirmed by X-ray crystal structure analysis (Figure 2).13 The BF3⋅OEt2-mediated 
reaction of 6b with tetrabutylammonium chloride resulted in the formation of the 
halogen-free 10-membered cyclic diether 8b in 66% yield. The employment of 
tetrabutylammonium bromide and iodide afforded 8b in 63 and 79% yield, respectively. 
The formation of 8b can be explained by dimerization of intermediate I. The reaction of 
spirocyclopropane 6c with tetrabutylammonium bromide afforded a separable mixture of 
phenol 7g (30%) and dimer 8c (51%). The employment of tetrabutylammonium iodide 
resulted in the formation of phenol 7h and dimer 8c in 33 and 59% yield, respectively. 
The reaction of spirocyclopropane 6d with tetrabutylammonium chloride gave 
exclusively dimer 8d (50%), whereas phenol 7j (41%) was isolated when 
tetrabutylammonium iodide was used. In conclusion, the product distribution seems to 
depend on the substituent R and on the tetraammonium halide employed. 
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Scheme 4. Reaction of 6a-d with nBu4NX; i: nBu4NX (1.0 equiv), BF3⋅OEt2  (0.5 equiv.), 
–78 → 20 °C, 12 h  
                        Table 3. Synthesis of phenols 7 and their dimers 8 
7 8 R X  % (7) a  % (8) a
a a Me Cl 65 0 
b a Me Br 77 0 
c a Me I 81 0 
d b Ph Cl 0 66 
e b Ph Br 0 63 
f b Ph I 0 79 
g c 4-ClC6H4 Br 30 51 
h c 4-ClC6H4 I 33 59 
i d 4-FC6H4 Cl 0 50 
j d 4-FC6H4 I 41 0 
                                 a Yields of isolated products 
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Figure 2. Ortep plot of 7a
In conclusion, the cyclization of 1,1-diacylopropanes with the dianions of diethyl 2-
oxopropylphosphonate and acetone afforded hydroxyspiro[5.2]cyclooctenones which 
were transformed, by homo-Michael reactions, into functionalized phenols or their 
dimers. The preparative scope and applications of the methodology reported is currently 
being studied. 
2.3 Experimental Section. 
Typical procedure for the cyclization of 1,3-dicarbonyl dianions with 1-acetyl-1-
benzoylcyclopropane. A THF solution (27 ml) of LDA was prepared by addition of 
nBuLi (9.8 ml, 24.7 mmol, 2.5 M solution in hexane) to a THF solution of 
diisopropylamine (3.48 ml, 24.7 mmol) at 0 °C. After stirring for 1 h, diethyl 2-
oxopropylphosphonate 1 (2.4g, 12.37mmol) was added at –78 °C and the solution was 
stirred for 1 h. To the solution was added 1-acetyl-1-benzoylcyclopropane.  (2) (2.32g, 
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12.37 mmol) at –78 °C and the solution was allowed to warm to 20 °C during 14 h. To 
the reaction mixture was added an aqueous solution of HCl (1 M) and the organic and 
aqueous layers were extracted with CH2Cl2 and the combined organic layers were washed 
with brine, dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The 
residue was purified by chromatography (silica gel, hexane/EtOAc) to give 3 as a yellow 
solid (850mg, 30%). 
8-Hydroxy-4-methyl–8-phenylspiro[2.5]oct-4-en-6-one (3): 1H NMR (250 MHz, 
CDCl3): δ = 0.79 (m, 1 H, CH2), 0.99 (m, 1 H, CH2), 1.13 (m, 1 H, CH2), 1.25 (m, 1 H, 
CH2), 1.34 (s, 3 H, CH3), 2.60.(d, 1 H, J = 16.1 Hz, CH2), 2.76.(d, 1 H, J = 15.8 Hz, CH2), 
5.88 (s, 1 H, CH), 7.0 (m, 2 H, ArH), 7.30 (m, 2 H, ArH);  13C NMR (62 MHz, CDCl3): δ
= 9.1, 9.4 (CH2), 25.4 (CH3), 35.2(C), 51.1 (CH2), 74.3(C), 126.7 (CH), 127.5 (ArCH), 
127.9 (2C, ArCH), 128.4 (2C, ArCH), 143.4, 157.2, 198.2 (C);  IR (Neat): ν~ = 3395 (S), 
3056 (w), 2932(w), 1643 (s), 1442 (m), 1363 (s), 1268 (s), 1118 (s), 1030 (m), 700 (s), 
587 (s) cm−1; GC-MS (CI, 70 eV): m/z (%): 228(M+, 74), 213 (17), 145 (34), 131 (24), 
115 (17), 105 (100), 83 (8), 77 (62);  HRMS (CI): calcd (%) for C15H16O2 [M+] 
228.11448, found 228.114140. 
4-(2-Chloroethyl)-3-phenyl-5-methylphenol (4a): Starting with 3 (300 mg, 1.3  mmol), 
n-BuN4Cl (360 mg, 1.3 mmol), CH2Cl2 (9.8 ml) and BF3.OEt2 (0.16 ml, 1.3 mmol), 4a
was isolated (225 mg, 70%) as a gummy compound; 1H NMR (250 MHz, CDCl3): δ = 2. 
28 (s, 3 H, CH3), 2.96 (t, 2H, J = 7.8 Hz, CH2),  3.14 (t, 2 H, J = 7.7 Hz, CH2), 4.76 (s, 1 
H, OH); 6.46 (s, 1 H, ArH), 6.62 (s, 1 H, ArH), 7.16 (m, 2 H, ArH), 7.32 (m, 3 H, ArH), 
13C NMR (62 MHz, CDCl3): δ = 20.4 (CH3), 30.2, 33.5 (CH2), 115.2, 116.2, (ArCH), 
126.3 (C),  127.2 (ArCH), 128.2 (2C, ArCH), 128.7 (2C, ArCH), 138.6, 141.2, 144.2, 
153.5 (C); IR (Neat): ν~ = 3371 (w), 2921 (m), 2851 (w), 1711 (w), 1589 (s), 1283 (s), 
1176 (s), 1027 (w), 762 (s), 701 (m), cm−1; GC-MS (EI, 70 eV): m/z (%): 248 (M+, 37Cl, 
10), 246 (M+, 35Cl, 29), 197 (100), 182 (31), 165 (29), 152 (9);  HRMS (EI): calcd (%) 
for C15H15OCl [M+, 35Cl] 246.08059, found 246.08046 
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4-(2-Bromoethyl)-3-phenyl-5-methylphenol (4b): Starting with 3 (300 mg, 1.3 mmol), 
n-BuN4Br (418 mg, 1.3 mmol), CH2Cl2 (9.8 ml) and BF3.OEt2 (0.16 ml, 1.3 mmol), 4b
was isolated (288 mg, 75%) as a gummy compound; 1H NMR (250 MHz, CDCl3): δ = 2. 
29 (s, 3 H, CH3), 2.96 (t, 2H, J = 7.8 Hz, CH2), 3.12 (t, 2 H, J = 7.6 Hz, CH2), 4.78 (s, 1 
H, OH); 6.46 (s, 1 H, ArH), 6.61 (s, 1 H, ArH), 7.17 (m, 2 H, ArH), 7.33 (m, 3 H, ArH), 
13C NMR (62 MHz, CDCl3): δ = 20.4 (CH3), 30.7, 33.1 (CH2), 114.8, 116.6, 127.2 
(ArCH), 127.5 (C), 128.2 (2C, ArCH), 128.9 (2C, ArCH), 138.6, 141.4, 144.3, 153.5 (C); 
IR (Neat): ν~ = 3418 (w), 2945 (m), 2852 (w), 1587 (s), 1317 (s), 1287 (m), 1197 (s), 
1025 (m), 742 (s), 626 (m), cm−1; GC-MS (EI, 70 eV): m/z (%):292 (M+, 81Br, 26), 290 
(M+, 79Br, 26), 211 (28), 197 (100), 182 (36), 165 (23), 115 (10);  HRMS (EI): calcd (%) 
for C15H15OBr [M+, 79Br] 290.03008, found 290.03085. 
4-(2-Iodoethyl)-3-phenyl-5-methylphenol (4c): Starting with 3 (300 mg, 1.3 mmol), n-
BuN4I (479 mg, 1.3 mmol), CH2Cl2 (9.8 ml) and BF3.OEt2 (0.16 ml, 1.3 mmol), 4c was 
isolated (360 mg, 81%) as a gummy compound; 1H NMR (250 MHz, CDCl3): δ = 2. 26 
(s, 3 H, CH3), 2.87 (t, 2H, J = 7.4 Hz, CH2),  3.01 (t, 2 H, J = 7.7 Hz, CH2), 4.79 (s, 1 H, 
OH); 6.43 (s, 1 H, ArH), 6.60 (s, 1 H, ArH), 7.15 (m, 2 H, ArH), 7.31 (m, 3 H, ArH), 13C 
NMR (62 MHz, CDCl3): δ = 3.1 (CH2), 20.1 (CH3), 34.4 (CH2), 115.0, 116.6, 127.3 
(ArCH), 128.2 (C), 128.6 (2C, ArCH), 129.9 (2C, ArCH), 138.3, 141.4, 143.3, 153.3 (C); 
IR (Neat): ν~ = 3441 (m), 3056 (m), 2850 (w), 1692 (w1128 (s),), 1587 (s), 1450 (s), 1312 
(s), 1280 (s), 1171 (s), 1128 (s), 108 (s), 871 (s), 705 (s); cm−1; GC-MS (EI, 70 eV): m/z
(%):338 (M+, 8), 211 (100), 196 (17), 197 (100), 181 (20), 165 (18), 115 (5);  HRMS 
(EI): calcd (%) for C15H15OI [M+] 338.01621, found 338.01547. 
Typical procedure for the cyclization of 1,3-dicarbonyl dianions with 1,1-
diacetylcyclopropane A Diethylether (25 ml) solution of KH (2.85 g, 70 ml), To the 
solution was added a diethylether solution (25 ml) of acetone (4.4 ml, 60 mmol) at 0°C in 
20 minutes.  The temperature was allowed to rise for short period, the mixture of nBuLi 
(24 ml, 60  mmol, 2.5M solution in hexane) and TMEDA (6.96g) were added the reaction 
mixture at -20°C in 10 minutes. Now warmed the reaction mixture at 0°C for short 
43
period, and added the 1, 1-diacetylcyclopropane 6a (1.89 g, 15 mmol) at -30°C. Again 
temperature was allowed to rise to ambient during 15h, and the solution was stirred at 
15°C for 15h. The reaction mixture was poured into (10ml) acetic acid and 50 ml ice 
water, organic and aqueous layers were extracted with CH2Cl2 and the combined organic 
layers were washed with brine, dried (Na2SO4), filtered, and the filtrate was concentrated 
in vacuo. The residue was purified by chromatography (silica gel, hexane/EtOAc) to give 
6a as a yellow solid (1020 mg, 41%). 
8-Hydroxy–6,8-dimethylspiro[2.5]oct-5-en-4-one  (6a): 1H NMR (250 MHz, CDCl3): δ
= 0.85 (m, 1 H, CH2), 0.99 (m, 1 H, CH2), 1.10 (m, 1 H, CH2), 1.20 (S, 3 H, CH3), 1.24 
(m, 1 H, CH2), 1.99 (s, 3 H, CH3), 2.42.(d, 1 H, J = 15.74 Hz, CH2), 2.61.(d, 1 H, J = 
15.83 Hz, CH2), 5.88 (s, 1 H, CH); 13C NMR (62 MHz, CDCl3): δ = 11.1, 12.2 (CH2), 
24.5, 25.1 (CH3), 35.8 (C), 41.1 (CH2), 71.1 (C), 125.6 (CH), 155.0, 198.4 (C); IR (KBr): 
ν~ = 3419 (S), 2974 (w), 2932(w), 1647 (m), 1437 (s), 1381 (m), 1360 (m), 1328 (s), 1225 
(s), 1197 (s), 876 (s) cm−1; GC-MS (CI, 70 eV): m/z (%): 166 (M+, 19), 151 (100), 123 
(37), 111 (24), 123 (37), 83 (25), 69 (30), 43 (42);  HRMS (CI): calcd (%) for C10H14O2
[M+] 166.09883, found 166.09862. 
8-Hydroxy–6-methyl–8-phenylspiro[2.5]oct-5-en-4-one  (6b): 1H NMR (250 MHz, 
CDCl3): δ = 0.85 (m, 1 H, CH2), 1.1 (m, 1 H, CH2), 1.25 (m, 1 H, CH2), 1.60 (m, 1 H, 
CH2), 1.70 (s, 3 H, CH3), 2.78.(d, 1 H, J = 15.7 Hz, CH2), 2.92.(d, 1 H, J = 15.8 Hz, CH2), 
5.88 (s, 1 H, CH), 7.2 (m, 2 H, ArH), 7.56 (m, 2 H, ArH); 13C NMR (62 MHz, CDCl3): δ
= 12.1, 12.6 (CH2), 24.2 (CH3), 35.2 (C), 52.3 (CH2), 74.3(C), 126.7 (CH), 127.5 
(ArCH), 127.9 (2C, ArCH), 128.3 (2C, ArCH), 143.4, 157.2, 198.2 (C);  IR (Neat): ν~ = 
3392 (S), 3056 (w), 2912(w), 1613 (s), 1442 (s), 1366 (s), 1262 (s), 1158 (s), 1020 (m), 
701 (s), 582 (s) cm−1; GC-MS (CI, 70 eV): m/z (%): 228(M+, 74), 213 (17), 145 (32), 131 
(24), 115 (13), 105 (100), 82 (8), 77 (64); HRMS (CI): calcd (%) for C15H16O2 [M+] 
228.11448, found 228.114140. 
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8-4(-Chlorophenyl)-8-hydroxy–6-methylsprio[2.5]oct-5-en-4-one ( 6c): 1H NMR (250 
MHz, CDCl3): δ = 0.66 (m, 1 H, CH2), 0.99 (m, 1 H, CH2), 1.0 (m, 1 H, CH2), 1.16 (m, 1 
H, CH2), 1.79 (s, 3 H, CH3), 2.67.(d, 1 H, J = 16.4Hz, CH2), 2.84.(d, 1 H, J = 15.2 Hz, 
CH2), 5.74 (s, 1 H, CH), 7.13 (d, 2 H, J = 8.6 Hz, ArH), 7.28 (m, 2 H, J = 7.8 Hz, ArH);  
13C NMR (62 MHz, CDCl3): δ = 10.7, 11.8 (CH2), 19.5 (CH3), 38.3 (C), 45.5 (CH2), 77 
(C),  126.4 (CH), 128.1 (2C, ArCH), 128.9 (2C, ArCH), 133.7, 142.2, 164.3, 208.4 (C);  
IR (Neat): ν~ = 3380 (S), 2972 (w), 2932(w), 1643 (s), 1433 (s), 1378 (s), 1358 (m), 1186 
(s), 1091 (s), 827 (s), 705 (s) cm−1; GC-MS (CI, 70 eV): m/z (%): 264 (M+, 37Cl, 9), 262 
(M+, 35Cl, 29), 227 (163), 180 (31), 165 (27), 145 (9), 139 (100), 111 (35), 83 (56), 39 
(20); HRMS (EI): calcd (%) for C15H15O2Cl [M+, 35Cl] 262.05051, found 262.06056. 
Typical procedure for the synthesis of functionalized phenols from 
spirocyclopropanes: To a CH2Cl2 solution (15 mL) of 8-hydroxy-6,8-
dimethylspiro[2.5]oct-5-en-4-one (6a) (334 mg, 2.0 mmol) and of nBu4NCl (554 mg, 2.0  
mmol) was dropwise added BF3OEt2 (0.24 mL, 2.0 mmol) at –78 °C under argon 
atmosphere. The solution was allowed to warm to 20 °C over 6 h and was stirred for 
additional 6 h at 20 °C. The solution was filtered and the filtrate was poured into 
hydrochloric acid (1.0 M). The organic and the aqueous layer were separated and the 
latter was extracted with CH2Cl2. The combined organic layers were washed with brine, 
dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue was 
purified by chromatography (silica gel, hexane/EtOAc) to give 7a as a colourless solid 
(242 mg, 65%). 
2-(2-Chloroethyl)-3,5-dimethylphenol (7a): 1H NMR (250 MHz, CDCl3): δ = 2.24(s, 3 
H, CH3), 2.30(s, 3 H, CH3), 3.11 (t, 2 H, J = 8.0 Hz, CH2), 3.67 (t, 2 H, J = 7.4 Hz, CH2), 
6.44 (s, 1 H, ArH), 6.61 (s, 1 H, ArH). 13C NMR (62 MHz, CDCl3): δ = 19.4 (CH3), 19.5 
(CH3), 30.2 (CH2), 43.2 (CH2), 113.8 (CH), 120.0 (C), 123.8 (CH), 137.5, 138.2, 153.8 
(C). IR (KBr): ν~ = 3350 (m), 3453 (S), 2870 (m), 1716 (s), 1632 (s), 1562 (m), 1439 (s), 
1325 (m), 1142 (m), 1152 (s), 1122 (w), 834 (m), cm−1. GC-MS (EI, 70 eV): m/z (%):  
186 (M+, 37Cl, 9), 184 (M+, 35Cl, 21), 148 (6), 135 (100), 105 (11), 91 (13), 77 (14). 
HRMS (EI): calcd.for C10H13OCl [M+,35Cl]: 184.06494, found 184.06527.  
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2-(2-Bromoethyl)-3,5-dimethylphenol (7b): Starting with 6a (278 mg, 1.67 mmol), n-
BuN4Br (539 mg, 1.67 mmol), CH2Cl2 (12.6 ml) and BF3.OEt2 (0.20 ml, 1.67 mmol), 7b
was isolated (295 mg, 77%) as a gummy compound; 1H NMR (250 MHz, CDCl3): δ = 2. 
22 (s, 3 H, CH3), 2.28 (s, 3 H, CH3), 3.18 (t, 2H, J = 7.6 Hz, CH2), 3.48 (t, 2 H, J = 7.5 
Hz, CH2), 4.76 (s, 1 H, OH); 6.43 (s, 1 H, ArH), 6.59 (s, 1 H, ArH), 13C NMR (75 MHz, 
CDCl3): δ = 19.4, 20.9 (CH3), 30.2, 31.0 (CH2), 113.8 (ArCH), 120.9 (C), 123.8 (ArCH), 
137.5, 138.0, 153.7 (C); IR (Neat): ν~ = 3390 (w), 2945 (m), 2858 (w), 1674 (m), 1584 
(m), 1444 (s), 1292 (w), 1128 (m), 741 (s), 704 (w), cm−1; GC-MS (EI, 70 eV): m/z
(%):230 (M+, 81Br, 22), 228 (M+, 79Br, 20), 149 (49), 135 (100), 105 (20), 91 (20), 77 
(11);  HRMS (EI): calcd (%) for C10H13OBr [M+, 79Br] 228.01443, found 228.01386. 
2-(2-Iodoethyl)-3,5-dimethylphenol (7c): Starting with 6a (216 mg, 1.30 mmol), n-
BuN4I (479 mg, 1.30 mmol), CH2Cl2 (9.8 ml) and BF3.OEt2 (0.16 ml, 1.30 mmol), 7c was 
isolated (295 mg, 81%) as a gummy compound; 1H NMR (250 MHz CDCl3,): δ = 2. 14 
(s, 3 H, CH3), 2.20 (s, 3 H, CH3), 3.12 (t, 2H, J = 7.5 Hz, CH2), 3.20(t, 2 H, J = 7.8 Hz, 
CH2), 4.74 (s, 1 H, OH); 6.43 (s, 1 H, ArH), 6.58 (s, 1 H, ArH), 13C NMR (62 MHz, 
CDCl3): δ = 3.3 (CH2), 19.4, 20.1 (CH3), 31.3 (CH2), 113.8 (ArCH), 123.1 (C), 123.8 
(ArCH), 136.6, 137.6, 153.4 (C); IR (Neat): ν~ = 3112 (w), 2916 (m), 1620 (m), 11442 
(s), 1296 (m), 1163 (s), 1117 (m), 841 (m), 601 (m), 577 (w), cm−1; GC-MS (EI, 70 eV): 
m/z (%):276 (M+, 12),  149 (100), 133 (13), 116 (8), 105 (8), 91 (16); HRMS (EI): calcd 
(%) for C10H13OI [M+] 276.00056, found 276.00076. 
4-(2-Bromoethyl)-3,5-dimethyl-2-cyanophenol (7g): Starting with 6c (288 mg, 
1.1mmol), n-BuN4Br (354 mg, 1.1 mmol), CH2Cl2 (8.3 ml) and BF3.OEt2 (0.13 ml, 1.1 
mmol), 7g was isolated (110 mg, 30%) as a solid, mp = 101-104 °C; 1H NMR (300 MHz, 
CDCl3): δ = 2. 29 (s, 3 H, CH3), 2.95 (t, 2H, J = 7.7 Hz, CH2),  3.12 (t, 2 H, J = 7.8 Hz, 
CH2), 4.68 (s, 1 H, OH); 6.42 (s, 1 H, ArH), 6.62 (s, 1 H, ArH), 7.09 (d, 2 H, J = 8.5 Hz, 
ArH), 7.32 (d, 2 H, J = 8.4 Hz, ArH); 13C NMR (62 MHz, CDCl3): δ = 20.1 (CH3), 30.4, 
33.0 (CH2), 114.9, 116.9 (ArCH), 127.4 (C), 128.4 (2C, ArCH), 130.1 (2C, ArCH), 
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133.3, 138.8, 139.8, 143.0, 153.6 (C); IR (Neat): ν~ = 3006 (w), 2918 (m), 2852 (w), 1722 
(w), 1582 (s), 1495 (s), 1386 (s), 1297 (w), 762 (s), 1001 (m), 978 (s), 824 (s), 569 (s), 
cm−1; GC-MS (EI, 70 eV): m/z (%): 326 (M+, 37Cl,81Br, 45), 324 (M+, 35Cl, 79Br, 35), 231 
(100), 210 (14), 196 (65), 181 (34);  HRMS (EI): calcd (%) for C15H14OClBr [M+, 35Cl, 
79Br] 324.05069, found 324.05076. 
4-(2-Bromoethyl)-3,5-dimethyl-2-cyanophenol (7h): Starting with 6c (288 mg, 1.1 
mmol), n-BuN4I (405 mg, 1.1 mmol), CH2Cl2 (8.6 ml) and BF3.OEt2 (0.3 ml, 1.1 mmol), 
7h was isolated (138 mg, 33%) as a solid, mp = 105-108 °C; 1H NMR (300 MHz, 
CDCl3): δ = 2.30 (s, 3 H, CH3), 2.81 (t, 2H, J = 7.5 Hz, CH2),  2.95 (t, 2 H, J = 7.8 Hz, 
CH2), 4.68 (s, 1 H, OH); 6.34 (s, 1 H, ArH), 6.61 (s, 1 H, ArH), 7.01 (d, 2 H, J = 8.5 Hz, 
ArH), 7.29 (d, 2 H, J = 8.4 Hz, ArH); 13C NMR (62 MHz, CDCl3): δ = 2.7 (CH2), 20.0 
(CH3), 34.0 (CH2), 114.9, 116.9 (ArCH), 128.4 (2C, ArCH), 129.7 (C), 130.0 (2C, 
ArCH), 133.3, 138.5, 139.8, 142.6, 153.5 (C); IR (Neat): ν~ = 3495 (w), 2954 (w), 1698 
(w), 1585 (m), 1448 (s), 1327 (m), 1287 (s), 1197 (s), 1162 (s), 1089 (s), 832 (s), 716 
(m), 536 (s), cm−1; GC-MS (EI, 70 eV): m/z (%): 374 (M+, 37Cl, 7), 372 (M+, 35Cl, 16), 
245 (100), 210 (50), 195 (44), 165 (24); HRMS (EI): calcd (%) for C15H14OICl [M+, 35Cl] 
372.01015, found 372.01001. 
3,10-Dimethyl-1,8-diphenyl-6,7,13,14-tetrahydroibenzo[b,g][1,6]dioxecine (8b):
Starting with 6b (613 mg, 2.6 mmol), n-BuN4Cl (744 mg, 2.6 mmol), CH2Cl2 (19.7 ml) 
and BF3.OEt2 (0.32 ml, 0.49 mmol), 8b was isolated (750 mg, 66%) as a solid, mp = 192-
196 °C; 1H NMR (250 MHz, CDCl3): δ = 2.27 (s, 3×2H, CH3), 3.15 (t, 2×2H, J = 8.6 Hz, 
CH2),  4.47 (t, 2×2H, J = 8.6 Hz, CH2),  6.56 (s, 2×1H, CH), 6.68 (s, 2×1H, CH), 7.22-
7.30 (m, 2×2H, ArH), 7.31-7.36 (m, 3×2H, ArH); 13C NMR (62 MHz, CDCl3): δ = 20.4 
(2C, CH3), 28.5 (2C, CH2), 70.3 (2C, CH2), 108.1 (2C, CH), 120.4 (2C, CH), 120.7 (2C, 
C), 126.0 (2C, ArCH), 127.0 (2×2C, ArCH),   127.5 (2×2C, ArCH), 137.3 (2C, C), 137.5 
(2C, C), 139.6 (2C, C), 159.6 (2C, C); IR (Neat): ν~ = 3435 (w), 2949 (s), 2867 (m), 2556 
(m), 2207 (m), 1719 (s), 1616 (s), 1450 (m), 1378 (s), 1119 (m), 1075 (m), 920 (m), 712 
(w), cm−1; 
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3,10-Dimethyl-1,8-diphenyl-6,7,13,14-tetrahydrobenzo[b,g][1,6]dioxecine (8b):
Starting with 6b (355 mg, 1.23 mmol), n-BuN4Br (395 mg, 1.23 mmol), CH2Cl2 (9.3 ml) 
and BF3.OEt2 (0.15 ml, 1.23 mmol), 8b was isolated (415 mg, 63%) as a solid, mp = 192-
196 °C. 
3,10-Dimethyl-1,8-diphenyl-6,7,13,14-tetrahydroibenzo[b,g][1,6]dioxecine (8b): 
Starting with 6b (371 mg, 1.28 mmol), n-BuN4I (472 mg, 1.28 mmol), CH2Cl2 (9.7 ml) 
and BF3.OEt2 (0.16 ml, 1.28 mmol), 8b was isolated (47 5 mg, 69%) as a solid, mp = 
192-196 °C. 
3,10-Dimethyl-1,8-bis(dichlorophenyl)-6,7,13,14-tetrahydroibenzo[b,g][1,6]dioxecine 
(8c): Starting with 6a (288 mg, 1.10 mmol), n-BuN4Br (354 mg, 1.1 mmol), CH2Cl2 (8.3 
ml) and BF3.OEt2 (0.13 ml, 1.10 mmol), 8c was isolated (179 mg, 50%) as a solid, mp = 
104-106 °C; 1H NMR (300 MHz, CDCl3): δ = 2.26 (s, 3×2H, CH3), 3.12 (t, 2×2H, J = 7.8 
Hz, CH2),  4.47 (t, 2×2H, J = 7.9 Hz, CH2),  6.50 (s, 2×1H, CH), 6.63 (s, 2×1H, CH), 7.99 
(m, 4×2H, ArH); 13C NMR (62 MHz, CDCl3): δ = 21.4 (2C, CH3), 29.5 (2C, CH2), 71.1 
(2C, CH2), 108.1 (2C, CH), 121.3 (2C, CH), 122.2 (2C, C), 128.5 (2×2C, ArCH), 129.3 
(2×2C, ArCH), 133.1 (2C, C), 137.2 (2C, C), 139.4 (2C, C), 160.0 (2C, C); IR (Neat): 
ν~ = 33350 (w), 2963 (w), 2853 (w), 1904 (w), 1703 (w), 1787 (s), 1452 (s), 1318 (m), 
1378 (s), 1280 (m), 1191 (s), 1090 (m), 831 (s), cm−1; 
3,10-Dimethyl-1,8-bis(dichlorophenyl)-6,7,13,14-tetrahydroibenzo[b,g][1,6]dioxecine 
(8c): Starting with 6c (288 mg, 1.1 mmol), n-BuN4I (405 mg, 1.1 mmol), CH2Cl2 (8.6 ml) 
and BF3.OEt2 (0.13 ml, 1.1 mmol), 8c was isolated (23 0 mg, 59%) as a solid, mp = 103-
106 °C. 
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                                                                                          Chapter 3  
Regioselective Synthesis of -Bromo3-ketosulfones, -Bromo-3- 
ketonitriles and 2-(-Bromoalkyl) benzo-furans based on a Ring-
Closing / Ring-Opening Strategy. 
                                                                                                          Tetrahedron 2007, 63, 11626-11635
                                                                       
3.1 Introduction 
Boron tribromide (BBr3) represents a widely used reagent for the cleavage of 
methoxyarenes.1 besides this well-known application of BBr3, other reactions have only 
scarcely been reported in the literature. -Bromoalcohols2 and -halocarboxylic acids3
were prepared by BBr3 mediated ring opening of cyclic ethers and lactones, respectively.3
Recently, we reported the synthesis of 6-bromo-3-oxoalkanoates by reaction of BBr3 with 
2-alkylidenetetrahydrofurans.4 The synthesis of benzofuran-3-carboxylic esters 
containing a remote bromide groups – based on a BBr3 mediated ring transformation – 
has also been reported.5 Herein, we report the synthesis of -bromo-3-ketosulfones, -
bromo-3-ketonitriles and 2-(-haloalkyl)benzofurans based on the synthesis of 2-
(sulfonylmethylidene) and 2-(cyanomethylidene)-tetrahydrofurans and their subsequent 
BBr3-mediated cleavage. The products repoted herein are not readily by other methods. 
Notably, functionalized benzofurans are of considerable pharmacological relevance and 
represent versatile synthetic building blocks in organic and medicinal chemistry.6 For 
example; the benzofuran amiodarone is used in the clinic as a potent antiarrythmic and 
antianginal drug.7 various benzofurans occur in natural products. This includes, for 
example, longicaudatin,8 the sessiliflorols A and B, flemistrictin E, tovophenone C, 
vismiaguianone C or piperaduncin B.
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  3.2. Results and Discussion
3.2.1 Reactions of 3-ketosulfone dianions. 2-(2-Oxoalkylidene)tetrahydrofurans are 
available by cyclization10 of 1,3-dicarbonyl dianions or 1,3-bis(silyl enol ethers) 
(‘masked dianions’) with various electrophiles, such as 1-bromo-2-chloroethane, 11 1,4-
dibromobut-2-ene, 12 or epoxides.13 2-(Sulfonylmethylidene)tetrahydrofurans were 
prepared, for example, from β-iodovinyl sulfones,14 -halo and -hydroxy--
ketosulfones,15 or -hydroxypropargylic sulfones.16 Another approach relies on the 
cyclization of 3-ketosulfone dianions with cyclic sulfates.17 Some years ago, we reported 
the synthesis of 7-sulfonyl-2,3,3a,4,5,6-hexahydrobenzofurans, which can be regarded as 
bicyclic  2-(sulfonylmethylidene)tetrahydrofurans, by cyclization of cyclic 3-ketosulfone 
dianions with 1,4-dibromobut-2-ene.12
The cyclization of the dianions of 3-ketosulfones 1a-c, generated by LDA (2.5 equiv.), 
with 1-bromo-2-chloroethane afforded the 2-(sulfonylmethylidene)-tetrahydrofurans 1a-c
(Scheme 1, Table 1). The reaction of a CH2Cl2 solution of 2a-c with BBr3 and subsequent 
addition of water afforded the -bromo--ketosulfones 3a-c. The formation of 3a-c can 
be explained as follows: The interaction of BBr3 with the sulfonyl group effects a drmatic 
increase of the electrophilicity of carbon atom C-5 of the tetrahydrofuran moiety. 
Nucleophilic attack of a BBr3-derived bromide ion onto carbon C-5 results in ring-
opening and formation of an open-chain boron enolate. The latter is subsequently 
protonated upon addition of water. Notably, products 3a-c are not directly available by 
reaction of 3-ketosulfone dianions with 1,2-dibromoethane, due to a competing SET 
process (oxidative dimerization of the dianion and reduction of 1,2-dibromoethane to 
ethylene).18 
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Scheme 1. Synthesis of -bromo-3-ketosulfones 3a-c. i: 1) 2.5 equiv. LDA, THF, 0 °C, 1 
h, 2) Br(CH2)2Cl, −78 → 20 °C, 14 h, then reflux, 14 h; ii: 1) 4.0 equiv. BBr3, CH2Cl2, 0 
→ 20 °C, 12 h, 20 °C, 8 h; 2) H 
                     Table 1. Synthesis of 3a-c
2,3 Ar % (2)a E/Z 
(2)b
% (3)a
a Ph 45 7:3 95 
b 4-MeC6H4 45 7:3 92 
h 4-ClC6H4 40 6:4 65 
                         a Yields of isolated products; b by 1H NMR 
2-(Sulfonylmethylidene)-5-vinyltetrahydrofurans 4a-c were prepared by cyclization of 
dilithiated 3-ketosulfones 1a-c with 1,4-dibromobut-2-ene (Scheme 2, Table 2). The 
reaction of 4a-c with BBr3 afforded the -bromo-3-ketosulfones 5a-c. The products were 
formed by cleavage of the 2-alkylidenetetrahydrofuran by a SN reaction. Notably, the 
products are not available by direct reaction of the dianions of 1a-c with 1,4-dibromobut-
2-ene, due to rapid cyclization.  
3-Ketosulfones 7a-d were prepared by acylation of aryl-[(2-methoxyphenyl)methyl]-
sulfones 6a-c. The cyclization of the dianions of 7a-c with 1-bromo-2-chloroethane 
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afforded the 2-alkylidenetetrahydrofurans 8a-d. Treatment of 8a-d with BBr3 afforded 
the 2-(-bromoalkyl)-3-sulfonylbenzofurans 9a-d (Scheme 3, Table 3). The reaction of 
8a-c with BCl3 gave 2-(-hydroxypropyl)-3-sulfonylbenzofuran 9e-g. The formation of 
benzofurans 9 can be explained by ring-opening of 8 and deprotection of the arylmethyl 
ether to give intermediate A, hydrolysis upon aqueous work-up (intermediate B) and 
subsequent acid mediated cyclization by attack of the hydroxy onto the carbonyl group. 
In case of 9e-g, the chloride group was hydrolyzed.  
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Scheme 2. i: 1) 2.5 equiv. LDA, THF, 0 °C, 1 h, 2) 1,4-dibromobut-2-ene, −78 → 20 °C,    
20 h; ii: 1) 5.0 equiv. BBr3, CH2Cl2, 0 → 20 °C, 12 h, 20 °C, 8 h; 2) H2O 
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               Table 2. Synthesis of 5a-c
4,5 Ar % (4)a E/Z (4) b % (5)a
a Ph 50 6:4 75 
b 4-MeC6H4 38 6:4 75 
c 4-ClC6H4 40 > 98:2 70 
                    a Yields of isolated products b by 1H NMR 
The structure of all products was established by spectroscopic methods. The structures of 
8a and 9a were independently confirmed by X-ray crystal structure analyses (Figures 1 
and 2).1 
                                                         Figure 1. Ortep plot of 8a
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Scheme 3. Synthesis of benzofurans 9a-e, i: 1) 2.5 equiv. LDA, THF, 0 °C, 45 min, 2) 
acid chloride, −78 → 20 °C, 14 h; ii: 2.5 equiv. LDA, THF, 0 °C, 1 h, 2) Br(CH2)2Cl, −78 
→ 20 °C, 14 h; then reflux, 14 h; iii: 1) 5.0 equiv. BBr3, CH2Cl2, 0 → 20 °C, 12 h, 20 °C, 
12 h; 2) H2O 
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Table 3. Synthesis of benzofurans 9a-g
7,8 9 Ar R X % (7) a % (8) a, c % (9) a
a a Ph H Br 56 45 (E) + 22 (Z) 72 
b b 4-MeC6H4 H Br 78 55 (E) 61 
c c 4-ClC6H4 H Br 61 49 (E) + 19 (Z) 68 
d d Ph Me Br 40 46 (E/Z= 8:1) 63 
a e Ph H OH b 56 45 (E) + 22 (Z) 40 
b f 4-MeC6H4 H OH b 28 55 (E) 34 
c g 4-ClC6H4 H OH b 61 49 (E) + 19 (Z) 47 
a Yields of isolated products; b the product was formed when BCl3 was used (by 
hydrolysis of the chloride group in the product); c in brackets: configuration of the 
exocyclic double bond. 
Figure 2. Ortep plot of 9a 
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3.2.2. -Ketonitriles 
The known11a 2-alkylidenetetrahydrofuran 11 was prepared by cyclization of the dianion 
of cyanoacetone, generated by treatment of 5-methyl-isoxazole with LDA, with 1-bromo-
2-chloroethane. Treatment of 11 with BBr3 afforded 1-cyano-5-bromo-pentan-2-one (12) 
(Scheme 4). Despite its relatively low molecular weight, it was possible to independently 
confirm the structure of 12  by an X-ray crystal structure analysis (Figure 3).19 
The cyclization of the dianion of cyanoacetone, generated by treatment of 5-methyl-
isoxazole with LDA, with 1,4-dibromobut-2-ene afforded the known11a 2-
alkylidenetetrahydrofuran 13. Treatment of 13 with BBr3 unexpectedtly afforded 
tribromide 14 (Scheme 5). Product 14 is presumably formed by BBr3 mediated ring 
opening and formation of intermediate A. Subsequently, the double bond is brominated 
(by the action of bromine formed under the reaction conditions from BBr3).
                 
8 BBr3
Br Cl
CNO
CN
O
Br
N
OH3C
10 11
i
ii
12
 41% (E) + 40% (Z)
(85%)
Br
Br
Scheme 4. Synthesis of 1-cyano-5-bromopentan-2-one (12). i: 1) 2.5 equiv. LDA, THF, 0 
°C, 1 h, 2) Br(CH2)2Cl, −78 → 20 °C, 14 h, then reflux, 14 h; ii: 1) 8.0 equiv. BBr3, 
CH2Cl2, 0 → 20 °C, 12 h, 20 °C, 8 h; 2) H2O 
58
                 
8 BBr3
CNO
CN
O
N
OH3C
10 13
i
ii
14
40% (E) + 36% (Z)
(70%)
Br Br
Br
Br
Br
CN
O
Br
A
2 BBr3         B2Br4 + Br2
Br2
Scheme 5. i: 1) 2.5 equiv. LDA, THF, 0 °C, 1 h, 2) 1,4-dibromobut-2-ene, −78 → 20 °C, 20 h;;
ii: 1) 8.0 equiv. BBr3, CH2Cl2, 0 → 20 °C, 12 h, 20 °C, 6 h; 2) H2O 
The acylation of [(2-methoxyphenyl)acetonitrile with acetyl chloride afforded -
ketonitrile 15. The cyclization of the dianion of 15 with 1-bromo-2-chloroethane gave 2-
alkylidenetetrahydrofuran 16. Treatment of the latter with BBr3 and subsequently with 
HBr (62%) afforded the 2-(-bromoalkyl)-3-carboxybenzofuran 17 (Scheme 6). During 
the optimization of this reaction, the addition of conc. hydrobromic acid proved to be 
important in order to induce a complete rearrangement. This was necessarry, since nitrile 
15 proved to be less reactive than sulfones 8 in the reaction with BBr3. This can be 
explained by the lower electron-withdrawing effect of the nitrile compared to the sulfone. 
The nitrile was hydrolyzed to a carboxylic acid group upon addition of conc. 
hydrobromic acid.  
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17 (41%) 16 (72%, Z/E = 8:1)
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Scheme 6. Synthesis of benzofuran 17, i: 1) 2.5 equiv. LDA, THF, 0 °C, 45 min, 2) acid 
chloride, −78 → 20 °C, 14 h; ii: 2.5 equiv. LDA, THF, 0 °C, 1 h, 2) Br(CH2)2Cl, −78 →
20 °C, 14 h; then reflux, 14 h; iii: 1) 7.0 equiv. BBr3, CH2Cl2, 0 → 20 °C, 12 h, 20 °C, 72 
h; 2) HBr (62%) 6.0 equiv. 20 °C, 20 h;  3) H2O 
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BBr3
O
CN
MeO
O
CN
MeO
18 (34%, Z/E = 8:1)
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ii
Scheme 7. Synthesis of benzofuran 19, i: 1) 2.5 equiv. LDA, THF, 0 °C, 1 h, 2) 1,4-
dibromobut-2-ene, −78 → 20 °C, 20 h;; ii: 1) 8.0 equiv. BBr3, CH2Cl2, 0 → 20 °C, 12 h, 
20 °C, 72 h; 2) HBr (62% , 6.0 equiv.), 20 °C, 20 h;  3) H2O. 
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The cyclization of the dianion of 15 with 1,4-dibromobut-2-ene gave 2-alkylidene-5-
vinyltetrahydrofuran 18. Treatment of the latter with BBr3 and subsequently with HBr 
(62%) afforded the 2-(-bromoalkyl)-3-carboxybenzofuran 19 (Scheme 7). The nitrile 
was again hydrolyzed to a carboxylic acid group upon addition of conc. hydrobromic 
acid.  
In conclusion, we reported an efficient approach to -bromo-3-ketosulfones, -bromo-3-
ketonitriles, and 2-(-bromoalkyl)benzofurans based on one-pot cyclizations of 3-
ketonitrile and 3-ketosulfone dianions and application of a ′ring-closing/ring-opening′
strategy.  
3.3. Experimental section 
General Procedure for the Cyclization of 1-Bromo-2-chloroethane with Dianions: 
To a THF solution of LDA (prepared by addition of  5.0 mmol of n-BuLi, 2.5 M in 
hexane, to a solution of diisopropylamine (0.57 ml, 5.0 mmol) in 12 ml of THF, stirred 
for 30 min), was added 1-phenylsulfonyl-2-propanone (397 mg, 2.0 mmol) at 0 °C. The 
solution was stirred at 0 °C for 45 min. To this solution was added 1-bromo-2-
chloroethane (0.17 ml, 2.1 mmol) at -78 °C. The temperature was allowed to rise to 20 °C 
during 14 h, and the solution was subsequently refluxed for 14 h. To the solution was 
added hydrochloric acid (1 M) and the mixture was subsequently extracted with EtOAc 
(3× 200 ml). The organic layers were dried and filtered, the solvent of the filtrate was 
removed in vacuo, and the residue was purified by chromatography (silica gel, EtOAc / 
n-heptane).   
2[((4-Methyphenyl)sulfonyl)methylidene]tetrahydrofuran (2b): Starting with 1-(4-
methylphenyl)sulfonyl-2-propanone 1b (3.00 g, 14.13 mmol), 1-bromo-2-chloroethane 
(1.4 ml, 16.96 mmol),  2b was isolated as a colourless solid (1.51 g, 45%, E/Z = 7:3), mp. 
87 °C; 1H NMR (300 MHz, CDCl3): δ = 1.98-2.09 (m, 2 ×2 H, CH2, both isomers), 2.34 (s, 
3H, CH3), 2.37 (s, 3H, CH3), 2.59 (m, 2 H, CH2), 3.06 (dt, 2 H, J = 7.8 Hz, J = 1.7 Hz, 
CH2), 4.14 (t, 2 H, J = 7.0 Hz, CH2), 4.31 (t, 2 H, J = 6.9 Hz, CH2), 5.39 (t, 1 H, J = 1.3 
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Hz, C=CH, Z-isomer), 5.67 (t, 1 H, J = 1.7 Hz, C=CH, E- isomer), .7.19-7.29 (m, 2 ×2 H, 
ArH, both isomers), 7.66-7.79 (m, 2 ×2 H, ArH, both isomers); 13C NMR (75 MHz, 
CDCl3): δ = 21.9, 22.0 (CH3), 29.7, 32.2, 36.8, 41.3, 72.7, 75.3 (CH2), 99.2, 100.6 (CH), 
128.5 (2C, CH), 128.6 (2C, CH), 130.0 (2C, CH), 130.3 (2C, CH), 136.4, 138.0, 145.0, 
145.7, 169.5, 173.7 (C);  IR (KBr): ν~ = 2968 (w), 2925 (w), 2886 (w), 1719 (m), 1597 
(w), 1314 (s), 1142 (s), 1079 (s), 995 (m), 777 (m), 561 (s) cm−1; GC-MS (EI, 70 eV): m/z
(%): 238 (M+, 100), 174 (15), 172 (18), 132 (20), 131 (33), 118 (22), 105 (15), 91 (70), 65 
(37); HRMS (ESI): calcd (%) for C12H14O3S ([M+1]) 238.06581, found 238.06582. 
General Procedure for the Reaction of 2-(Alkylidene)-tetrahydrofurans with 
Borontribromide or Borontrichloride: To a CH2Cl2 solution (10 mL per 1 mmol of 
substrate) of 2-(alkylidene)tetrahydrofuran (1.0 equiv.) was added BBr3 (4.0-8.0 equiv.) 
at 0 °C. The reaction mixture was allowed to warm to 20 °C during 12 h and was stirred 
for 12 h at 20 °C. Water (15 mL per 1 mmol of substrate) was slowly added to the 
reaction mixture and the organic layer was separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (Na2SO4), filtered, 
and the filtrate was concentrated in vacuo. The residue was purified by chromatography 
(silica gel, n-heptane/EtOAc). 
5-Bromo-1-[(4-methylphenyl)sulfonyl]-2-pentanone (3b): Starting with 2b (200 mg, 
0.84 mmol) and BBr3 (0.31 ml, 3.2 mmol), 3b was isolated as a colourless solid (246 mg, 
92%), mp. 48 °C; 1H NMR (300 MHz, CDCl3): δ = 2.04 (quint, 2 H, J = 6.4 Hz, CH2), 
2.38 (s, 3 H, CH3), 2.84 (t, 2 H, J = 6.8 Hz, CH2), 3.33 (t, 2 H, J = 6.4 Hz, CH2), 4.08 (s, 
1 H, CH2), 7.29 (d, 2 H, J = 8.0 Hz, ArH), 7.69 (d, 2 H, J = 8.5 Hz, ArH);  13C NMR (75 
MHz, CDCl3): δ = 22.1 (CH3), 26.4, 32.8, 42.8, 67.6 (CH2), 128.6 (2C, CH), 130.4 (2C, 
CH), 136.1, 145.9, 197.5 (C); IR (KBr): ν~ = 3043 (w), 2920 (w), 1718 (s), 1405 (m), 
1317 (s), 1149 (s), 1005 (w), 817 (m), 618 (w), 514 (m) cm−1; GC-MS (EI, 70 eV): m/z
(%): 320 (M+, 81Br, 0.40), 318 (M+, 79Br, 0.53), 256 (5), 254 (5), 238 (4), 212 (13), 155 
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(56), 151 (32), 149 (36), 148 (33), 91 (100), 65 (30), 41 (19); HRMS (ESI): calcd (%) for 
C12H15BrO3S ([M+1]+ ,81Βr) 317.99132, found 317.99198. 
General Procedure for the Cyclization of 1,4-Dibromo-2-butene with Dianions: A 
THF solution of LDA (2.5 equiv.) was prepared by addition of n-BuLi (1 ml, 2.5 mmol, 
2.5 M solution in hexanes) to a THF solution (7 ml) of diisopropylamine (0.36 ml, 2.5 
mmol) at 0 °C. After the solution was stirred for 30 min, 1-phenylsulfonyl-2-propanone 
(198 mg, 1.0 mmol) was added at 0 °C. After stirring for 45-60 min, to the solution was 
added a THF solution (4 ml) of 1,4-dibromo-2-butene (256 mg, 1.2 mmol) at -78 °C. The 
temperature was allowed to rise to 20 °C during 12-14 h, and the solution was stirred at 
20 °C for 8-14 h. To the solution was added a diluted aqueous solution of HCl and the 
mixture was subsequently extracted with EtOAc (3×200 ml). The combined organic 
layers were dried and filtered, the solvent of filtrate was removed in vacuo, and the 
residue was purified by chromatography (silica gel, EtOAc / n-heptane).   
2-[((4-Methylphenyl)sulfonyl)methylidene]-5-vinyltetrahydrofuran (4b): Starting 
with 1-(4-methylphenyl)sulfonyl-2-propanone 1b (1.00 g, 4.71 mmol), and 1,4-dibromo-
2-butene (1.30 g, 5.65 mmol), 4b was isolated as a highly viscos colourless oil (475 mg, 
38%, E/Z = 6:4); 1H NMR (300 MHz, CDCl3): δ = 1.66-1.78 (m, 2×1 H, CΗ−CH2, both 
isomers), 2.12-2.24 (m, 2×1 H, CΗ−CH2, both isomers), 2.33, 2.37 (2×s, 6H, CH3), 2.59 
(dt, 1 H, J = 7.9 Hz, J = 1.8 Hz, CΗ2−C), 2.87-2.99 (m, 1 H, CΗ2−C), 3.17-3.28, 3.46-
3.50 (2×m, 2 H, CH2	C, E-Z), 4.69-4.77, 4.99-5.01 (2×m, 2 H, CΗ−CH2), 5.10-5.26 (m, 4 
H, CH2=CH, both isomers ), 5.40 (t, J = 1.4 Hz, C=CH, Z isomer), 5.68 (distorted t, J = 
1.9 Hz, C=CH, E isomer),  5.71- 5.78 (m, 2 H, CH2=CH, both isomers), 7.22, 7.28 (2×d, 
4H, J = 8.0 Hz, J = 8.0 Hz, ArH, both isomers), 7.67, 7.78 (2×d, 4 H, J = 8.2 Hz, J = 8.3 
Hz,  ArH, both isomers); 13C NMR (75 MHz, CDCl3): δ = 21.9, 22.0 (CH3), 29.3, 29.7, 
30.0, 31.6 (CH2), 85.0, 87.0, 99.7, 100.7 (CH), 117.7, 118.4 (CH2), 126.8 (2C, CH), 
127.7 (2C, CH), 129.5 (2C, CH), 129.9 (2C, CH), 135.3, 135.6 (CH), 141.0, 141.4, 143.5, 
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143.6, 169.0, 173.0 (C);  IR (neat): ν~ = 3482(w), 2983 (w), 2925 (w), 2211 (w), 1719 
(m), 1628 (s), 1428 (m), 1317 (s), 1151 (s), 816 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 
264.1 (M+, 27), 197 (28), 155 (23), 139.1 (8), 109.1 (50), 91.1 (100), 79.1 (20), 65.1 (23), 
39.1 (11); HRMS (ESI): calcd (%) for C14H16O3S ([M+1] ) 264.081655, found 264.08147. 
7-Bromo-1-[(4-methylphenyl)sulfonyl]-5-hepten-2-one (5b): Starting with 4b (110 mg, 
0.49 mmol) and BBr3 (0.23 ml, 2.5 mmol), 5b was isolated as a highly viscos colourless 
oil (109 mg, 75%); 1H NMR (300 MHz, CDCl3): δ = 2.27 (m, 2 H, CH2), 2.39 (s, 3 H, 
CH3), 2.76 (t, 2 H, J = 7.0 Hz, CH2), 3.84 (distorted d, 2 H, J = 6.4 Hz, CH2),  4.05 (s, 2 
H, CH2), 5.63-5.66 (m, 2 H, CH=CH ), 7.30 (d, 2 H, J = 8.1 Hz, ArH), 7.66 (d, 2 H, J = 
8.1 Hz, ArH); 13C NMR (75 MHz, CDCl3): δ = 22.1 (CH3), 25.8, 33.1, 43.6, 67.5 (CH2), 
128.2 (CH), 128.6 (2C, CH), 130.4 (2C, CH), 133.8, (CH), 136.0, 145.9, 197.5 (C);  IR 
(neat): ν~ = 3031 (w), 2925 (m), 2210 (w), 1720 (s), 1320 (s), 1206 (m), 1152 (s), 815 
(m), 733 (w), 515 (m) cm−1; GC-MS (CI): m/z (%): 347 ([M+H]+ , 81Br, 7), 345 ([M+H]+,
79Br, 7), 267 (6), 266 (13), 265 (100), 170 (2), 139 (3), 109 (4); elemental analysis: calcd 
(%) for C14H17BrO3S(345.25): C 48.70, H 4.96; found: C 48.19, H 4.98.
2-(Z)(3-Phenyldihydro)-2(3H)-furanylidene-2-(2-methoxyphenyl)-4- phenylsulfone 
(8a): 1H NMR (300 MHz, CDCl3): δ = 1.81-1.93 (m, 2 H, CH2), 2.27-2.432 (m, 2 H, 
CH2), 3.56 (s, 3 H, OCH3), 4.29-4.38 (m, 2 H, CH2), 6.71-6.91 (m, 2 H, ArH), 7.12-7.24 
(m, 2 H, ArH), 7.31-7.28 (m, 3 H, ArH), 7.85 (m, 2 H, ArH); 13C NMR (75 MHz, 
CDCl3): δ = 23.3-31.8 (CH2), 55.6 (OCH3), 75.1 (CH2), 108.0 (C), 111.3, 121.0 (CH), 
122.5 (C),  128..2 (2C, CH), 128.5 (2C,CH), 130.6, 132.4, 133.9 (CH), 143.8, 158.1, 
167.0 (C); IR (KBr): ν~ = 3064 (w), 29641 (w), 2904 (w), 2837 (w), 1723 (w), 1634 (s), 
1595 (s), 1491 (m), 1446 (s), 1302 (s), 1141 (s), 1117 (m), 1084 (m), 1025 (m), 985 (m), 
756 (s), 533 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 330 (M+, 28), 189 (27), 131 (10), 
105 (9), 91 (24), 77 (26), 71 (100), 43 (25); HRMS (ESI): calcd (%) for C18H18SO4
([M+1]) 330.0923, found 330.09180. 
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2-(3-Phenyldihydro)-2(3H)-furanylidene-2-(2-methoxyphenyl)-(4-
chlorophenyl)sulfone (8c): Starting with 1-(2-methoxyphenyl)-1-(4-
chlorophenylsulfonyl)acetone (7c) (3.49 g, 10.32 mmol), and 1-bromo-2-chloroethane 
(1.0 ml, 12.38 mmol), 8c (E-isomer) was isolated as a colourless oil (1.84 g, 49%) and 8c 
(Z-isomer) was isolated as a colourless solid, mp. 144 °C.  E-Isomer: 1H NMR (300 MHz, 
CDCl3): δ = 2.07 (m, 2 H, CH2), 3.28 (t, 2 H, J = 6.48 Hz, CH2), 3.32 (s, 3 H, OCH3), 
4.07 (t, 2 H, J = 7.44 Hz, CH2), 6.62-6.88 (m, 2 H, ArH), 7.14-7.26 (m, 4 H, ArH), 7.44-
7.49 (m, 2 H, ArH); 13C NMR (75 MHz, CDCl3): δ = 23.02, 27.4 (CH2), 55.5 (OCH3), 
72.6 (CH2),  110.4 (C), 111.7, 120.8 (CH), 122.9 (C),  128..6 (2C,CH), 129.5 (2C,CH), 
133.8, 138.9 (CH), 140.5, 142.9, 159.1, 171.8 (C);  IR (KBr): ν~ = 3095(w), 3081 (w), 
2957 (w), 2902 (w), 1631 (s), 1594 (s), 1594 (m), 1490 (m), 1463 (m), 1306 (s), 1253 (s), 
1239 (s), 1148 (s), 1052 (s), 899 (s),  761 (m),  616 (m), 599 (s): cm−1; GC-MS (EI, 70 
eV): m/z (%): 364 (M+, 28), 189 (28), 161 (16), 131 (10), 91 (23), 71 (100), 43 (21); 
HRMS (ESI): calcd (%) for C18H17ClSO4 ([M+1]) 364.05306, found 364.052826. Z-
Isomer: 1H NMR (300 MHz, CDCl3): δ = 1.84-1.97 (m, 2 H, CH2), 2.31-2.38 (m, 2 H, 
CH2), 3.60 (s, 3 H, OCH3), 4.31-4.40 (m, 2 H, CH2), 6.68-6.93 (m, 2 H, ArH), 7.14-7.35 
(m, 4 H, ArH), 7.76-7.81 (m, 2 H, ArH); 13C NMR (75 MHz, CDCl3): δ = 20.8, 23.3 
(CH2), 55.6 (OCH3), 75.2 (CH2), 108.4 (C), 111.3, 121.1 (CH), 122.2 (C),  128.6 
(2C,CH), 129.9 (2C,CH), 131.3, 138.9 (CH), 138.5, 143.3, 158.3, 168.2 (C);  IR (KBr):
ν~ = 3080 (w), 3050 (w), 2951 (m), 2804 (m), 1631 (s), 1594 (m), 1585 (m), 1490 (s), 
1463 (s), 1304 (s), 1253(m), 1232 (s), 1144 (m), 1052 (s), 899 (m),  762 (s),  616 (s),  591 
(s): cm−1; GC-MS (EI, 70 eV): m/z (%): 364 (M+, 24), 189 (28), 161 (7), 131 (10), 111 
(10), 91 (23), 71 (100), 43 (22); HRMS (ESI): calcd (%) for C18H17ClSO4 ([M+1]) 
364.05306, found 364.05463. 
(2-Methoxyphenyl)-[3-methyldihydo-2(3H)-furanylidene]methyl-phenylsulfone (8d): 
Starting with 1-(2-methoxyphenyl)-1-(phenylsulfonyl)-2-butanone 7d (500 mg, 1.5 
mmol), 1-bromo-2-chloroethane (0.15 ml, 1.8 mmol),  8d was isolated as a colourless oil 
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(248 mg, 46%, E/Z = 8:1); 1H NMR (300 MHz, CDCl3): δ = 0.70 (t, 3 H, J(Z) = 5.25 Hz, 
CH3), 0.79  (t, 3 H, J(E) = 7.25 Hz, CH3), 1.52-1.62  (m, 2×1 H, CH2, Z isomer), 1.99-2.15 
(m, 2×1H, CH2, E isomer), 2.25-2.67 (m, 2×1 H, CH2, Z isomer),  2.70-2.81 (m, 2×1H, 
CH2, E isomer), 3.49 (s, 3 H, OCH3), 3.68 (s, 3 H, OCH3), 4.24-4.39 (m, 2×2H, CH, both 
isomers), 6.72-7.02 (m, 5 H, ArH both isomers), 7.21-7.47 (m, 4×2 H, ArH, both 
isomers), 7.77-7.83 (m, 2×1 H ArH, Z isomer), 7.88-7.92 (m, 2×1 H ArH, E isomer); 13C 
NMR (75 MHz, CDCl3): δ = 16.8, 18.2 (CH3), 31.8, 31.9 (CH2), 38.1, 38.9 (CH), 55.6 
(OCH3), 72.6 (CH2), 110.0 (C), 111.2, 120.6, 121.0 (CH), 122.4 (C), 128.2 (2C, CH), 
128.5 (2C, CH), 130.6, 130.9, 133..4, 133.5, (CH), 143.7, 144.0, 158.0, 159.7, 170.5, 
171.8, (C); IR (KBr): ν~ = 3065 (w), 2968 (m), 2907 (m), 2934 (m), 1719 (m), 1633 (m), 
1491 (s), 1447 (s), 1302 (s), 1290 (s), 1253 (s), 1145 (s), 1024 (s), 975 (w), 688 (s), 529 
(m): cm−1; GC-MS (EI, 70 eV): m/z (%): 340 (M+, 27), 203 (100), 173 (15), 131 (14), 91 
(42), 77 (33), 43 (27); HRMS (ESI): calcd (%) for C19H20O4S ([M+1]) 340.10768, found 
340.10798. 
2-(3-Bromopropyl)-3-(phenylsulfonyl)-benzofuran (9a): Starting with 8a (148 mg, 
0.44mmol) and BBr3 (0.21 ml, 2.24 mmol), 9a was isolated as a colourless solid (122 mg, 
72%), mp. 92 °C; 1H NMR (300 MHz, CDCl3): δ = 2.62 (quint, 2 H, J = 6.6 Hz,  CH2), 
3.65 (t, 2 H, J = 7.4 Hz,  CH2), 3.76 (t 2H, J = 6.4 Hz,  CH2-Br), 7.60 (m, 2 H, ArH), 
7.70 (m, 1 H, ArH), 7.75-7.87 (m, 3 H, ArH), 8.16 (m, 1 H, ArH), 7.89 (dd, 2 H, J = 8.17, 
1.5 Hz, ArH); 13C NMR (75 MHz, CDCl3): δ = 26.6, 31.3, 32.6 (CH2), 111.8 (CH), 118.7 
(C), 120.8 (CH), 124.5 (C), 124.9 (CH), 125.9 (2C, CH), 127.1 (2C, CH), 129.7, 133.8 
(CH), 142.7, 153.7, 162.7 (C); IR (KBr): ν~ = 3058 (w), 2927 (w), 1569 (s), 1451 (s), 
1327 (s), 1111 (m), 1011 (w), 752 (s), 688 (s), 599 (s), 551 (s) cm−1; GC-MS (EI, 70 eV): 
m/z (%): 380 (M+, 81Br, 100), 78 (M+, 79Br, 93), 330 (12), 299 (26), 237 (6), 272 (34), 
181 (8) 158 (17), 131 (34), 69 (30), 43 (24); HRMS (ESI): calcd (%) for C!7H15BrO3S 
([M+1]
 , 81Βr) 377.99143, found 377.99198. 
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2-(3-Bromopropyl)-3-[(4-chlorophenyl)sulfonyl]-benzofuran (9c):  Starting with 8c
(663mg, 1.8 mmol) and BBr3  (0.86 ml, 9.1 mmol), 9c  was isolated as a colourless solid 
(515 mg, 68%), mp. 116 °C; 1H NMR (300 MHz, CDCl3): δ = 2.28 (quint, 2 H, J = 6.6 
Hz,  CH2), 3.31 (t, 2 H, J = 7.4 Hz, CH2 ), 3.43 (t 2H, J = 6.4 Hz,  CH2-Br), 7.26 (m, 2 H,
ArH), 7.36-7.42 (m, 3 H, ArH), 7.79 (m, 1 H, ArH), 7.89 (d, 2 H, J = 8.17 Hz, ArH); 13C 
NMR (75 MHz, CDCl3): δ = 26.6, 31.2, 32.6 (CH2), 111.9 (CH), 118.4 (C), 120.7 (CH), 
124.3 (C), 125.0, 126.1 (CH), 128.6 (2C, CH), 130.0 (2C, CH), 140.4, 141.1, 153.7, 
162.9 (C); IR (KBr): ν~ = 3083 (w), 3059 (w), 1575 (s), 1452 (s), 1157 (s), 1085 (s), 829 
(m), 760(s), 658 (s), 567 (s), 479 (w) cm−1; GC-MS (EI, 70 eV): m/z (%): 414 (M+, 81Br, 
100), 412 (M+, 79Br, 75), 306 (27), 305 (22), 237 (6), 205 (17), 159 (41) 131 (53), 102 
(35), 75 (20); HRMS (ESI): calcd (%) for C!7H14BrClO3S ([M+1] 
 , 81Βr) 412.96127, 
found 412.96083. 
2-(3-Bromo-1-methylpropyl)-3-(phenylsulfonyl)-benzofuran (9d): Starting with 8d
(90 mg, 0.26 mmol) and BBr3 (0.12 ml, 1.3 mmol), 9d  was isolated as a highly viscos 
colourless oil (65 mg, 63%); 1H NMR (300 MHz, CDCl3): δ = 1.30 (d, 3 H, J = 6.8 Hz,  
CH3), 2.10-2.19 (m, 1 H, CH 	CH2), 2.30-2.38 (m, 1 H, CH	CH2), 3.19-3.25 (m, 2H, CH2-
Br), 4.02-4.09 (m, 1 H, CH3	CH), 7.24-7.28 (m, 2 H, ArH), 7.35-7.38 (m, 1 H, ArH), 
7.42-7.52 (m, 3 H, ArH), 7.86-7.90 (m, 1 H, ArH), 7.96-8.01 (m, 2 H, ArH); 13C NMR 
(75 MHz, CDCl3): δ = 19.5 (CH3), 30.6 (CH2), 31.8 (CH), 38.0 (CH2), 111.8 (CH), 118.4 
(C), 121.1 (CH), 124.5 (C), 124.9 (CH), 125.9 (2C, CH), 127.1 (2C, CH), 129.7, 133.7 
(CH), 142.8, 153.6, 165.8 (C); IR (KBr): ν~ = 2974 (w), 2921 (s), 2847(w), 1567 (s), 1473 
(s), 1251 (s), 1091 (s), 928 (w), 754 (s), 645 (m), 554 (s) cm−1; GC-MS (EI, 70 eV): m/z
(%): 394.1 (M+, 81Br, 47), 392.1 (M+, 79Br, 45), 285 (100), 233 (4), 156 (9), 144.1 (37), 
128.1 (13) 115.1 (34), 89.1 (5), 77.1 (18), 51.1 (8); HRMS (ESI): calcd (%) for 
C!8H17BrO3S ([M+1] 
 , 81Βr) 392.00756, found 392.00763. 
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2-(3-Hydroxypropyl)-3-(phenylsulfonyl)-benzofuran (9e): Starting with 8a (227 mg, 
0.68 mmol) and BCl3  (0.53 ml, 3.4 mmol), 9e was isolated as a higly viscos colourless 
oil (87 mg, 40%); 1H NMR (300 MHz, CDCl3): δ = 1.99 (quint, 2 H, J = 6.4 Hz,  CH2), 
3.24 (t, 2 H, J = 7.2 Hz,  CH2 ), 3.63 (t 2H, J = 6.0 Hz,  CH2-OH), 7.23-7.27 (m, 2 H, 
ArH), 7.36-7.38 (m, 1 H, ArH), 7.40-7.53 (m, 3 H, ArH), 7.81-7.84 (m, 1 H, ArH), 7.94 
(dd, 2 H,  J = 8.0, 1.7 Hz, ArH); 13C NMR (75 MHz, CDCl3): δ = 24.0, 31.2, 61.2 (CH2), 
111.7 (CH),118.7 (C),120.8 (CH),124.5 (C), 124.8, 125.8 (CH), 127.0 (2C, CH), 129.7 
(2C, CH), 133.8 (CH), 142.6, 153.7, 163.9 (C); IR (KBr): ν~ = 2929 (s), 2851 (w), 1711 
(w),1568 (s), 1448 (s), 1156 (s), 999 (m), 753 (s), 648 (s), 533 (s), 437 (w) cm−1; GC-MS 
(EI, 70 eV): m/z (%):316.1 (M+, 35), 298.1 (40), 233.1 (12), 219.1 (24), 175.1 (100), 
158.1 (15), 145.1 (21) 133 (48), 131.1 (64), 115.1 (50), 77.1 (48); HRMS (ESI): calcd 
(%) for C!7H16O4S ([M+1]
) 316.07716, found 316.07638. 
2-(3-Hydroxypropyl)-3-[(4-chlorophenyl)sulfonyl]-benzofuran (9g): Starting with 8c
(663 mg, 1.8 mmol)  and BCl3  (3.4 ml, 21.6 mmol), 9g  was isolated as a highly viscos 
colourless oil (300 mg, 47%); 1H NMR (300 MHz, CDCl3): δ = 1.94-2.03 (m, 2 H, J = 
6.8 Hz,  CH2), 3.23 (t, 2 H, J = 7.2 Hz,  CH2), 3.63 (t 2 H, J = 5.9 Hz,  CH2-OH), 7.24-
7.27 (m, 2 H, ArH), 7.35-7.37 (m, 1 H, ArH), 7.39 (d, 2 H, J = 8.7 Hz, ArH), 7.77-7.80 
(m, 1 H, ArH), 7.87 (d, 2 H, J = 8.7 Hz, ArH); 13C NMR (75 MHz, CDCl3): δ = 42.0, 
31.1, 61.3 (CH2), 111.8 (CH), 118.4 (C), 120.6 (CH), 124.3 (C), 125.0, 126.0 (CH), 128.5 
(2C, CH), 130.0 (2C, CH), 140.4, 141.1, 153.8, 164.2 (C); IR (neat): ν~ = 3404 (w), 2932 
(w), 2876 (w), 1573 (s), 1452 (s), 1155 (s), 759 (s), 619 (s), 567 (m), 480 (m) cm−1; GC-
MS (EI, 70 eV): m/z (%): 350 (M+, 13), 332 (16), 288 (5), 218 (21), 175 (100), 156 (11), 
144 (26) 131 (61), 115 (42), 75 (15); HRMS (ESI): calcd (%) for C17H15ClO4S ([M+1]) 
350.03687, found 350.03741. 
2-Dihydro-2(3H)-furanylidene-2-(2-methoxyphenyl)acetonitrile (16): Starting with 2-
(2-methoxyphenyl)-3-oxobutanenitrile 15 (1.20 g, 6.38 mmol), and 1-bromo-2-
chloroethane (0.58 ml, 7.1 mmol), 16 was isolated as a colourless solid (1.00 g, 72%, Z/E
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= 8:1), mp. 54 °C; 1H NMR (300 MHz, CDCl3): δ = 2.15-2.21 (m, 2 H, CH2, Z- isomer), 
2.27-2.36 (m, 2 H, CH2, E- isomer),  2.74, 3.20 (2×t, 4 H, J(Z) = 7.8 Hz, J(E) = 7.8 CH2), 
3.97 (s, 3 H, OCH3), 3.99 (s, 3 H, OCH3), 4.45-4.57 (m, 2×2 H, CH2, both isomers), 7.06 
(dd, 1 H, J = 8.9, 7.8 Hz, ArH), 7.29 (dd, 1 H, J = 5.91, 1.5 Hz, ArH), 7.37-7.49 (m, 2 H, 
ArH); 13C NMR (75 MHz, CDCl3): δ = 24.1, 24.5, 30.2, 30.8 (CH2), 55.9, 56.0 (CH3), 
73.9, 75.0 (CH2), 77.1, 78.9, 109.0 (C), 111.0 (CH), 116.0 (CN), 120.7, 129.6, 131.4 
(CH), 154.6, 155.0, 170.8, 172.5 (C);  IR (KBr): ν~ = 3441 (w), 2963 (w), 2935 (w), 2205 
(s), 1628 (s), 1578 (m), 1462 (m), 1265 (s), 1184 (s), 762 (s), 656 (w) cm−1; GC-MS (EI, 
70 eV): m/z (%): 215 (M+, 100), 184 (15), 158 (22), 144 (29), 115 (18), 84 (52), 75 (10); 
HRMS (ESI): calcd (%) for C13H13NO2 ([M+1]) 215.09408, found 215.09436. 
2-(3-Bromopropyl)-benzofuran-3-carboxlic acid (17): Starting with 16 (600 mg, 2.7 
mmol), BBr3 (1.5 ml, 16.7 mmol), and HBr (0.7 ml, 16.7 mmol), 17 was isolated as a 
highly viscos colourless oil (322 mg, 41%); 1H NMR (250 MHz, CDCl3): δ = 1.92-2.02 
(m, 2 H, CH2), 2.91 (t, 2 H, J = 8.04 Hz CH2), 3.70 (t, 2 H, J = 6.98 Hz CH2), 6.98-7.19 
(m, 3 H, ArH), 7.36-7.42 (m, 4 H, ArH); 13C NMR (75 MHz, CDCl3): δ = 25.6, 37.9, 
61.7 (CH2), 93.8 (C), 190.2, 117.7, 120.8, 123.2 (CH), 125.0, 148.2, 164.2, 194.6 (C); IR 
(KBr): ν~ = 3385 (s), 3273 (m), 3064 (w), 2924 (s), 2854 (m), 1653 (s), 1493 (s), 1459 
(m), 1243 (w), 1173 (m), 1019(m), 743 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 281 (M+, 
25), 201 (100), 175 (20), 160 (80), 103 (10), 82 (12); HRMS (ESI): calcd (%) for 
C12H11BrO3 ([M+1]) 281.52341, found 281.53216. 
2-(5-Vinyldihydro)-2(3H)-furanylidene-2-(2-methoxyphenyl)-acetonitrile (18):
Starting with 2-(2-methoxyphenyl)-3-oxobutanenitrile 15 (1.30 g, 6.8 mmol), and 1,4-
dibromo-2-butene (1.60 g, 7.5 mmol), 18 was isolated as a colourless oil (622 mg, 37%, 
Z/E = 8:1); 1H NMR (250 MHz, CDCl3): δ = 2.51-2.69 (m, 2×2 H, CH2, both isomers), 
2.99 (t, 2 H, J = 7.6 Hz, CH2), 4.18 (s, 3 H, OCH3), 4.20 (s, 3 H, OCH3), 5.27-5.40 (m, 1 
H, CH), 5.60 (d, 2×1 H, J = 13.1 Hz, CH2), 5.67 (d, 2×1 H, J = 17.1 Hz, CH2), 6.18-6.33 
(m, 2×1 H, CH, both isomers), 7.18-7.35 (m, 2 H, ArH), 7.51-7.81 (m, 2 H, ArH); 13C 
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NMR (75 MHz, CDCl3): δ = 30.0, 31.6 (CH2), 56.0 (OCH3), 81.5 (C), 86.0, 87.2 (CH), 
111.0 (CH), 116.0 (CN), 118.1 (CH2), 119.4 (C), 120.8, 121.8, 128.9, 129.6, 131.5, 135.8 
(CH), 156.9, 172.3, 173.9 (C);  IR (KBr): ν~ = 2936 (m), 2839 (w), 2207 (m), 1731 (m), 
1635 (s), 1595 (m), 1580 (w), 1464 (s), 1262 (s), 996 (s), 757 (m) cm−1; GC-MS (EI, 70 
eV): m/z (%): 241 (M+, 100), 210 (39), 184 (15), 173 (49), 158 (21), 115 (28), 67 (23); 
HRMS (ESI): calcd (%) for C15H15NO2 ([M+1]) 241.10983, found 241.10973. 
2-(3-Bromo-4-pentenyl)-benzofuran-3-carboxylic acid (19): Starting with 18 (502 mg, 
2.07 mmol), BBr3 (1.17 ml, 12.44 mmol), and HBr (0.58 ml, 12.44 mmol), 19 was 
isolated as a colourless solid  (375 mg, 58%), mp. 112 °C; 1H NMR (300 MHz, CDCl3): 
δ = 1.84-2.09 (m, 2 H, CH2), 287 (t, 2 H, J = 8.4 Hz, CH2), 4.20 (m, 1 H, CH ), 5.07 (d, 1 
H, J = 13.4 Hz CH2), 5.25 (d, 1 H, J = 17.4 Hz, CH2), 5.77-5.92 (m, 1 H, CH), 7.11-7.49  
(m, 4 H, ArH); 13C NMR (75 MHz, CDCl3): δ = 30.0,37.8 (CH2), 72.0 (CH), 94.1 (C), 
110.7 (CH), 115.0 (CH2), 119.1, 122.1, 124.6 (CH) ,125.9 (C), 141.2 (CH), 149.1, 165.3, 
195.4 (C); IR (KBr): ν~ = 3410 (m), 3252 (m), 3195 (m), 1653 (s), 1495 (s), 1479 (s), 
1416 (m), 1371 (w), 1173 (m), 1017 (m), 959 (m), 729 (m): cm−1; GC-MS (EI, 70 eV): 
m/z (%): 309 (M+, 19), 227 (20), 175 (33), 160 (100), 133 (17), 104 (10), 77 (15); HRMS 
(ESI): calcd (%) for C14H13BrO3 ([M+1])309.23461, found 309.23156. 
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                                                                                           Chapter 4 
Regioselective Synthesis of Diaryl Ethers based  on One-Pot 
Cyclizations of 4-Aryloxy-1,3- bis(trimethylsilyloxy)-1,3-dienes 
                                                                                                        Tetrahedron 2008, 64, 529-535.
4.1. Introduction 
Functionalized diaryl ethers are of pharmacological relevance and occur in a variety of 
natural products.1 This includes, for example, geodinhydrate methylester, methyl 
chloroasterrate,2a,b 1-desgalloylsanguiin,2c dehydrotrigallic acid,2d epiphorellic acid,2e
jolkianin,2f remurin A,2g  and micareic acid (Scheme 1).2h The most important approach 
to diaryl ethers relies on the Ullmann3 and Buchwald-Hartwig4 reaction and on related 
transformations.5 Although these methods are very important, the scope is limited by the 
availability of the starting materials, In fact, the synthesis of more complex aryl halides or 
triflates by regioselective functionalizations of arenes is often a difficult task. In addition, 
the transition metal catalyzed formation of diaryl ethers containing a sterically 
encumbered ether linkage is often difficult or not possible at all. Some years ago, Chan et 
al. developed6 a convenient approach to salicylates based on the cyclization of 1,3-
bis(trimethylsilyloxy)-1,3-dienes7 with 3-trimethylsilyloxy-2-en-1-ones. We reported the 
application of this method to the synthesis of a variety of substituted benzene 
derivatives.8 Recently, we reported the synthesis of 5-aryloxysalicylates9 and 5-
thioaryloxysalicylates based on reactions of 2-aryloxy- and 2-thioaryloxy-3-
trimethylsilyloxy-2-en-1-ones, respectively.10 Herein, we report, for the first time, the 
synthesis of 4-aryloxy-1,3-bis(trimethylsilyloxy)-1,3-dienes and their application to the 
synthesis of diaryl ethers. Noteworthy, the reactions reported herein allow a convenient 
and regioselective synthesis of sterically encumbered and functionalized diaryl ethers 
which are not readily available by other methods.  
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Scheme 1. Micareic acid 
4.2.Results and Discussion 
Ethyl 4-phenoxyacetoacetate (2a) was prepared by base-mediated reaction of ethyl 4-
chloroacetoacetate and phenol (Scheme 2, Table 1). The methyl 4-phenoxyacetoacetates 
2b,c were prepared by Claisen condensation of methyl acetate with the corresponding α-
aryloxyacetic chlorides. The silylation of 2a-c gave the 3-silyloxy-2-en-1-ones 3a-c. The 
novel 4-aryloxy-1,3-bis(silyloxy)-1,3-dienes 4a-c were prepared by deprotonation (LDA) 
of 3a-c at −78 °C and subsequent addition of trimethylchlorosilane. The Me3SiOTf-
catalyzed cyclization of 4-aryloxy-1,3-bis(silyloxy)-1,3-dienes 4a-c with 1,1,3,3-
tetramethoxypropane, following our recently reported protocol,11 afforded the 3-
aryloxysalicylates 5a-c. During the optimization of the cyclization, the concentration and 
the stoichiometry proved to play an important role.
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Scheme 2. Synthesis of 5a-c; i: NEt3/KOH, CH2Cl2/DMSO, 30 min, 0 °C/ 5 h, 20 °C; ii: :
LDA, THF, –78  20 °C, 14 h; iii: Me3SiCl, NEt3, C6H6, 20 °C, 72 h; iv: : LDA, THF, –
78  20 °C; v: Me3SiOTf, CH2Cl2, –78  20 °C, 20 h 
                      Table 1. Synthesis of diaryl ethers 5a-c 
                                   Isolated yields 
2-5 R1 R2 % 
(2) a
 %  
(3) a
 %  
(4) a
 %  
(5) a
a H OEt 60 91 82 45 
b Cl OMe 30 74 82 46 
c M
e 
OMe 40 75 84 48 
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The TiCl4-mediated [3+3] cyclization of 1,3-bis(silyloxy)-1,3-dienes 4a-c with 3-
silyloxy-2-en-1-ones 6a-e afforded the 3-aryloxysalicylates 7a-g (Scheme 3, Table 2). 
During the optimization, it proved to be important to carry out the reactions in a highly 
concentrated solution. In addition, the stoichiometry and the temperature are important 
parameters. 
                           
OSiMe3Me3SiO
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O
R1
Me Me
Me3SiO O
R3
OH O
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R1 Me
R3
Me
7a-g
i
6a-e
4a-c
+
                    Scheme 3. Synthesis of 7a-g; i: TiCl4, CH2Cl2, –78  20 °C, 20 h 
                   Table 2. Synthesis of diaryl ethers 7a-g
                       a Isolated yields; b Ar = 3,4-(MeO)2C6H3
              
                                       
4 6 7 R1 R2 R3  % (7)a
a a a H OEt H 37 
a b b H OEt Me 43 
a c c H OEt Cl 38 
a d d H OEt ArO b 30 
a e e H OEt PhS 30 
b c f Me OMe Cl 40 
c b g Cl OMe Me 40 
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The TiCl4- and TiBr4-mediated reaction of 1,3-bis(silyloxy)-1,3-diene 4a with 1,1-
diacetylcyclopropane (8) afforded the 3-phenoxysalicylates 9a,b containing a remote 
halide function (Scheme 4, Table 3). The formation of the products can be explained by 
means of a domino [3+3]-cyclization-homo-Michael reaction.13 The structures of 9a and
9b were independently confirmed by X-ray crystal structure analyses (Figures 2 and 3).  
       
OSiMe3Me3SiO
OEt
O
Me
O O
Me
O
OEt
O
MeMe
OH
i
4a
+
8
TiX4
9a,b
X
           Scheme 4. Synthesis of 9a,b; i: TiX4 (X = Cl, Br), CH2Cl2, –78  20 °C, 20 h 
                                                   Table 3. Synthesis of 9a,b 
                                                      a Isolated yields
The Me3SiOTf-catalyzed reaction of 1,3-bis(silyloxy)-1,3-diene 4a with 3-
formylchromone 10 afforded the highly functionalized diaryl ether 11 (Scheme 5). The 
products are formed by a domino Michael−retro-Michael−Mukaiyama-Aldol reaction.14 
9 X  % (9) a
a Cl 40 
b Br 33 
77
       
Figure 2. Ortep plot of 9a 
Figure 3. Ortep plot of 9 
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OH
Scheme 5. Synthesis of 11; i: Me3SiOTf (0.3 equiv), 20 °C, 10 min; ii: 1) 4a (1.3 equiv), CH2Cl2, 
0  20 °C, 12 h; 2) HCl (10%) 
The Me3SiOTf-catalyzed reaction of 4a with chromone (12) afforded product 13 which 
was transformed (without purification) into the diaryl ether 14 (Scheme 6). The 
transformation of 13 into 14 proceeds by a domino Michael−retro-
Michael−lactonization reaction.15  
OSiMe3Me3SiO
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i4a
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12 13
14 (70% from 12)
O
Scheme 6. Synthesis of 14; i: 1) Me3SiOTf (0.3 equiv), 20 °C, 1 h; 2) 4a (1.3 equiv), 
CH2Cl2, 0  20 °C, 12 h; 3) HCl (10%); ii: NEt3 (2.0 equiv), EtOH,  20 °C, 12 
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In conclusion, a variety of sterically encumbered diaryl ethers were prepared based on 
formal [3+3] cyclizations of novel 4-aryloxy-1,3-bis(trimethylsilyloxy)-1,3-dienes. The 
products are not readily available by other methods. 
 4.3. Experimental section 
General Comments. All solvents were dried by standard methods and all reactions 
were carried out under an inert atmosphere. For 1H and 13C NMR spectra the deuterated 
solvents indicated were used. Mass spectrometric data (MS) were obtained by electron 
ionization (EI, 70 eV), chemical ionization (CI, H2O) or electrospray ionization (ESI). 
For preparative scale chromatography, silica gel (60-200 mesh) was used. Melting 
points are uncorrected.  
General procedure for the synthesis of aryloxyacetoacetates 2a-c: Method A: To a 
mixture of  potassium hydroxide (2.0 mmol) in 2 mL of DMSO was dropwise added a 
solution of phenol (1.0 mmol) in 0.2 mL of DMSO. The mixture was stirred at room 
temperature for 30 min and then ethyl 4-chloroacetoacetate (1.0 mmol) was added. The 
mixture was stirred at room temperature overnight and then acidified by addition of 
hydrochloric acid (4 M). The mixture was extracted with  EtOAc and the organic layer 
was washed with water and then with brine, and dried over Na2SO4. The solution was 
filtered and the solvent of the filtrate was removed under reduced pressure. The crude 
product was purified by chromatography (silica gel, EtOAc / n-heptane). 
Method B: A THF solution of 2.3 equiv. of LDA was prepared by addition of n-BuLi 
(0.93 mL, 2.3 mmol, 2.5 M solution in hexanes) to a THF solution (6 mL) of 
diisopropylamine (0.32 mL, 2.3 mmol) at 0 °C. After stirring of the solution for 30 min, 
methyl acetate (0.09 mL, 1.1 mmol) was added at 0 °C. After stirring for 45-60 min, to 
the solution was added a THF solution (4 mL) of the acid chloride (205 mg, 1.0 mmol) 
at −78 °C. The temperature was allowed to rise to 20 °C during 5-6 h and the solution 
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was stirred at 20 °C for 8 h. To the solution was added a diluted aqueous solution of 
HCl and the mixture was extracted with EtOAc (3× 
200 mL). The organic layers were 
dried and filtered, the solvent of the filtrate was removed in vacuo, and the residue was 
purified by chromatography (silica gel, EtOAc / n-heptane).   
General procedure for the synthesis of diaryl ethers 5a-c: To a dichloromethane 
solution (2 mL / mmol of 4) of 4 (1.0 mmol) and of 1,1,3,3-tetramethoxypropane was 
added TMSOTf (0.1 mmol) at –78 °C. The solution was allowed to warm to 20 °C within 
20 h. To the solution was added a saturated aqueous solution of HCL (15 mL). The 
organic and the aqueous layer were separated and the latter was extracted with 
dichloromethane (3 x 15 mL). The combined organic layers were dried (Na2SO4), 
filtered, and the filtrate was concentrated in vacuo and the residue was purified by 
chromatography.  
General procedure for the synthesis of diaryl ethers 7a-g: To a dichloromethane 
solution (2 mL / mmol of 4) of 4 (1.0 mmol) and of 6 (1.0 mmol) was added TiCl4 (1.0 
mmol) at –78 °C. The solution was allowed to warm to 20 °C within 20 h. To the solution 
was added a saturated aqueous solution of NaHCO3 (15 mL). The organic and the 
aqueous layer were separated and the latter was extracted with diethyl ether (3 x 20 mL). 
The combined organic layers were dried (Na2SO4), filtered, and the filtrate was 
concentrated in vacuo and the residue was purified by chromatography (silica gel, EtOAc 
/ n-heptane = 1:4). 
Synthesis of ethyl-5-(2-hydroxy-3-methylbenzoyl)-3-phenoxysalicylate (11):
Me3SiOTf (0.3 equiv) was added to the 3-formylchromone (1.0 equiv) at 20 °C. After 
stirring for 10 min, CH2Cl2 (8 mL) was added, the solution was cooled to 0 °C and the 1, 
3-bis (silyl enol ether) (1.3 equiv) was added. The mixture was stirred at 20 °C for 12 h 
and was subsequently poured into an aqueous solution of HCl (10%). The organic and the 
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aqueous layer were separated and the latter was extracted with CH2Cl2 (3 x 15 mL). The 
combined organic layers were washed with brine (25 mL) and dried over Na2SO4. The 
mixture was filtered and the solvent of the filtrate was removed under reduced pressure. 
The crude product was purified by chromatography (silica gel, EtOAc / n-heptane). 
Synthesis of 8-phenoxy-7-hydroxy-6H-benzo[c]chromen-6-one (14): Me3SiOTf (1.3 
equiv) was added to the chromone (1.0 equiv) at 20 °C. After stirring for 1 h, CH2Cl2 (8 
mL) was added, the solution was cooled to 0 °C and the 1,3-bis(silyl enol ether) (1.3 
equiv)  was added. The mixture was stirred at 20 °C for 12 h and was subsequently 
poured into an aqueous solution of HCl (10%). The organic and the aqueous layer were 
separated and the latter was extracted with CH2Cl2 (3 x 15 mL) and dried over Na2SO4. 
The mixture was filtered and the solvent f the filtrate was removed under reduced 
pressure to give crude product 13. To an EtOH solution (10 mL) of the latter was added 
NEt3 (2.0 equiv) and the mixture was stirred for 12 h at 20 °C. To the solution was added 
hydrochloric acid (1 M) and then EtOAc. The organic and the aqueous layer were 
separated and the latter was extracted with EtOAc and dried over Na2SO4. The mixture 
was filtered and the solvent of the filtrate was removed under reduced pressure. The 
crude product was purified by chromatography (silica gel, EtOAc / n-heptane). 
Ethyl 4,6-dimethyl-5-(2-chloroethyl)-3-phenoxysalicylate (9a): Starting 1,1-
diacetylclopropane (15) (300 mg, 2.4 mmol)  1,3-bis(silyl enol ether) 4a (1.200 g, 3.3 
mmol), TiCl4 (0.52 mL, 4.8 mmol) and CH2Cl2 (110 mL), 9a was isolated as colourless 
crystals (328 mg, 40%), mp. 75 °C; 1H NMR (250 MHz, CDCl3): δ = 1.34 (t, 3 H, J = 
7.25 Hz,  CH3), 2.14 (s, 3 H, CH3), 2.45 (s, 3 H, CH3), 3.07 (t, 2 H, J = 6.45 Hz, CH2), 
3.45 (t, 2 H, J = 7.5 Hz, CH2), 4.37 (q, 2 H, J = 6.5 Hz, CH2), 6.76 (m, 2 H, ArH), 6.94 
(m, 1 H, ArH), 7.76 (m, 2 H, ArH), 10.41 (s, 1 H, OH); 13C NMR (62 MHz, CDCl3): δ = 
12.4, 13.1, 17.3 (CH3), 32.2, 41.1, 60.9 (CH2), 112.9 (C), 113.6 (2C CH), 120.7 (CH), 
126.4 (C), 128.5 (2C CH), 133.9 136.0, 138.0, 151.9, 156.7, 169.8 (C); IR (Nujol): ν~ = 
3381 (w), 2981 (s), 1728 (m), 1669 (m), 1590 (m), 1491 (m), 1301 (m), 1218 (m), 1167 
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(m), 1036 (m), 788 (w) 750 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 450 (M+, 37Cl, 
13),448 (M+, 35Cl, 41), 403 (73), 267 (83), 253 (43), 105 (100), 77 (22); HRMS (EI): 
calcd for C19H21O4Cl [M+,35Cl]: 448.11229, found 448.11180.  
Ethyl 4,6-dimethyl-5-(2-bromoethyl)-3-phenoxysalicylate (9b): Starting with 1,1-
diacetylcyclopropane 15 (300 mg, 2.4 mmol), 1,3-bis(silyl enol ether) 4a (1.20 g, 3.3 
mmol), TiBr4 (873 mg, 2.4 mmol), and CH2Cl2 (110 mL), 9b was isolated as colourless 
crystals (315 mg, 33%), mp. 103 °C;  1H NMR (250 MHz, CDCl3): δ = 1.24 (t, 3 H, J = 
7.1 Hz, CH3), 2.03 (s, 3 H, CH3), 2.34 (s, 3 H, CH3), 3.05 (m, 2 H, CH2), 3.22 (m, 2 H,
CH2), 4.27 (q, 2 H, J = 7.1 Hz, CH2), 6.65 (m, 2 H, ArH), 6.83 (m, 1 H, ArH), 7.08 (m, 2 
H, ArH), 10.23 (s, 1 H, OH); 13C NMR (62 MHz, CDCl3): δ = 11.4, 12.2, 16.3 (CH3), 
27.6, 31.6, 59.9 (CH2), 111.9 (C), 112.6 (2C CH), 119.5 (CH), 126.5 (C), 127.6 (2C CH), 
132.8, 134.9, 137.0, 151.0, 155.7, 168.8 (C); IR (Nujol): ν~ = 3375 (w), 2978 (s), 1734 
(m), 1675 (m), 1590 (m), 1490 (m), 1319 (m), 1219 (m), 1176 (m), 1029 (m), 751 (w) 
690 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 393 (M+, 81Br, 40), 391 (M+, 79Br, 40), 347 
(62), 313 (26), 267 (100), 253 (33), 105 (89), 77 (34); HRMS (EI): calcd  for C19H21O4Br 
([(M+1)+ , 79Br]: 392.06177, found 392.06199. 
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                                                                                                                         Chapter 5
Synthesis of 1-Azaxanthones by Condensation of 1,3- Bis (trimethy 
lsilyloxy) -1,3-butadieneswith-(Cyano)-benzopyryliumTriflates and 
Subsequent Domino ′Retro-Michael-Nitrile-Addition Heterocyclization′
                                                                                               Tetrahedron 2008, submitted
5.1. Introduction 
Azaxanthones (i. e. 5-oxo-5H-[1]-benzopyrano [2,3-b]pyridines) are of considerable 
pharmacological relevance. For example, they show antiinflammatory activity and 
represent inhibitors of the passive cutaneous anaphylaxis.1 1-Azaxanthones are available, 
based on pioneering work of Ghosh and coworkers,2a by base-mediated reaction of 3-
cyanochromones with active methylene compounds.2 Despite its preparative utility, the 
scope of this approach is limited to specific substrates and substitution patterns. 4-
(Trimethylsilyloxy)benzopyrylium triflates can be readily generated by addition of 
trimethylsilyl-trifluoromethanesulfonate (TMSOTf) to chromones. Their reaction with 
nucleophiles allows the regioselective functionalization of carbon atom C-2 of the 
chromone moiety. The formal [4+2]-cycloaddition of 1,3-butadienes with 4-
(trimethylsilyloxy)benzopyrylium triflates was first reported by Akiba and coworkers.3
Later, the TMSOTf-mediated [4+2]-cycloaddition of 1,3-butadienes with 3-
cyanochromone, via its 4-(trimethylsilyloxy)benzopyrylium triflate, has been reported.4
In the course of our interest in the development of new domino reactions5 of 4-
(silyloxy)benzopyrylium triflates,6 we recently reported7 the TMSOTf-mediated reaction 
of 3-cyanochromones with 1,3-bis(trimethylsilyloxy)-1,3-butadienes.8 These reactions 
allow a convenient synthesis of functionalized 1-azaxanthones which are not readily 
available by other methods. Herein, full details of our methodology and a comprehensive 
study related to its preparative scope are reported.  
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5.2. Results and Discussion 
The TMSOTf-mediated reaction of 1a with 1,3-bis(trimethylsilyloxy)-1,3-butadiene 2a, 
readily available in two steps from methyl acetoacetate,9 afforded the condensation 
product 3a by regioselective attack of the terminal carbon atom of 2a onto carbon atom 
C-2 of 1a and subsequent hydrolysis. Treatment of an ethanol solution of crude 3a with 
triethylamine afforded 1-azaxanthone 4a (Scheme 1). The formation of 4a can be 
explained by a domino 'retro-Michael-lactonization-aldol' reaction. The base-mediated 
retro-Michael reaction of 3a gave open-chained intermediate B. The attack of the 
hydroxy group onto the nitrile gave intermediate C. The attack of the imino nitrogen 
atom onto the carbonyl group (intermediate D) and subsequent aromatization by 
extrusion of water afforded 4a. The transformation of 3a into 4a can be regarded as a 
domino 'retro-Michael / nitrile-addition / heterocyclization' reaction. 
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The reaction of 1,3-bis(trimethylsilyloxy)-1,3-butadienes 2a-c, prepared from methyl, 
ethyl and isopropyl acetoacetate, with parent 3-cyanochromone (1a) and with the alkyl- 
and halogen-substituted 3-cyanochromones 1b-g afforded products 3a-j which were 
transformed, by reaction with NEt3, into the 1-azaxanthones 4a-j (Scheme 2, Table 1). 
The reaction of parent 3-cyanochromone 1a with 1,3-bis(trimethylsilyloxy)-1,3-butadiene 
2d, prepared from methyl 3-oxopentanoate, afforded 3a. Treatment of 3a with 
triethylamine afforded dibenzo[b,d]pyran-6-one 5a rather than the expected methyl-
substituted azaxanthone 4k. The formation of 5a can be explained by a competing 
domino ′retro-Michael-aldol-lactonization′ reaction (Scheme 3).10 In contrast, the 
reaction of 2e (derived from ethyl 3-oxopentanoate) with chlorinated 3-cyanochromone 
1e afforded azaxanthone 4l (via 3l). The reaction of parent cyanochromone 1a with 1,3-
bis(silyl enol ether) 2f, prepared from ethyl 3-oxohexanoate, afforded 3m. Treatment of 
the latter with base resulted in formation of a separable mixture of ethyl-substituted 
azaxanthone 4m and dibenzo[b,d]pyran-6-one 5b. In contrast, the exclusive formation of 
azaxanthones 4n,o was observed when substituted cyanochromones 1e and 1h were 
employed. The propyl- and butyl-substituted dibenzo[b,d]pyran-6-ones 5c and 5d were 
isolated from the reaction of parent cyanochromone 1a with 1,3-bis(trimethylsilyloxy)-
1,3-butadienes 2g and 2h. The reaction of 2i with 1a and 1e exclusively afforded the 
heptyl-substituted azaxanthones 4r and 4s, respectively. The allyl-substituted 
azaxanthones 4t and 4u were prepared from 2j.  
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Table 1. Products and yields 
1 2 4 5 R1 R2 R3 R4 R5 R6 %  
(4,5)a
a a a  H H OMe H H H 41 
a b b  H H OEt H H H 46 
a c c  H H OiPr H H H 42 
b a d  H H OEt Me H H 40 
c c e  H H OiPr Et H H 31 
d a f  H H OEt iPr H H 41 
e a g  H H OEt Cl H H 37 
f a h  H H OEt Cl H Cl 48 
g a i  H H OEt Br H H 34 
g c j  H H OiPr Br H H 32 
a d k a Me H OMe H H H 0  
(34)b
e e l  Me H OEt Cl H H 41 
a f m b Et H OEt H H H 17  
(34)b
e f n  Et H OEt Cl H H 46 
h f o  Et H OEt Me Me H 38 
a g p c nPr H OMe H H H 0  
(37) b
a h q d nBu H OMe H H H 0  
(42) b
a i r  nHept H OEt H H H 25 
e i s  nHept H OEt Cl H H 38 
a j t  Allyl H OMe H H H 38 
e j u  Allyl H OMe Cl H H 30 
a k v  Ph H OMe H H H 62 
a l w  4-Cl(C6H4) H OMe H H H 50 
e m x  2-MeO(C6H4) H OMe Cl H H 40 
b m y  2-MeO(C6H4) H OMe Me H H 32 
a n z  MeO H OMe H H H 31 
a o aa  PhO H OEt H H H 66 
f o ab  PhO H OEt Cl H Cl 44 
h p ac  4-Cl(C6H4)O H OMe Me Me H 33 
f q ad  4-Me(C6H4)O H OMe Cl H Cl 42 
90
a r ae  PhS H OEt H H H 51 
h s af  4-Cl(C6H4)S H OEt Me Me H 56 
b t ag  4-Me(C6H4)S H OEt Me H H 63 
f u ah  4-MeO(C6H4)S H OEt Cl H Cl 45 
a v ai  H Me OEt H H H 44 
a w aj  H Et OEt H H H 42 
a x ak  
−(CH2)3− OEt H H H 36 
a y al  −CH2CHMeCH2− OMe H H H 32 
c
a z am  −(CH2)4− OMe H H H 0 
a aa an  
−(CH2)9− OMe H H H 0 
a ab ao  H H Ph H H H 0 
a ac ap  H H Me H H H 0 
a Yields of isolated products 4 over two steps (based on 1). b Yields in brackets refer to 
5a-d (structures see Scheme 3). c dr = 2:3 
The reaction of 4-aryl-1,3-bis(trimethylsilyloxy)-1,3-butadienes 2k-m with 3-
cyanochromones 1a,b,e gave the products 3v-y which were transformed into the 3-aryl-1-
azaxanthones 4v-y. 3-Methoxy-1-azaxanthone 4z was prepared from 4-methoxy-1,3-
bis(trimethylsilyloxy)-1,3-butadiene 2n which is available from methyl 4-
methoxyacetoacetate. The reaction of 4-aryloxy-1,3-bis(trimethylsilyloxy)-1,3-butadienes 
2o-q with 1a,f,h afforded the condensation products 3aa-ad which were transformed into 
the 3-aryloxy-1-azaxanthones 4aa-ad. Starting with 4-thioaryloxy-1,3-
bis(trimethylsilyloxy)-1,3-butadienes 2r-u, the 3-thioaryloxy-1-azaxanthones 4ae-ah
were prepared. 1-Azaxanthones 4ai and 4aj were prepared from 1a and from 2-methyl- 
and 2-ethyl-1,3-bis(trimethylsilyloxy)-1,3-butadienes 2v and 2w, respectively. The 
reaction of 1a with cyclohexanone-derived 1,3-bis(trimethylsilyloxy)-1,3-butadienes 2x 
and 2y gave 3ak and 3al which were transformed into the tetracyclic azaxanthones 4ak 
and 4al, respectively. The employment of 7- and 12-membered cyclic 1,3-
bis(trimethylsilyloxy)-1,3-butadienes 2z and 2aa proved to be unsuccessful. The reaction 
of 3-cyanochromones with 1,3-diketone-derived 1,3-bis(silyl enol ethers), such as 1-
phenyl-1,3-bis(trimethylsilyloxy)-1,3-butadiene (2ab) or 2,4-bis(trimethylsilyloxy)-1,3-
pentadiene (2ac), resulted in the formation of complex mixtures.  
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The overall yields of 1-azaxanthones 4a-al are, in most cases, only moderate. However, it 
has to be taken into account that the yields refer to two steps. In fact, a 50% overall yield 
is obtained when each individual step proceeds in ca. 70% yield. The moderate yields can 
be explained by the fact that, for the first step, the conversion is often not complete. 
However, the yields could not be increased by employment of an excess of the 1,3-
bis(trimethylsilyloxy)-1,3-butadiene or by longer reaction times.  
The yields depend on the type of 1,3-bis(trimethylsilyloxy)-1,3-butadiene and 3-
cyanaochromone employed. The synthesis of 3-alkyl-1-azachromones from parent 3-
cyanochromone is problematic, due to the competing formation of dibenzo[b,d]pyran-6-
ones which might be related to the steric influence of the alkyl group. In contrast, the 
synthesis of 3-alkyl-1-azachromones derived from substituted 3-cyanochromones proved 
to be possible. Relatively good yields are observed for 1-azaxanthones 4w-y prepared 
from the phenyl- and 4-chlorophenyl-substituted dienes 2k,l. The yields dropped for 
products 4x,y which were prepared from diene 2m (containing the sterically more 
demanding 2-methoxyphenyl group). The yields of 1-azaxanthones 4aa-ah, containing an 
aryloxy- or thioaryloxy-substituent, are again relatively good. These results can be 
explained by the assumption that, despite their steric effect, all these substituents exert an 
advantageous electronic effect in the first step (the addition of the diene onto the 
pyrylium salt) or in the second step (formation of intermediate B in Scheme 1). The 
yields of tetracyclic products 4ak and 4al are rather low and the synthesis of analogues 
containing larger annulated rings was not possible at all. This might be explained by 
steric effects. The failure of the synthesis of 3ao and 3ap (and, thus, of the corresponding 
1-azaxanthones) can be explained by the generally lower reactivity of 1,3-diketone- 
compared to β-ketoester-derived 1,3-bis(trimethylsilyloxy)-1,3-butadienes.   
In conclusion, a variety of 1-azaxanthones were prepared by TMSOTf-mediated 
condensation of 1,3-bis(trimethylsilyloxy)-1,3-butadienes with 3-cyanochromones and 
subsequent base-mediated domino 'retro-Michael−lactonization−aldol' reaction. 
Noteworthy, the syntheses can be carried out under mild conditions and the reactions 
proceed in acceptable yields with very good regio- and chemoselectivity. The products 
are not readily available by other methods. 
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5.3. Experimental Section 
General Comments. All solvents were dried by standard methods and all reactions were 
carried out under an inert atmosphere. For 1H and 13C NMR spectra the deuterated 
solvents indicated were used. Mass spectrometric data (MS) were obtained by electron 
ionization (EI, 70 eV), chemical ionization (CI, H2O) or electrospray ionization (ESI). 
For preparative scale chromatography, silica gel (60-200 mesh) was used. Melting points 
are uncorrected.  
General procedure for the synthesis of azaxanthones 4a-al and dibenzo[b,d]pyran-6-
ones 5a-d: To neat 3-cyanochromone 1 (1.0 equiv.) was added Me3SiOTf (1.3 equiv.) 
and CH2Cl2 (1 mL) at 20 °C. After stirring for 1 h, CH2Cl2 and 1,3-
bis(trimethylsilyloxy)-1,3-butadiene 2 (1.3 equiv.) were added at 0 °C. The mixture was 
stirred for 12 h at 20 °C and subsequently poured into hydrochloric acid (10%). The 
organic and the aqueous layer were separated and the latter was extracted with CH2Cl2 (3 
x 100 mL). The combined organic layers were washed with water, dried (Na2SO4), 
filtered and the filtrate was concentrated in vacuo. The residue was filtered through a pad 
of silica gel (EtOAc/hexane = 5:1) to give crude 3a-al. To an ethanol solution (10 mL) of 
3a-al was added NEt3 (2.0 equiv.) and the solution was stirred for 12 h at 20 °C. To the 
solution were subsequently added an aqueous solution of hydrochloric acid (1 M) and 
ether (50 mL). The organic and the aqueous layer were separated and the latter was 
extracted with ether (3 x 100 mL). The combined organic layers were washed with water, 
dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by column chromatography (silica gel, EtOAc/hexane).   
Ethyl 2-(7-chloro-3-methyl-5-oxo-5H-chromeno[2,3-b]pyrid-2-yl)acetate (4l):
Starting with 6-chlorocyanochromone (1e) (150 mg, 0.60 mmol), 2e (288 mg, 0.78 
mmol), Me3SiOTf (0.14 mL, 0.78 mmol), and NEt3 (0.16 mL, 1.20 mmol), 4l was 
isolated as a colourless solid (98 mg, 41%), mp. = 190 °C. 1H NMR (250 MHz, CDCl3): 
δ = 1.27 (t, 3 H, 3J = 7.1 Hz, CH3), 2.46 (s, 3 H, CH3), 3.99 (s, 2 H, CH2), 4.28 (q, 2 H, 3J
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= 6.9 Hz, OCH2CH3), 7.55. (d, 1 H, 3J = 8.9, Hz, ArH), 7.71. (dd, 1 H, 3J = 7.91, 4J =2.5 
Hz, ArH), 8.26. (d, 1 H, 4J = 2.5 Hz, ArH), 8.46 (s, 1 H, ArH). 13C NMR (62 MHz, 
CDCl3): δ = 14.1, 18.1 (CH3), 42.3, 61.4 (CH2), 115.6 (C), 120.2 (CH), 122.5 (2C, C), 
125.9 (CH), 130.0 (C), 135.5, 138.1 (CH), (C), 154.0, 157.1, 159.5 (C), 169.0, 176.5 
(C=O). IR (neat, cm−1): ~ν  =   3092 (w), 2977 (m), 2921 (w), 1724 (s), 1667 (s), 1603 
(m), 1439 (s), 1270 (s), 1180 (s), 843 (s), 788 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 
333 (M+, 37Cl, 27), 331 (M+, 35Cl, 87), 285 (70), 257 (100), 230 (29), 194 (4), 126 (15), 
63 (10). HRMS (ESI): calcd for C18H16NO4Cl (M+ , 35Cl): 331.06059, found 331.060408. 
Ethyl 2-(7-chloro-3-ethyl-5-oxo-5H-chromeno[2,3-b]pyrid-2-yl)acetate (4n): Starting 
with 6-chlorocyanochromone (1e) (150 mg, 0.60 mmol), 1,3-bis(silyl enol ether) 2f (305 
mg, 0.78 mmol), Me3SiOTf (0.14 mL, 0.78 mmol), and NEt3 (0.16 mL, 1.20 mmol), 4n
was isolated as a highly viscous yellowish oil (150 mg, 46%). 1H NMR (250 MHz, 
CDCl3): δ = 1.25 (t, 3 H, 3J = 7.3 Hz, CH3), 1.33 (t, 3 H, 3J = 7.5 Hz, CH3), 2.81 (q, 2 H, 
3J = 6.9 Hz, CH2CH3), 4.00 (s, 2 H, CH2), 4.20 (q, 2 H, 3J = 7.1 Hz, OCH2CH3), 7.55. (d, 
1 H, 3J = 8.9, Hz, ArH), 7.70 (dd, 1 H, 3J = 7.91, 4J =1.5 Hz, ArH), 8.28. (d, 1 H, 4J = 2.5 
Hz, ArH), 8.51 (s, 1 H, ArH). 13C NMR (62 MHz, CDCl3): δ = 13.9, 14.1 (CH3), 29.6, 
41.7, 61.4 (CH2), 115.2 (C), 120.2 (CH), 122.5 (C), 125.9 (CH), 130.0 (C), 135.5 (CH), 
136.3 (C), 136.4 (CH), 154.0, 157.2, 159.0 (C), 169.2, 176.5 (C=O). IR (neat): ν~ = 2956 
(w), 2921 (m), 2935 (w), 1726 (s), 1699 (s), 1583 (m), 1428 (s), 1180 (s), 1024 (s), 789 
(s), 710 (m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 347 (M+, 37Cl, 24), 345 (M+, 35Cl), 299 
(34), 271 (100), 257 (29), 208 (4), 139 (15), 63 (10). HRMS (ESI): calcd  for 
C18H16NO4Cl (M+, 35Cl): 345.0764, found 345.07626. 
Ethyl 2-(3-ethyl-7,8-dimethyl-5-oxo-5H-chromeno[2,3-b]pyrid-2-yl)acetate (4o):
Starting with 6,7-dimethylcyanochromone (1h) (150 mg, 0.75 mmol), 1,3-bis(silyl enol 
ether) 2f (302 mg, 0.97 mmol), Me3SiOTf (0.17 mL, 0.97 mmol), and NEt3 (0.20 mL, 1.5 
mmol), 4o was isolated as a colourless solid (100 mg, 38%), mp. = 149 °C. 1H NMR (250 
MHz, CDCl3): δ = 1.25 (t, 3 H, 3J = 7.1 Hz, CH3), 1.34 (t, 3 H, 3J = 7.5 Hz, CH3), 2.37 (s, 
94
3 H, CH3), 2.42 (s, 3 H, CH3), 2.79 (q, 2 H, 3J = 7.4 Hz, CH2CH3), 4.0 (s, 2 H, CH2), 4.21 
(q, 2 H, 3J = 7.2 Hz, OCH2CH3), 7.34 (s, 1 H, ArH), 8.00 (s, 1 H, ArH), 8.51 (s, 1 H, 
ArH). 13C NMR (62 MHz, CDCl3): δ = 14.0, 14.1, 19.2, 20.6 (CH3), 24.4, 41.7, 61.3 
(CH2), 115.6 (C), 118.5 (CH), 119.4 (C), 126.2 (CH), 133.7, 135.5 (C), 136.3 (CH), 
146.2, 154.2, 157.9, 158,0 (C), 169.4, 177.4 (C=O). IR (neat): ν~ = 2970 (w), 2921 (m), 
2856 (w), 1727 (s), 1663 (s), 1607 (m), 1425 (s), 1181 (s), 1158 (s), 1026 (s), 789 (s), 739 
(m) cm−1. GC-MS (EI, 70 eV): m/z (%) = 339 (M+, 96), 293 (61), 265 (100), 250 (16), 
222 (7), 1194 (15), 91 (10). HRMS (ESI): calcd for C20H21NO4 [M]: 339.14651, found 
339.14641. 
Ethyl 2-{3-[(4-chlorophenyl)sulfanyl]-7,8-dimethyl-5-oxo-5H-chromeno[2,3-b]pyrid-
2-yl}acetate (4af): Starting with 1h (400 mg, 2.0 mmol), 2s (418 mg, 2.6 mmol), 
Me3SiOTf (0.46 mL, 2.6 mmol), and NEt3 (0.55 mL, 4.0 mmol), 4af was isolated as a 
colourless solid (515 mg, 56%), mp. = 147 °C. 1H NMR (250 MHz, CDCl3): δ = 1.14 (t, 
3 H, 3J = 7.1 Hz, CH3), 2.09 (s, 3 H, CH3), 2.14 (s, 3 H, CH3), 4.10 (q, 2 H, 3J = 6.9 Hz, 
OCH2CH3), 4.43 (s, 2 H, CH2), 6.92. (m, 2H, ArH), 7.05 (s, 1 H, ArH), 7.09 (m, 2H, 
ArH), 7.73 (s, 1 H, ArH), 8.90 (s, 1 H, ArH). 13C NMR (62 MHz, CDCl3): δ = 14.2, 19.2, 
20.7, (CH3), 40.1, 60.9 (CH2), 114.8 (C), 118.7 (CH), 119.4, 122.6 (C), 126.4 (CH), 
129.0 (2C, CH), 132.3 (2C, CH), 133.1, 133.6, 134.6, 141.1, 147.0, 153.9, 160.0, 164.6 
(C), 164.9, 176.5 (C=O).  IR (neat): ν~ = 3054 (w), 2975 (w), 2895 (w), 1703 (s), 1605 
(s), 1463 (m), 1439 (s), 1240 (s), 1162 (s), 833 (s), 793 (m) cm−1. GC-MS (EI, 70 eV): 
m/z (%) = 455 (M+, 37Cl, 17), 453 (M+, 35Cl, 46), 407 (20), 311 (30), 282 (100), 266 (23), 
144 (20), 109 (15) 44 (78).  HRMS (ESI): calcd for C24H20NO4ClS (M+, 35Cl): 
453.07961, found 453.07890. 
Ethyl 2-{7-methyl-3-[(4-methylphenyl)sulfanyl]-5-oxo-5H-chromeno[2,3-b]pyrid-
2-yl}acetate (4ag): Starting with 1b (400 mg, 2.16 mmol), 2t (396 mg, 2.81 mmol), 
Me3SiOTf (0.50 mL, 2.81 mmol), and NEt3 (0.60 mL, 4.3 mmol), 4ag was isolated as a 
colourless solid (572 mg, 63%), mp. = 148 °C. 1H NMR (250 MHz, CDCl3): δ = 1.51 (t, 
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3 H, 3J = 7.2 Hz, CH3), 2.38 (s, 3 H, CH3), 2.58 (s, 3 H, CH3), 4.48 (q, 2 H, 3J = 7.1 Hz, 
OCH2CH3), 4.83 (s, 2 H, CH2), 7.15 (d, 2 H, 3J = 7.91, ArH), 7.37 (d, 2 H, 3J = 7.6 Hz, 
ArH), 7.60 (d, 1 H, 3J = 8.7 Hz, ArH),  7.70. (dd, 1 H, 3J = 6.91, 4J =2.5 Hz, ArH), 8.21 
(d, 1 H, 4J = 2.62 Hz, ArH), 9.30 (s, 1 H, ArH). 13C NMR (62 MHz, CDCl3): δ = 14.1, 
20.8, 21.0 (CH3), 40.6, 61.9 (CH2), 114.5 (C), 118.0 (CH), 121.0, 123.2 (C), 126.1 (CH), 
129.6 (2C, CH), 131.0 (C), 131.9 (2C, CH), 135.2 (C), 137.1 (CH), 137.3 (C), 140.9 
(CH), 153.7, 160.1, 164.7 (C), 165.5, 176.8 (C=O). IR (neat): ν~ = 3075 (w), 2979 (w), 
2810 (w), 1731 (s), 1695 (s), 1475 (m), 1339 (s), 1249 (s), 1062 (s), 803 (s), 796 (m) 
cm−1. GC-MS (EI, 70 eV): m/z (%) = 419 (M+, 91), 404 (5), 373 (21), 268 (100), 240 
(17), 210 (21), 105 (11). HRMS (ESI): calcd for C24H21NO4S (M+): 419.11858, found 
419.11936. 
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 Chapter 6 
Regioselective Synthesis of Functionalized Biaryls based on Cyclizations 
of 4-Aryl-1,3-bis(trimethyl-silyloxy)-1,3-butadienes  
                                                                                                Eur. J .Org. Chem. 2008, submitted
 6.1. Introduction 
Functionalized biaryls containing a 3-arylsalicylate substructure occur in a variety of 
pharmacologically relevant natural products. The simple biaryls cynandione A-C have 
been isolated from many plant sources and show a considerable in vitro activity against 
hepatocytes, human bladder carcinoma T-24 cells, epidermoid carcinoma KB cells, and 
human hepatoma PLC/PRF/5 cells.1 A number of natural products, such as knipholone, 
6'-O-methylknipholone or (+)-asphodelin, contain an anthraquinone moiety.2 Other 
compounds, e. g. secalonic acid A or globulixanthone E, contain a bixanthenyl 
substructure.3 3-Arylsalicylates are also present in many flavones (e. g. 2,3-
dihydroamentoflavone,4a bartramiaflavone,4b robustaflavone,4c dichamanetin).4d,e For 
some derivatives, inhibition of the human liver cathepsin B and K has been reported.4f,g
The natural product anastatin A, which contains a hydroxylated dibenzofuran moiety, 
shows hepatoprotective activity.5  
The most important synthetic approach to biaryls relies on palladium(0)-catalyzed 
cross-coupling reactions.6 Although these reactions are broadly applicable, the synthesis 
of sterically encumbered products can be difficult or not possible at all. In addition, the 
regioselective synthesis of the required aryl halides or triflates can be a very difficult 
task. Some years ago, Chan et al. developed7 a convenient approach to salicylates by 
formal [3+3] cyclizations8 of 1,3-bis(trimethylsilyloxy)-1,3-dienes9 with 3-
trimethylsilyloxy-2-en-1-ones. Recently, we developed a catalytic variant of this 
transformation.10 Herein, we report, for the first time, the synthesis of 4-aryl-1,3-
bis(trimethylsilyloxy)-1,3-butadienes and their application to the synthesis of 
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functionalized biaryls. The sterically encumbered and functionalized biaryls reported 
herein are not readily available by other methods. 
´6.2. Results and Discussion 
The 4-arylacetoacetates 2a-e were prepared by LDA-mediated reaction of methyl acetate 
with the α-arylacetyl chlorides 1a-e (Scheme 1, Table 1). The silylation of 2a-e afforded 
the 3-silyloxy-2-en-1-ones 3a-e. The novel 4-aryl-1,3-bis(silyloxy)-1,3-dienes 4a-e were 
prepared by deprotonation (LDA) of 3a-e at −78 °C and subsequent addition of 
trimethylchlorosilane. The Me3SiOTf-catalyzed cyclization of 4-aryl-1,3-bis(silyloxy)-
1,3-dienes 4a-e with 1,1,3,3-tetramethoxypropane, carried out following our recently 
reported procedure,10 afforded the 3-arylsalicylates 5a-e. The concentration and the 
stoichiometry proved to be important parameters during the optimization of this reaction. 
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Scheme 1. Synthesis of 5a-e; i: LDA, THF, –78  20 °C, 14 h; ii: Me3SiCl, NEt3, C6H6, 
20 °C, 72 h; iii: LDA, THF, –78  20 °C; iv: Me3SiOTf (0.1 equiv.), CH2Cl2, –78  20 
°C, 20 h 
                      Table 1. Synthesis of biaryls 5a-e
                                       a Isolated yields 
2-5 R1 R2 % 
(2)a
 %  
(3)a
 %  
(4)a
 %  
(5)a
a H H 60 82 80 44 
b H OMe 56 80 84 50 
c OMe H 48 75 82 34 
d H Cl 34 77 85 43 
e H Me 45 81 86 36 
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The TiCl4-mediated [3+3] cyclization of 1,3-bis(silyloxy)-1,3-dienes 4a-e with 3-
silyloxy-2-en-1-ones 6a-c afforded the 3-aryloxysalicylates 7a-j (Scheme 2, Table 2). 
During the optimization, it proved to be important to carry out the reactions in a highly 
concentrated solution.  
                  
Me Me
Me3SiO O
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7a-j
i
6a-c
+
OSiMe3Me3SiO
OMe
R2
R1
4a-e
R2 R1
OH
OMe
O
MeMe
R3
                         Scheme 2. Synthesis of 7a-j; i: TiCl4, CH2Cl2, –78  20 °C, 20 h 
             Table 1. Synthesis of biaryls 7a-j 
               a Isolated yields 
4 6 7 R1 R2 R3 % (7)a
a a a H H H 41 
a b b H H Cl 40 
c a c OMe H H 26 
c b d OMe H Cl 30 
b b e H OMe Cl 38 
b a f H OMe H 37 
b c g H OMe Me 38 
a c h H H Me 35 
d b i H Cl Cl 40 
e b j H Me Cl 30 
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The TiCl4-mediated reaction of 1,3-bis(silyloxy)-1,3-dienes 4a and 4d with 1,1-
diacetylcyclopropane (8) gave the 3-arylsalicylates 9a and 9b, respectively (Scheme 3). 
Products 9a,b are formed by a domino [3+3]-cyclization-homo-Michael reaction.11  
           
OSiMe3Me3SiO
OMe
R Me
O O
Me
O
OMe
MeMe
OH
Cl
R
TiCl4
i
4a,d
+
8 9a (R = H): 42%9b (R = Cl): 37%
                 Scheme 3. Synthesis of 9a,b; i: TiCl4, CH2Cl2, –78  20 °C, 20 h 
In conclusion, a variety of functionalized, sterically encumbered biaryls were prepared by 
formal [3+3] cyclizations of novel 4-aryl-1,3-bis(trimethylsilyloxy)-1,3-dienes. The 
products are not readily available by other methods. 
6.3. Experimental section 
General Comments. All solvents were dried by standard methods and all reactions were 
carried out under an inert atmosphere. For 1H and 13C NMR spectra the deuterated 
solvents indicated were used. Mass spectrometric data (MS) were obtained by electron 
ionization (EI, 70 eV), chemical ionization (CI, H2O) or electrospray ionization (ESI). 
For preparative scale chromatography, silica gel (60-200 mesh) was used. Melting points 
are uncorrected.  
General procedure for the synthesis of methyl 3-arylacetoacetates 2a-e: A THF 
solution of LDA (2.3 equiv.) was prepared by addition of  nBuLi (0.93 mL, 2.3 mmol, 
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2.5 M in hexane) to a THF solution (6 mL) of diisopropylamine (0.32 mL, 2.3 mmol) at 0 
°C. After the solution was stirred for 30 min, methyl acetate (0.09 mL, 1.1 mmol) was 
added at 0 °C. After stirring for 45-60 min, to the solution was added a THF solution (4 
mL) of the acid chloride (205 mg, 1.0 mmol) at −78 °C. The temperature was allowed to 
rise to ambient during 5-6 h and the solution was stirred at 20 °C for 10 h. To the solution 
was added a diluted aqueous solution of HCl and the mixture was extracted with EtOAc 
(3 x 200 mL). The combined organic layers were dried (Na2SO4) and filtered. The solvent 
of the filtrate was removed in vacuo and the residue was purified by chromatography 
(silica gel, EtOAc / n-heptane). 
General procedure for the synthesis of biaryls 7a-j: To a dichloromethane solution 
(2 mL / mmol of 4) of 4 (1.0 mmol) and of 6 (1.0 mmol) was added TiCl4 (1.0 mmol) at 
–78 °C. The solution was allowed to warm to ambient temperature within 20 h. To the 
solution was added a saturated solution of NaHCO3 (15 mL). The organic and the 
aqueous layers were separated and the latter was extracted with diethyl ether (3 x 20 
mL). The filtrate was concentrated in vacuo and the residue was purified by 
chromatography (silica gel, EtOAc / n-heptane = 1:4). 
Methyl 4,6-dimethyl-5-(2-chloroethyl)-3-phenylsalicylate (9a): Starting with 1,1-
diacetylclopropane (8) (252 mg, 2 mmol), 1,3-bis(silyl enol ether) 4a (673 mg, 2.0 
mmol), TiCl4 (0.22 mL, 2.0 mmol) and CH2Cl2 (60 mL), 9a was isolated as colourless 
solid (267 mg, 42%), mp. 110 °C. 1H NMR (250 MHz, CDCl3): δ =  2.04 (s, 3 H, CH3), 
2.48 (s, 3 H, CH3), 3.09 (t, 2 H, J = 6.4 Hz, CH2), 3.46 (t, 2 H, J = 7.4 Hz, CH2), 3.90 (s, 
3H, OCH3), 7.12 (m, 2 H, ArH), 7.31 (m, 1 H, ArH), 7.37 (m, 2 H, ArH), 10.54 (s, 1 H, 
OH). 13C NMR (62 MHz, CDCl3): δ = 18.3, 18.7 (CH3), 33.6, 42.3 (CH2), 52.4 
(OCH3), 112.7 (C), 127.2 (CH), 127.4 (C), 128.6 (2C, CH), 128.8 (C), 130.0 (2C, CH), 
137.3, 137.5, 141.8, 157.0 (C), 171.9 (C=O). IR (neat): ν~ = 3058 (w), 3023 (w), 2954 
(m), 2871 (w), 1727 (w), 1650 (s), 1603 (m), 1592 (m), 1562 (w), 1437 (s), 1397 (m), 
1331 (s), 1312 (s), 1210 (s), 1070 (m), 1042 (m), 957 (m), 806 (s), 733 (s), 697 (s) 530 
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(m) cm−1. GC-MS (EI, 70 eV): m/z (%): 320 (M+, 37Cl, 16), 318 (M+, 35Cl, 46), 286 
(100), 258 (8), 251 (36), 237 (75), 209 (30), 165 (40). HRMS (EI): calcd for 
C18H19O3Cl [M+, 35Cl]: 318.10172; found 318.101767. 
Methyl 4,6-dimethyl-5-(2-chloroethyl)-3-(4-chlorophenyl)salicylate (9b): Starting 
with 1,1-diacetylclopropane (8) (252 mg, 2 mmol)  1,3-bis(silyl enol ether) 4d (742 mg, 
2 mmol), TiCl4 (0.219 mL, 2 mmol) and CH2Cl2 (60 mL), 9b was isolated as colourless 
solid (260 mg, 37%), mp. 112 °C; 1H NMR (250 MHz, CDCl3): δ = 2.01 (s, 3 H, CH3), 
2.46 (s, 3 H, CH3), 3.06 (t, 2 H, J = 6.5 Hz, CH2), 3.43 (t, 2 H, J = 7.4 Hz, CH2), 3.89 
(s, 3 H, OCH3), 7.03 (d, 2 H, J = 8.7 Hz, ArH), 7.32 (d, 2 H, J = 8.5 Hz, ArH), 10.54 (s, 
1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 17.3, 17.71 (CH3), 32.4, 41.1 (CH2), 51.3 
(OCH3), 111.3 (C), 126.2, 126.9 (C), 128.7 (2C, CH), 129.9 (CH), 131.4 (2C CH), 
132.2, 134.7, 137.0, 140.8, 156.2 (C), 170.9 (C=O). IR (neat): ν~ = 3022 (w), 2998 (w), 
2953 (m), 2872 (w), 1727 (w), 1650 (s), 1588 (m), 1554 (m), 1492 (m), 1436 (m), 1381 
(m), 1346 (s), 1329 (s), 1309 (s), 1212 (s), 1088 (m), 1071 (m), 1040 (s), 1014 (m), 960 
(m), 805(s), 759 (s), 714 (s), 541 (s) cm−1. GC-MS (EI, 70 eV): m/z (%): 354 (M+, 37Cl, 
22), 352 (M+, 35Cl, 31), 320 (100), 285 (44), 271 (68), 243 (14), 207 (16), 165 (30), 118 
(20), 89 (16). HRMS (EI): calcd for C18H18O3Cl2 [M+, 35Cl]: 352.06275; found 
352.062346. 
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                                                                                        Chapter 7 
Regioselective Synthesis of Functionalized 2-Thio-phenoxybenzoates by 
Formal [3+3] Cyclizations of 1-Trimethylsilyloxy-3-thiophenoxy-1,3-
butadienes with 3-Silyloxy-2-en-1-ones 
                                                                                            Manuscript in preparation  
7.1. Introduction 
Functionalized diaryl sulfides are pharmacologically important molecules which occur in 
various natural products. For example, they are present in dibenzothiophenes,1 varacins 
(lissoclinotoxins),2 lissoclibadins,3 cyclic sulfides,4 and various other natural products 
isolated from Streptomyces griseus.5 Diaryl sulfides are synthetically available by 
reaction of arenes with sulphur6 and sulphur dichloride,7 by condensation of 
organometallic reagents with chlorophenyl-sulfide8 and by base-mediated reaction of 
chloroarenes with thiophenols.9 These reactions often suffer from their low 
regioselectivity and from the formation of polysulfides, due to the harsh reaction 
conditions. Chan and coworkers developed10 a convenient approach to salicylates (2-
hydroxybenzoates) based on formal [3+3] cyclizations11 of 1,3-bis(silyloxy)-1,3-
butadienes12 with 3-siloxy-2-en-1-ones. Recently, we reported the application of this 
methodology to the synthesis of 3- and 5-thioaryloxysalicylates.13 Herein we report, 
based on exploratory work of Chan et al.,14 the synthesis of 2-(thioaryloxy)benzoates and 
thioxanthones based on formal [3+3] cyclizations of 1-methoxy-1-trimethylsilyloxy-3-
thioaryloxy-1,3-butadienes with 3-silyloxy-2-en-1-ones and 1,1,3,3-
tetramethoxypropane. The sterically encumbered and functionalized products reported 
are not readily available by other methods. In contrast to the coupling reactions outlined 
above, our method relies on the assembly of one of the two arene moieties 
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7.2. Results and Discussion 
The 1-methoxy-1-trimethylsilyloxy-3-thioaryloxy-1,3-buta-dienes 3a-c were prepared by 
reaction of -ketoesters 1a-c with thiophenol to give 2a-c and subsequent silylation 
(Scheme 1, Table 1).16  
O
OMe
ArSH
1a-c
3a-c _ 78      20 °C
O
OSiMe3
OMe
SAr
R
R
O
OMe
SAr
R
2a-c
1) LDA, THF
_ 78 °C, 1 h
2) Me3SiCl
Scheme 1. Synthesis of 3a-c 
                                               Table 1. Synthesis of 3a-e 
  
                                        Isolated yields 
The TiCl4-mediated cyclization of 1-trimethylsilyloxy-3-thioaryloxy-1,3-butadiene 3a
with 3-silyloxy-2-en-1-one 4a, prepared from methyl acetoacetate, afforded the 2-
thiophenoxybenzoate 5a (Scheme 2, Table 2). The best yields were obtained when the 
reaction waqs carried out in a highly concentrated solution. The formation of 3a can be 
1-3 R Ar  % 
(2) 
 % 
(3) 
a H Ph 98 98 
b Me Ph 97 97 
c Et Ph 96 96 
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explained by TiCl4-mediated attack of the terminal carbon atom of 3a onto 4a to give 
intermediate A, cyclization via the central carbon atom (intermediate B), and subsequent 
aromatization.  
                 
Me Me
O OSiMe3 OMe
OSiMe3PhS OSPh
OMe
MeMei
4a 5a
3a
Me
OTiCl3
Me3SiO
PhS
O
OMe
Me
Me3SiCl
_
TiCl4
B
SPh O
OMe
MeMe
OTiCl3
A
                             Scheme 2. Possible mechanism of the formation of 5a 
The cyclization of dienes 3a-c with 3-silyloxy-2-en-1-ones 4a-e afforded the 2-
(thioaryloxy) benzoates 5a-j (Scheme 3, Table 2). Noteworthy, products 5d, 5g and 5j
were formed with very good regioselectivity. The selectivity can be explained by 
selective attack of the diene onto the acetyl rather than the propionyl or benzoyl group. 
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i
+
SAr
OMe
O
R1
Me R2
R3
SAr OSiMe3
R1 OMe
O OSiMe3
R3
R2 Me
3a-c
4a-e 5a-j
Scheme 3. Synthesis of 5a-j
                                 Table 1. Synthesis of 5a-j 
                            a Isolated yields 
The cyclization of dienes 3a,c with 1,1,3,3-tetramethoxypropane (6), in the presence of 
catalytic amounts of trimethylsilyl-trifluoromethanesulfonate (Me3SiOTf, 0.1 equiv.), 
afforded the 2-(thioaryloxy)benzoates 7a,b (Scheme 3).  
3 4 5 Ar R1 R2 R3  % (5)a
a a a Ph H Me Me 57 
a b b Ph H Me Cl 43 
a c c Ph H Me PhS  63 
a d d Ph H nPr  H 42 
b a e Ph Me Me Me 55 
b b f Ph Me Me Cl 49 
b e g Ph Me Ph H 52 
c a h Ph Et Me Me 55 
c b i Ph Et Me Cl 51 
c e j Ph   Et Ph   H  50 
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+
SPh
OMe
O
R
SPh OSiMe3
R OMe
MeO OMe
OMeOMe
i3a,c
6
7a (R = H): 53%
7b (R = Et): 51%
Scheme 3. Synthesis of 7a,b. Conditions: i, Me3SiOTf (0.1 equiv.), CH2Cl2, –78  20 
°C, 20 h 
Treatment of 2-(thioaryloxy)benzoates 5a,b,d,e,f,h,i with concentrated sulfuric acid 
resulted in an intramolecular Friedel-Crafts cyclization to give the thioxanthones 8a-g
(Scheme 4, Table 2).  
                   
S
OR
1
Me
R3
R2
i
SPh
R1
R2Me
OMe
O
R3
5a,b,d,e,f,h,i 8a-g
Scheme 4. Synthesis of 8a-g. Conditions: i, Conc.H2SO4,  20 °C, 2 h 
                                Table 2. Synthesis of thioxanthones 8a-g
                  
                                   Isolated yields 
5 8 R1 R2 R3 % (8) 
a a H Me Me 98 
b b H Me Cl 97 
d c H nPr H 95 
e d Me Me Me 97 
f e Me Me Cl 97 
h f Et Me Me 95 
i g Et Me Cl 96 
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In conclusion, we reported the first domino [3+3] cyclization / homo-Michael reaction 
of 1-trimethylsilyloxy-3-thiophenoxy-1,3-butadienes with 1,1-diacylcyclopropanes. This 
reaction provides a convenient approach to 2-thiophenoxybenzoates containing a remote 
halide function which are not readily available by other methods. The preparative scope 
of the methodology is currently being studied. 
7.3. Experimental Section 
General procedure for the synthesis of 2-(thiophenoxy)benzoates 5a-j: To a 
dichloromethane solution (5 mL / mmol of 3) of 3 (1.0 mmol) and of 4 (1.5 mmol) was 
added TiCl4 (1.5 mmol) at –78 °C. The solution was allowed to warm to 20 °C within 20 
h. To the solution was added a saturated aqueous solution of NaHCO3 (15 mL). The 
organic and the aqueous layer were separated and the latter was extracted with diethyl 
ether (3 x 20 mL). The combined organic layers were dried (Na2SO4), filtered, and the 
filtrate was concentrated in vacuo. The residue was purified by chromatography (silica 
gel, EtOAc / n-heptane = 1:4). 
Methyl 2,3,4,5-tetramethyl-6-(phenylsulfanyl)benzoate (5e): Starting with 3-
(siloxy)alk-2-en-1-one 4a (450 mg, 2.41 mmol), 3b (859 mg, 2.90 mmol), TiCl4 (0.37 
mL, 3.6 mmol), and CH2Cl2 (14 mL), 5e was isolated as a gummy compound (400 mg, 
55%); 1H NMR (250 MHz, CDCl3): δ =  2.15 (s, 3 H, CH3), 2.17 (s, 2×3 H, CH3), 2.24 
(s, 3 H, CH3), 3.73 (s, 3 H, OCH3), 6.99 (m, 2 H, ArH), 7.12 (m, 3 H, ArH); 13C NMR 
(62 MHz, CDCl3): δ = 16.5, 17.3, 17.8, 19.9 (CH3), 51.1 (OCH3), 124.0 (C), 125.1 
(ArCH), 126.8 (2C ArCH), 128.7 (2C ArCH), 130.5, 137.5, 137.7, 138.0, 139.1, 139.6, 
170.1 (C); IR (neat):  = 3056 (w), 2946 (w), 1729 (s), 1598 (m), 1580 (m), 1422 (s), 
1306 (m), 1232 (m), 1172 (s), 1068 (m), 737 (s) 688 (s) cm−1; GC-MS (EI, 70 eV): m/z
(%): 300 (M+, 86), 267 (100), 253 (12), 239 (10), 225 (7), 110 (89); HRMS (EI): calcd  
for C18H20O2S [M+]: 300.11785, found 300.11812. 
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Methyl 3-chloro-2,4,5-trimethyl-6-(phenylsulfanyl)benzoate (5f): Starting with 3-
(siloxy)alk-2-en-1-one 4b (550 mg, 2.6 mmol), 3b (943 mg, 3.1 mmol), TiCl4 (0.42 mL, 
3.9 mmol) and CH2Cl2 (110 mL), 5f was isolated as a gummy compound (417 mg, 49%); 
1H NMR (250 MHz, CDCl3): δ = 2.25 (s, 3 H, CH3), 2.26 (s, 3 H, CH3), 2.31 (s, 3 H, 
CH3),  3.74 (s, 3 H, OCH3), 7.00 (m, 2 H, ArH), 7.14 (m, 3 H, ArH); 13C NMR (62 MHz, 
CDCl3): δ = 17.2, 17.3, 17.5 (CH3), 51.2 (OCH3), 123.6 (C), 125.5 (ArCH), 126 (C), 
127.1 (2C ArCH), 128.9 (2C ArCH), 129.6, 136.0, 136.7, 139.4, 139.9, 166.2 (C);  IR 
(neat):  = 3010 (w), 2953 (w), 1722 (s), 1601 (m), 1580 (m), 1434 (m), 1383 (s), 1234 
(s), 1151 (s), 1009 (s), 732 (s), 685 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 322 (M+, 
37Cl, 28), 320 (M+, 35Cl, 74), 287 (100), 253 (17), 211 (10), 178 (20), 115; HRMS (EI): 
calcd  for C17H17O2ClS [M+, 35Cl]: 320.06323, found 320.06363. 
Methyl 2-phenyl-4,5-dimethyl-6-(phenylsulfanyl)benzoate (5g): Starting with 3-
(siloxy)alk-2-en-1-one 4e (500 mg, 2.0 mmol), 1b (743 mg, 2.0 mmol), TiCl4 (0.34 mL, 
3.1 mmol), and CH2Cl2 (12.5 mL), 5g was isolated as a gummy compound (380 mg, 
52%); 1H NMR (250 MHz, CDCl3): δ = 2.23 (s, 3 H, CH3), 2.25 (s, 3 H, CH3), 3.48 (s, 3 
H, OCH3), 7.12 (m, 3 H, ArH), 7.26 (m, 3 H, ArH), 7.36 (s, 1 H, ArH), 7.42 (m, 4 H, 
ArH); 13C NMR (62 MHz, CDCl3): δ = 13.6, 18.0 (CH3), 50.1 (OCH3), 124.0 (C), 125.9 
(ArCH), 126.4 (2C ArCH), 126.3 (C), 127.2 (2C, ArCH), 127.4 (2C ArCH), 127.5 (2C 
ArCH), 127.8 (ArCH), 131.5, 132.2 (C), 136.2 (ArCH), 137.5, 138.1, 138.7, 139.9, 166.2 
(C); IR (neat):  = 3056 (w), 2946 (w), 1730 (s), 1580 (m), 1476 (m), 1456 (s), 1384 (w), 
1246 (s), 1146 (s), 1023 (m), 697 (s) 688 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 348 
(M+, 100), 315 (89), 373 (26), 39 (9), 165 (18), 105 (7); HRMS (EI): calcd  for 
C22H20O2S [M+]: 348.11785, found 348.11834. 
Methyl 5-ethyl-2,4-dimethyl-6-(phenylsulfanyl)benzoate (5h): Starting with 3-
(siloxy)alk-2-en-1-one 4a (700 mg, 3.76 mmol), 3c (1.40 g, 4.51 mmol), TiCl4 (0.61 mL, 
5.64 mmol), and CH2Cl2 (18.8 mL), 5h was isolated as a gummy compound (650 mg, 
55%); 1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3 H, J = 7.4 Hz, CH3), 2.13 (s, 3 H, CH3), 
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2.15 (s, 3 H, CH3), 2.20 (s, 3 H, CH3), 2.76 (q, 2 H, J = 7.3 Hz, CH2), 3.67 (s, 3 H,
OCH3), 6.97 (m, 3 H, ArH), 7.10 (m, 2 H, ArH); 13C NMR (62 MHz, CDCl3): δ = 13.5, 
16.6, 16.9, 17.8 (CH3), 24.9 (CH2), 51.9 (OCH3), 123.2 (C), 125.0 (ArCH), 126.6 (2C, 
ArCH), 128.9 (2C, ArCH), 134.2, 137.0, 138.5, 140.3, 142.7, 145.1, 170.0 (C);  IR 
(neat):  = 356 (w), 2946 (w), 1729 (s), 1580 (m), 1477 (m), 1434 (m), 1294 (m), 1224 
(m), 1171 (s), 1024 (m), 736 (s) 688 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 314 (M+, 
100), 281 (56), 267 (21), 239 (16), 211 (12), 177 (23), 105 (27); HRMS (EI): calcd  for 
C19H22O2S [M+]:  314.13351, found 314.13418. 
Methyl 3-chloro-2,4-dimethyl-5-ethyl-6-(phenylsulfanyl)benzoate (5i): Starting with 
3-(siloxy)alk-2-en-1-one 4b (650 mg, 3.1 mmol), 3c (1.10 g, 3.72 mmol), TiCl4 (0.51 mL, 
4.65 mmol), and CH2Cl2 (15.5 mL), 5i was isolated as a gummy compound (524 mg, 
50%); 1H NMR (250 MHz, CDCl3): δ = 0.74 (t, 3 H, J = 7.1 Hz,  CH3), 2.11 (s, 3 H, 
CH3), 2.22 (s, 3 H, CH3), 2.65 (q, 2 H, J = 7.4 Hz, CH2), 3.55 (s, 3 H, OCH3), 6.92 (m, 3 
H, ArH), 7.10 (m, 2 H, ArH); 13C NMR (62 MHz, CDCl3): δ = 14.6, 18.9, 19.7 (CH3), 
24.3 (CH2), 52.1 (OCH3), 126.1 (C), 126.6 (ArCH), 128.2 (2C ArCH), 131.0 (2C ArCH), 
133.6, 136.9, 139.0, 139.2, 142.3, 148.1, 170.0 (C); IR (neat):  = 3053 (w), 297 (w), 
1727 (s), 1575 (m), 1431 (m), 1404 (m), 1280 (s), 1224 (s), 1152 (s), 1022 (s), 735 (s) 
685 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 336 (M+, 37Cl, 39), 334 (M+, 35Cl, 100), 301 
(52), 287 (21), 224 (10), 197 (23), 105 (34); HRMS (EI): calcd  for C16H15O2ClS [M+, 
35Cl]: 334.07888, found 334.07942. 
Methyl 2-methyl-3-phenyl-5-ethyl-6-(phenylsulfanyl)benzoate (5j): Starting with 3-
(siloxy)alk-2-en-1-one 4e (717 mg, 3.0 mmol), 3c (618 g, 2 mmol), TiCl4 (0.32 mL, 3.0 
mmol), and CH2Cl2 (10 mL), 5j was isolated as a gummy compound (362 mg, 50%); 1H 
NMR (250 MHz, CDCl3): δ = 0.88 (t, 3 H, J = 7.1 Hz,  CH3), 2.25 (s, 3 H, CH3), 2.73 (q, 
2 H, J = 6.4 Hz, CH2), 3.80 (s, 3 H, OCH3), 7.10 (m, 3 H, ArH), 7.26 (m, 5 H, ArH), 7.34 
(s, 1 H, ArH), 7.67 (m, 3 H, ArH); 13C NMR (62 MHz, CDCl3): δ = 13.7, (CH3), 20.1 
(CH2), 24.4, (CH3), 51.8 (OCH3), 123.0 (2C ArCH), 124.4 (ArCH), 125.3 (2C ArCH), 
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127.7 (ArCH),  128.4 (2C ArCH), 130.3 (2C ArCH), 130.2, 133.7, 134.9 (C), 136.3 
(ArCH), 137.1, 139.1, 140.6, 144.2, 148.2, 165.8 (C); IR (neat):  = 3058 (w), 2947 (w), 
1730 (m), 1597 (m), 1579 (m), 1453 (m), 1271 (s), 1191 (s), 739 (s), 698 (s), 618 (m) 556 
(m) cm−1; GC-MS (EI, 70 eV): m/z (%): 362 (M+, 100), 331 (19), 315 (20), 271(16), 225 
(20) 178 (13); HRMS (EI): calcd for C23H22O2S [M+]: 362.13350, found 362.13303. 
HRMS and MS different 
General procedure for the synthesis of 2-(thiophenoxy)benzoates 7a,b: To a 
dichloromethane solution (2 mL / mmol of 3) of 3 (1.5 mmol) and of 1,1,3,3-
tetramethoxypropane (1.0 mmol) was added TMSOTf (0.1 mmol) at –78 °C. The solution 
was allowed to warm to 20 °C within 20 h. To the solution was added a diluted aqueous 
solution of HCl (give exact concentration, 15 mL). The organic and the aqueous layer 
were separated and the latter was extracted with dichloromethane (3 x 15 mL). The 
combined organic layers were dried (Na2SO4), filtered, and the filtrate was concentrated 
in vacuo and the residue was purified by chromatography 
Methyl 2-(phenylsulfanyl)benzoate (7a): Starting with tetramethoxypropane (0.33 mL, 
2.0 mmol), 3a (843 mg, 3.0 mmol), and TMSOTf (0.036 mL, 0.2 mmol), CH2Cl2 (4 mL), 
7a was isolated as a highly viscous colourless oil (275 mg, 53%); 1H NMR (250 MHz, 
CDCl3): δ = 3.66 (s, 3 H, OCH3), 6.75 (dd, 1 H, 3J = 7.2, 4J =1.87 Hz, ArH), 7.06 (ddd, 1 
H, 3J = 7.2, 4J = 1.87, 5J = 0.92 Hz, ArH), 7.16 (m, 2 H, ArH), 7.36 (m, 3 H, ArH), 7.48 
(m, 2 H, ArH); 13C NMR (62 MHz, CDCl3): δ = 52.1 (OCH3), 124.2 (ArCH), 126.7 (C), 
127.4, 129.0 (ArCH), 129.7 (2C, ArCH), 131.1, 132.2 (ArCH), 124.6 (C), 135.5 (2C, 
ArCH), 143.1, 166.8 (C); IR (neat):  = 3056 (w), 2948 (w), 1711 (s), 1585 (m), 1562 
(m), 1433 (s), 1246 (s), 1189 (m), 1056 (s), 738 (s), 688 (s) 530 (m) cm−1; GC-MS (EI, 
70 eV): m/z (%): 244 (100), 213 (76), 184 (55), 152 (16), 139 (10), 108 (8); HRMS (EI): 
calcd  for C14H12O2S [M+]: 244.05525, found 244.05570. 
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General procedure for the synthesis of thioxanthones 8a-g: To 5 (1.0 mmol) was 
added concentrated sulfuric acid (98%, 12 mL / mmol of 5) at 20 °C and the solution was 
stirred for 2 h. To the solution was added ice water (50 mL). The organic and the aqueous 
layer were separated and the latter was extracted with dichloromethane (3 x 15 mL). The 
combined organic layers were dried (Na2SO4), filtered, and the filtrate was concentrated 
in vacuo. The residue was purified by chromatography (silica gel, heptanes / EtOAc). 
1,2,3,4-Tetramethylthioxanthone (8d): Starting with 5e (118 mg, 0.39 mmol) and conc. 
sulfuric acid, 8d was isolated as a colourless solid (102 mg, 97%), mp. = 221 °C; 1H 
NMR (250 MHz, CDCl3): δ = 2.32 (s, 3 H, CH3), 2.35 (s, 3 H, CH3), 2.45 (s, 3 H, CH3), 
2.68 (s, 3 H, CH3), 7.40 (m, 1 H, ArH), 7.52 (m, 2 H, ArH), 8.30 (m, 1 H, ArH); 13C 
NMR (62 MHz, CDCl3): δ = 16.5, 16.7, 17.6, 19.4 (CH3), 125.3, 125.8 (ArCH), 127.4, 
128.4 (C), 128.9, 131.1 (ArCH), 132.2, 134.4, 134.8, 135.8, 138.0, 139.4, 184.6 (C); IR 
(neat):  =  3064 (w), 2916 (w), 1622 (s), 1587 (s), 1433 (s), 1490 (m), 1301 (s), 1204 
(m), 1093 (s), 952 (m), 743 (s) 643 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 268 (100), 
253 (82), 239 (34), 184 (10), 119 (7), 69 (12); HRMS (EI): calcd  for C17H16O2S [M+]: 
268.09164, found 268.09113. 
2-Chloro-1,3,4-trimethylthioxanthone (8e): Starting with 5f (90 mg, 0.28 mmol) and 
conc. sulfuric acid, 8e was isolated as a colourless solid (78 mg, 97%), mp. = 194 °C; 1H 
NMR (250 MHz, CDCl3): δ = 2.50 (s, 3 H, CH3), 2.53 (s, 3 H, CH3), 2.86 (s, 3 H, CH3), 
7.45 (m, 1 H, ArH), 7.57 (m, 2 H, ArH), 8.34 (m, 1 H, ArH); 13C NMR (62 MHz, 
CDCl3): δ = 16.8, 18.7, 20.2 (CH3), 125.3, 126.3, 129.0 (ArCH), 130.0 (C), 131.6 
(ArCH), 131.6, 132.3, 132.7, 134.0, 134.1, 137.8, 138.7, 183.9 (C); IR (neat):  =  3063 
(w), 2918 (s), 1732 (m), 1624 (s), 1588 (m), 1432 (m), 1378 (m), 1229 (m), 1155 (s), 
1009 (s), 741 (s) 615 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 290 (M+, 37Cl, 45), 288 
(M+, 35Cl, 100), 253 (16), 225 (26), 208 (8), 119 (13), 69 (9); HRMS (EI): calcd for 
C16H13OClS [M +, 35Cl]: 288.03701, found 288.03628. 
115
1,2,3-Trimethyl-4-ethylthioxanthone (8f): Starting with 5h (181 mg, 0.57 mmol) and 
conc. sulfuric acid, 8f was isolated as a colourless solid (102 mg, 97%), mp. = 221 °C; 1H 
NMR (250 MHz, CDCl3): δ = 1.15 (t, 3 H, J = 7.5 Hz,  CH3), 2.23 (s, 3 H, CH3), 2.28 (s, 
3 H, CH3), 2.59 (s, 3 H, CH3), 2.90 (q, 2 H, J = 7.4 Hz, CH2), 7.30 (m, 1 H, ArH), 7.44 
(m, 2 H, ArH), 8.22 (m, 1 H, ArH); 13C NMR (62 MHz, CDCl3): δ = 12.9, 16.6, 16.8, 
19.5 (CH3), 23.7 (CH2), 125.2, 125.8 (ArCH), 127.8 (C), 128.8 (ArCH), 131.1 (ArCH), 
132.2, 133.7, 134.5, 135.3, 135.6, 136.1, 139.0, 184.9 (C); IR (neat):  = 3064 (w), 2927 
(s), 1624 (s), 1585 (m), 1431 (m), 1382 (s), 1366 (s), 1203 (m), 1085 (s), 1028 (m), 748 
(s), 643 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 282 (M+, 89), 267 (100), 253 (21), 224 
(10), 126 (9), 113 (9), 69 (16); HRMS (EI): calcd  for C18H18OS [M+]: 282.10729, found 
282.10724. 
2-Chloro-1,3-dimethyl-4-ethylthioxanthone (8g): Starting with 5i (302 mg, 0.92 mmol) 
and conc. sulfuric acid, 8g was isolated as a colourless solid (270 mg, 96%), mp. = 81 °C; 
1H NMR (250 MHz, CDCl3): δ = 1.14 (t, 3 H, J = 7.5 Hz,  CH3), 2.03 (s, 3 H, CH3), 2.40 
(s, 3 H, CH3),  2.85 (q, 2 H, J = 7.2 Hz, CH2), 7.28−7.40 (m, 2 H, ArH), 7.47−7.89 (m, 2 
H, ArH); 13C NMR (62 MHz, CDCl3): δ = 12.5, 18.0, 20.3, (CH3), 24.1 (CH2), 125.3 
(ArCH), 126.3 (2C ArCH), 129.0 (ArCH), 130.8, 131.7, 134.4, 136.3, 136.6, 137.6, 
138.4, 139.4, 184.2 (C); IR (neat):  = 3045 (w), 2938 (w), 1711 (w), 1624 (s), 1587 (s), 
1432 (s), 1373 (w), 1214 (s), 1174 (s), 1027 (s), 751 (m) 637 (s) cm−1; GC-MS (EI, 70 
eV): m/z (%): 304 (M+, 37Cl, 30), 302 (M+, 35Cl, 100), 267 (23), 251 (12), 221 (10), 210 
(8), 97 (15), 57 (27); HRMS (EI): calcd  for C17H15OClS [M, 35Cl]: 302.05268, found 
302.05282. 
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Synthesis of 3-[2-oxo-1- (phenylsulfonyl) propylidene] -2- benzofuran -1-one: 
(1); Starting with phthaloyl dichloride  (0.62 ml, 4.3 mmol), 2-(siloxy) -1-propenyl 
sulfone  (1.17 g, 4.3 mmol)  and  TiCl4 (0.47 ml, 4.3 mmol), 1 was isolated as a 
colourless solid (398 mg, 28%), mp. 186 °C; 1H NMR (300 MHz, Acetone-d6): δ = 
2.65 (s, 3 H, CH3), 7.65-7.83(m, 4 H,  ArH), 7.96 (m, 1 H, ArH), 8.03-8.16 (m, 3 H, 
ArH), 8.91  (d, 1 H, J = 8.1 Hz, ArH);  13C NMR (75 MHz, Acetone-d6): δ = 33.1, 
(CH3), 125.7 (C), 127.2 (CH),128.7 (2C, CH), 129.6(C), 130.6(CH),  130.7 (2C, 
CH),132.1 (CH), 135.4 (C), 135.6, 137.1 (CH), 142.7, 154.4, 164.6, 195.5 (C);  IR 
(KBr): ν~ = 3098 (w), 2922 (w), 2854 (w), 1811 (s), 1711 (s), 1624 (s), 1473 (m), 
1252 (s), 1001 (s), 721 (m), 618 (s), 595 (m) cm−1; GC-MS (CI, 70 eV): m/z (%): 
329 ([M+H]+, 48), 287 (100), 189 (50), 173 (6), 143 (7), 73 (10); elemental 
analysis: calcd (%) for C17H12O5S (328): C 62.19, H 3.68; found: C 61.65, H 3.78. 
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                                                   Figure 1. ORTEP plot of 1 
General procedure for synthesis 3-[2-oxo-1- (phenylsulfonyl) propylidene] -2- 
benzofuran -1-one: To a dichloromethane solution (13 mL) phthaloyl dichloride (0.62 
ml, 4.3 mmol), 2-(siloxy) -1-propenyl sulfone 2 (1.17 g, 4.3 mmol) and TiCl4 (0.47 ml, 
4.3 mmol), at –78 °C. The solution was allowed to warm to 20 °C within 20 h. To the 
solution was added a saturated aqueous solution of NaHCO3 (15 mL). The organic and 
the aqueous layer were separated and the latter was extracted with diethyl ether (3 x 20 
mL). The combined organic layers were dried (Na2SO4), filtered, and the filtrate was 
concentrated in vacuo. The residue was purified by chromatography (silica gel, EtOAc / 
n-heptane = 1:4). 
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Synthesis of trimethyl 4-oxo-1,2,5-pentanetricarboxylate:(2);Starting dichloromethane 
solution (12 mL ),dimethyl maleate (0.37 ml, 3 mmol), 1,3-bis (silyl enol ether), (780 mg, 
3 mmol)  and  TiCl4 (0.32 ml, 3 mmol), 3 was isolated as a colourless solid (350 mg, 
44%); 1H NMR (250 MHz, CH2Cl2): δ = 2.56 (m, 1 H, CH), 2.74 (d, 1 H, J = 6.9. Hz, 
CH2), 2.93 (d, 1 H, J = 7.0. Hz, CH2), 3.01 (d, 1 H, J = 6.9. Hz, CH2), 3.18 (d, 1 H, J = 
6.9. Hz, CH2), 3.37 (s, 2H, CH2), 3.61 (s, 3 H, OCH3), 3:67 (s, 2×3 H, CH3); 13C NMR 
(62 MHz, CH2Cl2): δ = 27.1 (CH2), 30.2 (CH), 44.1, 48.2 (CH2), 53.0, 54.0, 54.2 
(OCH3), 167.0, 171.3, 173.6, 200.2 (C); IR (Neat): ν~ = 3002 (w), 2955 (w), 2850 (w), 
1737 (s), 1624 (s), 1437 (m), 1367 (m), 1168 (m), 1008 (w), 848 (m), cm−1; GC-MS (EI, 
70 eV): m/z (%) = 260 (M+, 18), 228 (21), 197 (25), 187 (81), 169 (42), 127 (100), 101 
(29). HRMS (ESI): calcd for C11H16O7 (M+)  260.08905, found 260.08978. 
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X-Ray crystals data 
Data of compound 3b (chapter 1): 
Table 1.  Crystal data and structure refinement for3b
Identification code  nrr76 
Empirical formula  C17H20O4S 
Formula weight  320.39 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c   
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 16.0830(3) Å α= 90°. 
b = 7.94020(10) Å β= 102.7740(10)°. 
c = 12.7097(2) Å γ = 90°. 
Volume 1582.89(4) Å3
Z 4 
Density (calculated) 1.344 Mg/m3
Absorption coefficient 0.220 mm-1
F(000) 680 
Crystal size 0.42 x 0.28 x 0.25 mm3
Θ range for data collection 1.30 to 29.99°. 
Index ranges -22h21, -11k10, -17l17 
Reflections collected 18799 
Independent reflections 4601 [R(int) = 0.0342] 
Completeness to Θ = 29.99° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9471 and 0.9133 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4601 / 0 / 206 
Goodness-of-fit on F2 1.048 
Final R indices [I>2σ(I)] R1 = 0.0466, wR2 = 0.1221 
R indices (all data) R1 = 0.0644, wR2 = 0.1326 
Largest diff. peak and hole 0.400 and -0.334 e.Å-3
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for nrr76.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
S(1) 2702(1) 8674(1) 3607(1) 31(1) 
O(1) 2224(1) 9841(2) 2828(1) 44(1) 
O(2) 2724(1) 9022(2) 4721(1) 45(1) 
O(3) 3239(1) 5611(2) 4852(1) 44(1) 
O(4) 908(1) 2054(2) 3306(1) 38(1) 
C(1) 2259(1) 6625(2) 3315(1) 24(1) 
C(2) 2602(1) 5352(2) 4156(1) 26(1) 
C(3) 2169(1) 3665(2) 4070(1) 28(1) 
C(4) 1252(1) 3714(2) 3432(1) 26(1) 
C(5) 1252(1) 4545(2) 2340(1) 25(1) 
C(6) 1690(1) 6196(2) 2392(1) 24(1) 
C(7) 1306(1) 3411(3) 1384(1) 39(1) 
C(8) 474(1) 4195(3) 1449(2) 41(1) 
C(9) 682(1) 4703(2) 4020(2) 33(1) 
C(10) 1477(1) 7270(3) 1394(1) 40(1) 
C(11) 3748(1) 8602(2) 3403(1) 30(1) 
C(12) 3885(1) 8919(3) 2382(2) 40(1) 
C(13) 4708(1) 8915(3) 2230(2) 45(1) 
C(14) 5396(1) 8597(3) 3074(2) 42(1) 
C(15) 5245(1) 8253(3) 4084(2) 48(1) 
C(16) 4423(1) 8263(3) 4259(2) 41(1) 
C(17) 6297(2) 8644(4) 2903(2) 63(1) 
________________________________________________________________________________
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Data of compound 4f (chapter 1):
Table 1.  Crystal data and structure refinement for 4f 
Identification code  nrr83 
Empirical formula  C17H19IO3S 
Formula weight  430.28 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n   
Space group (Hall)  -P 2yn  
Unit cell dimensions a = 8.95860(10) Å = 90°. 
b = 15.7104(3) Å = 97.7080(10)°. 
c = 12.3853(2) Å  = 90°. 
Volume 1727.40(5) Å3
Z 4 
Density (calculated) 1.655 Mg/m3
Absorption coefficient 1.984 mm-1
F(000) 856 
Crystal size 0.38 x 0.19 x 0.14 mm3
Θ range for data collection 2.11 to 30.00°. 
Index ranges -12h12, -22k22, -17l17 
Reflections collected 31411 
Independent reflections 5029 [R(int) = 0.0251] 
Completeness to Θ = 30.00° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. And min. transmission 0.7687 and 0.5194 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5029 / 0 / 207 
Goodness-of-fit on F2 1.051 
Final R indices [I>2σ(I)] R1 = 0.0238, wR2 = 0.0570 
R indices (all data) R1 = 0.0296, wR2 = 0.0632 
Extinction coefficient 0.0008(2) 
Largest diff. peak and hole 1.596 and -1.041 e.Å-3
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Table 2.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) 
For nrr83.  U (eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
________ 
 x y z U(eq) 
________________________________________________________________________
________ 
I(1) 9994(1) 10425(1) 8414(1) 39(1) 
S(1) 5693(1) 7845(1) 3550(1) 36(1) 
O(1) 5627(2) 9383(1) 1979(1) 45(1) 
O(2) 5132(2) 7814(1) 2392(2) 51(1) 
O(3) 4740(2) 7482(1) 4274(2) 54(1) 
C(1) 6165(2) 8916(1) 3883(2) 30(1) 
C(2) 6155(2) 9521(1) 3043(2) 31(1) 
C(3) 6727(2) 10329(1) 3289(2) 32(1) 
C(4) 7272(2) 10565(1) 4345(2) 30(1) 
C(5) 7198(2) 9981(1) 5202(1) 28(1) 
C(6) 6691(2) 9149(1) 4979(2) 29(1) 
C(7) 7930(3) 11443(1) 4536(2) 41(1) 
C(8) 7686(2) 10272(1) 6368(2) 32(1) 
C(9) 9323(2) 10048(2) 6742(2) 38(1) 
C(10) 6712(3) 8512(2) 5898(2) 41(1) 
C(11) 7447(2) 7318(1) 3743(2) 29(1) 
C(12) 8586(2) 7617(1) 3185(2) 30(1) 
C(13) 9983(2) 7225(1) 3352(2) 31(1) 
C(14) 10245(2) 6531(1) 4055(2) 32(1) 
C(15) 9072(2) 6239(1) 4586(2) 34(1) 
C(16) 7670(2) 6631(1) 4443(2) 34(1) 
C(17) 11752(3) 6098(2) 4224(2) 49(1) 
________________________________________________________________________ 
________ 
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Data of compound 7b (chapter 1): 
Table 1.  Crystal data and structure refinement for 7b. 
Identification code  nrr85 
Empirical formula  C11H12BrNO 
Formula weight  254.13 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c   
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 4.36360(10) Å = 90°. 
b = 9.8334(2) Å = 93.0300(10)°. 
c = 25.0206(4) Å  = 90°. 
Volume 1072.11(4) Å3
Z 4 
Density (calculated) 1.574 Mg/m3
Absorption coefficient 3.800 mm-1
F(000) 512 
Crystal size 0.30 x 0.13 x 0.08 mm3
Θ range for data collection 2.23 to 29.99°. 
Index ranges -6h5, -13k13, -35l35 
Reflections collected 16714 
Independent reflections 3109 [R(int) = 0.0438] 
Completeness to Θ = 29.99° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7508 and 0.3952 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3109 / 0 / 134 
Goodness-of-fit on F2 1.043 
Final R indices [I>2σ(I)] R1 = 0.0309, wR2 = 0.0718 
R indices (all data) R1 = 0.0459, wR2 = 0.0773 
Extinction coefficient 0.0029(9) 
Largest diff. peak and hole 0.413 and -0.554 e.Å-3
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) 
for nrr85.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
________ 
 x y z U(eq) 
________________________________________________________________________
________ 
Br(1) 981(1) 1633(1) 4584(1) 34(1) 
O(1) 9732(4) 3971(2) 7439(1) 36(1) 
N(1) 8280(6) 6955(2) 6846(1) 47(1) 
C(1) 7779(5) 3508(2) 7044(1) 26(1) 
C(2) 6621(5) 4477(2) 6674(1) 26(1) 
C(3) 4629(5) 4102(2) 6238(1) 25(1) 
C(4) 3742(4) 2742(2) 6182(1) 23(1) 
C(5) 4896(5) 1767(2) 6559(1) 26(1) 
C(6) 6890(5) 2164(2) 6981(1) 27(1) 
C(7) 7519(6) 5857(2) 6764(1) 33(1) 
C(8) 3512(6) 5188(2) 5846(1) 34(1) 
C(9) 1627(4) 2310(2) 5710(1) 27(1) 
C(10) 3529(5) 1935(2) 5240(1) 30(1) 
C(11) 3999(6) 291(2) 6512(1) 34(1) 
________________________________________________________________________
________                                                                                                                                                    
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Data of compound 8a(chapter 3): 
Table 1.  Crystal data and structure refinement for 8a 
Identification code  nrr59a 
Empirical formula  C18H18O4S 
Formula weight  330.38 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.) P21/n   
Space group (Hall) -P 2yn 
Unit cell dimensions a = 9.0345(5) Å = 90°. 
b = 18.1451(10) Å = 105.293(4)°. 
c = 10.1977(6) Å  = 90°. 
Volume 1612.53(16) Å3
Z 4 
Density (calculated) 1.361 Mg/m3
Absorption coefficient 0.218 mm-1
F(000) 696 
Crystal size 0.36 x 0.23 x 0.15 mm3
Θ range for data collection 2.59 to 29.00°. 
Index ranges -12h12, -24k24, -13l13 
Reflections collected 14223 
Independent reflections 4236 [R(int) = 0.0510] 
Completeness to Θ = 29.00° 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9680 and 0.9255 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4236 / 0 / 209 
Goodness-of-fit on F2 1.017 
Final R indices [I>2σ(I)] R1 = 0.0481, wR2 = 0.1225 
R indices (all data) R1 = 0.0701, wR2 = 0.1376 
Largest diff. peak and hole 0.435 and -0.332 e.Å-3
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) 
for nrr59a.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
S(1) 5055(1) 1771(1) 1043(1) 25(1) 
O(1) 5338(2) 1801(1) -281(2) 37(1) 
O(2) 6331(2) 1592(1) 2189(2) 33(1) 
O(3) 1876(2) 222(1) 111(1) 28(1) 
O(4) 936(2) 1902(1) 1204(1) 30(1) 
C(1) 4341(2) 2637(1) 1408(2) 25(1) 
C(2) 4732(2) 2893(1) 2733(2) 32(1) 
C(3) 4133(3) 3562(1) 3015(2) 41(1) 
C(4) 3170(3) 3961(1) 1980(3) 43(1) 
C(5) 2802(2) 3700(1) 660(2) 39(1) 
C(6) 3372(2) 3033(1) 357(2) 31(1) 
C(7) 3553(2) 1159(1) 1031(2) 22(1) 
C(8) 2982(2) 700(1) -18(2) 23(1) 
C(9) 3355(2) 587(1) -1361(2) 31(1) 
C(10) 2043(3) 95(1) -2149(2) 36(1) 
C(11) 1525(3) -293(1) -1030(2) 34(1) 
C(12) 3022(2) 1159(1) 2293(2) 22(1) 
C(13) 1690(2) 1544(1) 2356(2) 23(1) 
C(14) 1220(2) 1543(1) 3548(2) 32(1) 
C(15) 2064(3) 1163(1) 4681(2) 37(1) 
C(16) 3380(3) 786(1) 4642(2) 36(1) 
C(17) 3848(2) 786(1) 3448(2) 29(1) 
C(18) -263(2) 2404(1) 1306(2) 40(1) 
________________________________________________________________________________
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Data of compound 9a(chapter 3): 
Table 1.  Crystal data and structure refinement for nrr63. 
Identification code  nrr63 
Empirical formula  C17H15BrO3S 
Formula weight  379.26 
Temperature  298(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1    
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.3485(2) Å = 97.4920(10)°. 
b = 8.7659(2) Å = 103.9260(10)°. 
c = 11.4679(3) Å  = 94.3050(10)°. 
Volume 802.67(3) Å3
Z 2 
Density (calculated) 1.569 Mg/m3
Absorption coefficient 2.700 mm-1
F(000) 384 
Crystal size 0.43 x 0.25 x 0.17 mm3
Θ range for data collection 2.53 to 29.00°. 
Index ranges -11h11, -11k11, -15l15 
Reflections collected 17426 
Independent reflections 4206 [R(int) = 0.0204] 
Completeness to Θ = 29.00° 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6568 and 0.3898 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4206 / 0 / 199 
Goodness-of-fit on F2 1.016 
Final R indices [I>2σ(I)] R1 = 0.0767, wR2 = 0.2342 
R indices (all data) R1 = 0.1038, wR2 = 0.2663 
Largest diff. peak and hole 2.772 and -1.326 e.Å-3
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) 
for nrr63.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
________ 
 x y z U(eq) 
________________________________________________________________________
________ 
Br(1) 7239(1) 7760(1) 14064(1) 86(1) 
S(1) 6740(1) 6244(1) 8406(1) 44(1) 
O(1) 7663(5) 10397(4) 10341(3) 55(1) 
O(2) 6623(5) 5338(4) 9342(4) 59(1) 
O(3) 7804(5) 5860(5) 7629(4) 62(1) 
C(1) 7328(5) 8165(5) 9061(4) 40(1) 
C(2) 7962(5) 9362(5) 8483(4) 42(1) 
C(3) 8371(6) 9450(6) 7390(5) 53(1) 
C(4) 8897(7) 10903(7) 7161(6) 63(1) 
C(5) 9038(8) 12212(7) 8006(7) 69(2) 
C(6) 8662(7) 12169(6) 9106(6) 62(1) 
C(7) 8136(6) 10708(6) 9313(5) 50(1) 
C(8) 7157(6) 8843(6) 10159(4) 46(1) 
C(9) 4736(6) 6267(5) 7478(4) 45(1) 
C(10) 3392(6) 6150(6) 7999(6) 56(1) 
C(11) 1819(7) 6255(8) 7280(8) 78(2) 
C(12) 1600(9) 6448(9) 6075(8) 87(2) 
C(13) 2942(10) 6569(10) 5569(7) 87(2) 
C(14) 4532(8) 6459(7) 6278(5) 62(1) 
C(15) 6567(7) 8240(7) 11153(5) 58(1) 
C(16) 6334(9) 9503(8) 12113(6) 69(2) 
C(17) 5667(10) 8881(11) 13091(7) 87(2) 
________________________________________________________________________
________ 
                                            
130
Data of compound 9a(chapter 4): 
Table 1.  Crystal data and structure refinement for 9a. 
Identification code  nrr100 
Empirical formula  C19H21ClO4
Formula weight  348.81 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.) P-1    
Space group (Hall) -P 1 
Unit cell dimensions a = 9.1581(2) Å = 73.691(2)°. 
b = 9.3847(3) Å = 75.225(2)°. 
c = 11.4211(3) Å  = 68.448(2)°. 
Volume 863.46(4) Å3
Z 2 
Density (calculated) 1.342 Mg/m3
Absorption coefficient 0.241 mm-1
F(000) 368 
Crystal size 0.19 x 0.15 x 0.05 mm3
Θ range for data collection 2.43 to 27.57°. 
Index ranges -11≤h≤11, -12≤k≤12, -14≤l≤14 
Reflections collected 16888 
Independent reflections 3931 [R(int) = 0.0530] 
Completeness to Θ = 27.57° 98.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9881 and 0.9557 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3931 / 0 / 224 
Goodness-of-fit on F2 1.017 
Final R indices [I>2σ(I)] R1 = 0.0466, wR2 = 0.1040 
R indices (all data) R1 = 0.0938, wR2 = 0.1260 
Largest diff. peak and hole 0.427 and -0.402 e.Å-3
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for nrr100.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
Cl(1) 14501(1) 2012(1) 5365(1) 46(1) 
O(1) 5742(2) 352(2) 8734(2) 42(1) 
O(2) 7823(2) -779(2) 7423(2) 49(1) 
O(3) 6847(2) 867(2) 10496(2) 31(1) 
O(4) 8901(2) 1905(2) 10992(1) 28(1) 
C(1) 8068(2) 1092(2) 8315(2) 26(1) 
C(2) 7913(2) 1285(2) 9517(2) 25(1) 
C(3) 8947(2) 1907(2) 9759(2) 24(1) 
C(4) 10077(2) 2397(2) 8842(2) 26(1) 
C(5) 10170(2) 2289(3) 7620(2) 27(1) 
C(6) 9170(2) 1640(2) 7343(2) 28(1) 
C(7) 7081(3) 221(3) 8164(2) 30(1) 
C(8) 6957(3) -1752(4) 7290(4) 74(1) 
C(9) 7970(4) -3342(4) 7353(4) 74(1) 
C(10) 11156(3) 3049(3) 9181(2) 35(1) 
C(11) 11436(3) 2792(3) 6617(2) 34(1) 
C(12) 12969(3) 1425(3) 6525(2) 38(1) 
C(13) 9219(3) 1611(3) 6017(2) 41(1) 
C(14) 7756(2) 3091(2) 11513(2) 25(1) 
C(15) 6684(3) 4328(3) 10875(2) 31(1) 
C(16) 5585(3) 5476(3) 11488(2) 39(1) 
C(17) 5562(3) 5391(3) 12717(2) 39(1) 
C(18) 6650(3) 4152(3) 13343(2) 38(1) 
C(19) 7751(3) 2998(3) 12750(2) 32(1) 
________________________________________________________________________________ 
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Data of compound 9b(chapter 4): 
Table 1.  Crystal data and structure refinement for 9b 
Identification code  nrr101 
Empirical formula  C19H21BrO4
Formula weight  393.27 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1    
Space group (Hall)  -P 1  
Unit cell dimensions a = 9.2053(3) Å = 72.8050(10)°. 
b = 9.4398(3) Å = 75.5310(10)°. 
c = 11.5253(3) Å  = 68.299(2)°. 
Volume 877.72(5) Å3
Z 2 
Density (calculated) 1.488 Mg/m3
Absorption coefficient 2.361 mm-1
F(000) 404 
Crystal size 0.80 x 0.70 x 0.30 mm3
Θ range for data collection 2.38 to 29.99°. 
Index ranges -12h12, -13k13, -13l16 
Reflections collected 23057 
Independent reflections 4992 [R(int) = 0.0302] 
Completeness to Θ = 29.99° 97.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5377 and 0.2539 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4992 / 0 / 221 
Goodness-of-fit on F2 1.049 
Final R indices [I>2σ(I)] R1 = 0.0318, wR2 = 0.0871 
R indices (all data) R1 = 0.0366, wR2 = 0.0899 
Largest diff. peak and hole 0.954 and -0.689 e.Å-3
133
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) 
for nrr101.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
________ 
 x y z U(eq) 
________________________________________________________________________
________ 
Br(1) 14522(1) 7110(1) 287(1) 40(1) 
O(1) 5717(2) 5376(2) 3746(1) 39(1) 
O(2) 7805(2) 4192(2) 2512(2) 46(1) 
O(3) 6840(1) 5865(1) 5497(1) 28(1) 
O(4) 8900(1) 6881(1) 5975(1) 26(1) 
C(1) 8040(2) 6098(2) 3333(1) 23(1) 
C(2) 7890(2) 6285(2) 4524(1) 22(1) 
C(3) 8927(2) 6896(2) 4764(1) 22(1) 
C(4) 10047(2) 7388(2) 3846(1) 24(1) 
C(5) 10127(2) 7289(2) 2634(1) 25(1) 
C(6) 9130(2) 6643(2) 2373(1) 25(1) 
C(7) 7056(2) 5228(2) 3201(2) 27(1) 
C(8) 6939(3) 3213(3) 2425(4) 75(1) 
C(9) 8022(4) 1677(3) 2313(3) 64(1) 
C(10) 7789(2) 8079(2) 6476(1) 23(1) 
C(11) 7826(2) 7987(2) 7692(2) 28(1) 
C(12) 6753(2) 9162(2) 8266(2) 34(1) 
C(13) 5658(2) 10407(2) 7628(2) 37(1) 
C(14) 5650(2) 10489(2) 6415(2) 36(1) 
C(15) 6721(2) 9330(2) 5820(2) 29(1) 
C(16) 11132(2) 8027(2) 4177(2) 32(1) 
C(17) 11366(2) 7809(2) 1634(2) 31(1) 
C(18) 12892(2) 6443(2) 1548(2) 35(1) 
C(19) 9175(2) 6599(2) 1064(2) 39(1) 
________________________________________________________________________
________                                    
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Data of compound 1(manuscript in preparation): 
Table 2.  Crystal data and structure refinement for nso2. 
Identification code  nso2 
Empirical formula  C17 H12 O5 S 
Formula weight  328.33 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.) P212121
Space group (Hall) P 2ac 2ab 
Unit cell dimensions a = 5.9644(2) Å = 90°. 
b = 8.0764(2) Å = 90°. 
c = 30.6452(9) Å  = 90°. 
Volume 1476.21(8) Å3
Z 4 
Density (calculated) 1.477 Mg/m3
Absorption coefficient 0.243 mm-1
F(000) 680 
Crystal size 0.61 x 0.40 x 0.17 mm3
Θ range for data collection 2.66 to 28.99°. 
Index ranges -7h8, -11k9, -41l40 
Reflections collected 11922 
Independent reflections 3846 [R(int) = 0.0232] 
Completeness to Θ = 28.99° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9598 and 0.8658 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3846 / 0 / 209 
Goodness-of-fit on F2 1.115 
Final R indices [I>2σ(I)] R1 = 0.0313, wR2 = 0.0790 
R indices (all data) R1 = 0.0327, wR2 = 0.0800 
Absolute structure parameter 0.00(6) 
Largest diff. peak and hole 0.286 and -0.266 e.Å-3
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 Table 3.  Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) 
for nso2.  U (eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________
________  
 x y z U(eq) 
________________________________________________________________________
________   
S(1) 4808(1) 4082(1) 8500(1) 20(1) 
O(1) 4788(2) 5747(1) 8668(1) 28(1) 
O(2) 6910(2) 3200(2) 8492(1) 30(1) 
O(3) 2199(2) 335(2) 8434(1) 41(1) 
O(4) 335(2) 2035(1) 9311(1) 19(1) 
O(5) -2243(2) 1736(1) 9839(1) 27(1) 
C(1) 2966(2) 2832(2) 8805(1) 18(1) 
C(2) 1396(2) 3329(2) 9088(1) 17(1) 
C(3) 370(2) 4889(2) 9242(1) 18(1) 
C(4) 635(3) 6550(2) 9126(1) 22(1) 
C(5) -695(3) 7708(2) 9340(1) 24(1) 
C(6) -2259(3) 7263(2) 9655(1) 26(1) 
C(7) -2560(3) 5610(2) 9765(1) 23(1) 
C(8) -1220(2) 4461(2) 9554(1) 18(1) 
C(9) -1215(2) 2655(2) 9607(1) 19(1) 
C(10) 3258(2) 976(2) 8719(1) 21(1) 
C(11) 4890(3) 74(2) 8998(1) 34(1) 
C(12) 3670(2) 4069(2) 7970(1) 22(1) 
C(13) 1632(3) 4869(2) 7893(1) 30(1) 
C(14) 788(3) 4893(2) 7470(1) 35(1) 
C(15) 1958(3) 4123(2) 7137(1) 36(1) 
C(16) 3977(4) 3330(2) 7216(1) 36(1) 
C(17) 4848(3) 3290(2) 7639(1) 29(1) 
________________________________________________________________________________
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                         PART- B 
  Synthesis of tetraarylthiophenes by regioselective 
        Suzuki cross-coupling reactions 
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                                                                                  Chapter 8 
Regioselective Functionalization of Tetrabromothiophene by Suzuki-
Cross-Coupling Reactions.
                                                                         Tetrahedron Lett. 2007, 48, 845-847 
 8.1. Introduction
Regioselective functionalizations of polyhalogenated heterocycles play an increasingly 
important role in organic synthesis.[1] These reactions rely on the higher reactivity of 
more electron-deficient carbon atoms while the other reactive positions remain 
unattacked. This concept has been applied to regioselective palladium(0) catalyzed 
coupling reactions which rely on the different rate of the oxidative addition of 
palladium(0) species to different carbon-halide bonds of the substrate. Thiophene-
containing compounds constitute an important class of materials which show intrinsic 
electronic properties such as luminescence, redox activity, nonlinear optical chromism 
and electron-transport.[2] Thiophenes are also present in pharmacologically relevant 
natural products. This includes, for example, dibenzothiophenes,[3] 
[2,2';5',2'']terthiophenes,[4] and thienyl-diynes.[5]
2,3-Dibromothiophene has been functionalized by regioselective Sonogashira coupling 
of carbon atom C-2.[6] A very good C-2 regioselectivity was observed also for the 
Kumada cross coupling of 2,3- and 2,4-dibromothiophene.[7] 2,5-Disubstituted thiophenes 
were prepared by regioselective Sonogashira coupling reactions of tetraiodothiophene[8]
and tetrabromothiophene.[9] Recently, we reported the synthesis of tetraarylthiophenes by 
regioselective Suzuki reactions of tetrabromothiophene.[10] Herein, we report full details 
of these studies. In addition, we report the regioselective functionalization of 
tetrabromothiophene based on metal-halide exchange reactions.we studied the 
preparative scope of this method and its application to the synthesis of a wide range of 
functionalized thiophenes. 
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 8.2. Results and Discussion
Tetrabromothiophene (1) was prepared by bromination of thiophene (following a 
modified literature procedure).[11] The tetraarylthiophenes 2a-g, containing four identical 
aryl groups, were successfully prepared by Suzuki reaction[12] of 1 (1.0 equiv.) with 5.0 
equiv. of various boronic acids (Scheme 1, Table 1). The reaction of 1 (1.0 equiv.) with 
2.2 equiv. of boronic acids allowed the regioselective synthesis of the 2,5-diaryl-3,4-
dibromothiophenes 3a-f (Scheme 2, Table 2). Products 3a,b (1.0 equiv.) could be further 
functionalized by Suzuki-reaction with 3.0 equiv. of various arylboronic acids to give the 
tetraarylthiophenes 4a-f which contain two different types of aryl groups (Scheme 2, 
Table 3). All reactions were carried out based on optimization studies of related Suzuki 
reactions  carried out in our laboratory.[13] The stoichiometry of the reagents, the 
temperature, the solvent, and the presence of  water proved to be important parameters. 
Oxygen-containing boronic acids showed a better solubility in 1,4-dioxane than in 
toluene. On the other hand, the higher boiling point of toluene proved to be advantageous 
in many cases. All reactions were carried out in the presence of water (solvent/water = 
4:1) which proved to be very important in order to obtain good yields.[14]  
S BrBr Ar1 B(OH)2
i
1 2a-g
Br Br
S Ar1Ar1
Ar1 Ar1
Scheme 1. Synthesis of tetraarylthiophenes 2a-g. Conditions: i, 1 (1.0 equiv.), Ar1B(OH)2
(5.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (8.0 equiv.), solvent/H2O = 4:1 (solvent see 
Table 1) 
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                                 Table 1. Synthesis of tetraaryl-thiophenes 2a-g
2 Ar1 Solvent % (2)  
a 
b 
c 
d 
e 
f 
g 
Ph 
4-(MeO)C6H4
2-(MeO)C6H4 
1-Naphthyl
4-MeC6H4 
4-ClC6H4 
4-FC6H4
Toluene 
1,4-Dioxane 
1,4-Dioxane 
Toluene 
Toluene 
Toluene 
Toluene 
37 a
94 b
38 b
65 b
87 a
89 b 
93b
            a Isolated yields (conditions: 90 °C, 12 h); b isolated yields (conditions: 90 °C, 24 
h) 
S BrBr Ar1 B(OH)2
S Ar1Ar1
Ar2 B(OH)2
i
1 3a-f
4a-f
ii
Br Br Br Br
S Ar1Ar1
Ar2 Ar2
Scheme 2. Synthesis of tetraaryl-thiophenes 4a-f. Conditions: i, 1 (1.0 equiv.), Ar1B(OH)2
(2.2 equiv.), Pd(PPh3)4 (6 mol-%), K3PO4 (4.0 equiv.), solvent/H2O = 4:1 (solvent see 
Table 2); ii, 3a,b (1.0 equiv.), Ar2B(OH)2 (3.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 
equiv.), solvent/H2O = 4:1 (solvent see Table 3)  
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                      Table 2. Synthesis of 2,5-diaryl-3,4-dibromo-thiophenes 3a-f
3 Ar1 Solvent % (3) 
a 
b
c 
d
e 
f 
Ph 
4-MeC6H4
4-MeOC6H4
2-MeOC6H4
3,5-Me2C6H3
2-Thienyl 
Toluene 
Toluene 
1,4-Dioxane 
1,4-Dioxane 
Toluene 
Toluene 
32 a
77 a
43 b
35  b
54  b
48  b
a Isolated yields (conditions: 90 °C, 12 h); b isolated yields (conditions: 90 °C, 24 h) 
Table 3. Synthesis of tetraaryl-thiophenes 4a-f
4 Ar1 Ar2 Solvent % (4) 
a 
b 
c 
d 
e 
f 
Ph 
4-MeC6H4
4-MeC6H4
4-MeC6H4
4-MeC6H4
4-MeC6H4
4-MeC6H4
Ph 
4-(MeO)C6H4
4-(EtO)C6H4
4-(HO)C6H4
4-ClC6H4
Toluene 
Toluene 
Toluene+Dioxane c
Toluene+Dioxane c
Toluene+Dioxane c
Toluene 
86 a
51 a
76 b
93 b
82 b
91 b
a Isolated yields (conditions: 90 °C, 12 h); b isolated yields (conditions: 90 °C, 24 h); c
toluene / dioxane = 1:1  
The structures of all products were established by spectroscopic methods. The structure 
of 3e was independently confirmed by an X-ray crystal structure analysis.10 Detailed 
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inspection of the 1H and 13C NMR spectra and dynamic NMR studies (variable 
temperature NMR etc.) of tetrakis(2-methoxyphenyl)thiophene (2c) show that the 
rotation of the aryl-groups is sterically hindered and that two (out of theoretically 
possible six) rotamers are present at room temperature. However, the structure of the 
rotamers could not be unambigiously assigned.  
                     
The double Suzuki reaction of diester 4g with 4-chlorophenyl, 2-methoxyphenyl, and 2-
hydroxyphenylboronic acid afforded the thiophenes 5a-c (Scheme 4, Table 5).  
       
S CO2MeCO2Me
iBr Br
ArB(OH)2
S CO2MeCO2Me
Ar Ar
4g 5a-c
  
Scheme 4. Suzuki reactions of 4g. Conditions: i, 4g (1.0 equiv.), ArB(OH)2 (3.0 equiv.), 
Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv.), solvent/H2O = 4:1 (solvent see Table 4) 
           Table 4. Synthesis of thiophenes 5a-c
5 Ar % a Solvent 
a 4-ClC6H4 42 Toluene 
b 2-(MeO)C6H4 45 Toluene+Dioxane b
c 2-(HO)C6H4 49 Toluene+Dioxane b
                a Isolated yields; b toluene / dioxane = 1:1 
For 3,4-di(2-methoxyphenyl)thiophene 5b two rotamers are present at room temperature, 
due to the hindered rotation of the aryl groups. In contrast, only one set of signals is 
observed for 3,4-di(2-hydroxyphenyl)thiophene 5c.  
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8.3. Conclusions 
In conclusion, tetrasubstituted thiophenes were prepared based on regioselective Suzuki 
reactions of tetrabromothiophene. The Suzuki reaction of tetrabromothiophene resulted in 
regioselective functionalization of carbon atoms C-2 and C-5 which more rapidly 
undergo the odidative addition with the palladium(0) catalyst. Carbon atoms C-3 and C-4 
could be subsequently functionalized by Suzuki reactions. Tetraarylthiophenes containing 
four identical substituents could be prepared in one step from tetrabromothiophene. The 
yields of the Suzuki reactions are generally good, except for reactions of parent 
phenylboronic acid and of 2-methoxyphenylboronic acid.  The yields depend also on the 
individual quality of the starting materials and on the handling of each individual 
experiment.  
8.4. Experimental Section 
General Comments. All solvents were dried by standard methods and all reactions were 
carried out under an inert atmosphere. For 1H and 13C NMR spectra the deuterated 
solvents indicated were used. Mass spectrometric data (MS) were obtained by electron 
ionization (EI, 70 eV), chemical ionization (CI, H2O) or electrospray ionization (ESI). 
For preparative scale chromatography, silica gel (60-200 mesh) was used. Melting points 
are uncorrected.  
8.4.1.Synthesis of tetrabromothiophene (1):[12] To a chloroform solution (10 mL) of 
thiophene (25 mL) a chloroform solution (20 mL) of bromine (60 mL) was dropwise 
added within 45 minutes. The reaction mixture was warmed to room temperature and an 
additional amount of bromine (10 mL) was added and the reaction mixture was 
subsequently stirred under reflux for three hours. A saturated aqueous solution of NaOH 
was added and the mixture was stirred under reflux for 6 h to remove the bromine. The 
solvent and the excess of bromine was removed in vacuo. The product was recrystallized 
from a 1:1 solution of chloroform and methanol. The crude product (red to brownish 
crystals) was washed with cold ethyl acetate for several times to give pure 1 as colourless 
crystals (87%). 13C NMR (75 MHz, CDCl3):  = 110.3, 116.9; MS (EI, 70 eV): m/z (%) = 
400 (M+, 100), 321 (65), 240 (34), 161 (41). 
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8.3.2.General procedure for synthesis of tetraarylthiophenes 2a-g: To a toluene 
solution (6 mL) of 1 (0.400 g, 1.0 mmol) was added Pd(PPh3)4 (0.116 g, 10 mol-%) at 20 
°C. After stirring for 30 min, the arylboronic acid (5.0 mmol), K3PO4 (8.0 mmol) and 
water (2.0 mL) were added. The mixture was stirred at 90 °C for 12 h. After cooling to 
ambient temperature, the mixture was diluted with EtOAc, dried (Na2SO4), and filtered 
through a short Celite pad. The solution was concentrated in vacuo and the residue was 
purified by flash column chromatography (fine flash silica gel, n-heptane). 
Synthesis of tetraphenylthiophene (2a). Starting with 1 (0.400 g, 1.0 mmol) and 
phenylboronic acid (5.0 mmol), 2a was isolated (0.144 g, 37%) as a colourless solid; mp 
168−170 oC. 1H NMR (300 MHz, CDCl3):  = 6.87 (m, 4×2H, Ar), 7.03 (m, 4×2H, Ar), 
7.14 (m, 2×2H, Ar). 13C NMR (75 MHz, CDCl3):  = 126.6, 127.2, 127.8, 128.2, 129.1, 
130.8 (2×10CH, Ar), 134.2, 136.4, 138.5, 139.4 (8C, ArC); IR (KBr, cm	−1):  = 3058 (w), 
3022 (w), 1596 (m), 1495 (m), 1480 (m), 1444 (w), 1073 (w), 1029 (w), 793 (w), 750 (s), 
695 (s), 592 (m), 518 (w). MS (EI, 70 eV): m/z (%) = 388 (M+, 100), 354 (4), 310 (6), 
267 (4), 178 (3), 165 (6), 121 (3), 77 (2). HRMS (EI, 70 eV): calcd for C28H20S (M+): 
388.1280; found: 388.1274.  
Synthesis of tetra(4-methoxy)thiophene (2b). Starting with 1 (0.400 g, 1.0 mmol) and 
4-tolylboronic acid (5.0 mmol), 2b was isolated (0.477 g, 94%) as a colourless solid; mp 
183−185 oC. 1H NMR (300 MHz, CDCl3):  = 3.65, 3.72 (s, 12 H, 2×2OCH3), 6.59, 6.69, 
6.82, 7.09 (d, 4×4H, CH, Ar). 13C NMR (75 MHz, CDCl3):  = 55.00, 56.06 (2×2C, 
OCH3), 114.8, 116.0, 130.2, 131.9  (2×8CH, Ar), 127. 0, 129.0, 137.1, 138.3, 158.0, 
158.6 (2×C, ArC); IR (KBr, cm	−1):  = 3431 (w), 3031 (m), 3003 (m), 2957 (m), 2924 
(m), 2840 (m), 1607 (m), 1511 (s), 1495 (s), 1286 (s), 1175 (s), 1031 (s), 834 (s), 799 
(m); MS (EI, 70 eV): m/z (%) = 508 (M+, 100), 255 (31), 178 (15), 172 (29), 160 (26), 96 
(10). HRMS (EI, 70 eV): calcd for C32H28O4S (M+): 508.6273; found: 508.6277.  
Synthesis of tetra(2-methoxy)thiophene (2c). Starting with 1 (0.400 g, 1.0 mmol) and 
4-tolylboronic acid (5.0 mmol), 2c was isolated (0.193 g, 38%) as a colourless solid; mp 
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171−173 oC. A doubling of some signals in the 1H and 13C NMR spectra is observed, due 
to the presence of two rotamers. 1H NMR (300 MHz, CDCl3):  = 3.08, 3.15, 3.26, 3.43 
(4 x s, 12 H, 4 OCH3), 6.52 (m, 4 H, Ar), 6.69 (m, 4 H, Ar), 6.90 (m, 4 H, Ar), 7.07 (m, 4 
H, Ar). 13C NMR (75 MHz, CDCl3):  = 54.6, 54.8, 54.9, 55.1 (OCH3), 110.1, 110.5, 
110.8, 110.9, 119.8, 119.7, 120.1, 120.2, 127.4, 127.5, 128.4, 128.5, 131.3, 132.0, 132.1, 
132.2 (CH, Ar), 123.7, 123.9, 134.9, 135.1, 136.9, 137.3, 156.5, 156,6, 156.7, 156.8 (C, 
ArC); IR (KBr, cm−1)  = 3432 (w), 3067 (m), 2932 (w), 2830 (w), 1597 (s), 1578 (s), 
1493 (s), 1460 (s), 1240 (s), 1117 (s), 1023 (s), 752 (s), 617 (w); MS (EI, 70 eV): m/z (%) 
= 508 (M+, 100), 387 (18), 354 (9), 294 (8), 224 (6), 178 (4), 151 (3), 91 (5). HRMS (EI, 
70 eV): calcd for C32H28O4S (M+): 508.1703; found: 508.1706.  
Synthesis of tetra(1-naphthyl)thiophene (2d). Starting with 1 (0.400 g, 1.0 mmol) 
and 1-naphthylboronic acid (5.0 mmol), 2d was isolated (0.382 g, 65%) as a colourless 
solid; 293−294 oC. 1H NMR (300 MHz, CDCl3):  = 6.82 (m, 4 H, Ar), 7.89 (m, 2 H, Ar), 
7.06 (m, 8 H, Ar), 7.21 (m, 4 H, Ar), 7.34 (m, 4 H, Ar), 7.49 (m, 2 H, Ar), 8.21, 8,29 (d,d, 
3J = 7.8 Hz, 2 H, Ar), 8.58, 8,65 (d,d, 3J = 7.8 Hz, 2 H, Ar). 13C NMR (75 MHz, CDCl3): 
 = 124.5−129.3 (CH, Ar), 131.4, 131.6, 133.1, 133.7, 134.2, 134.6, 138.3, 140.6 (2×8C, 
ArC); IR (KBr, cm	−1):  = 3053 (w), 2923(w), 1592 (w), 1506 (w), 1387 (w), 1261 (w), 
1016 (w), 796 (s), 772 (s), 559 (w), 427 (w); MS (EI, 70 eV): m/z (%) = 388 (M+, 100), 
354 (4), 310 (6), 267 (4), 178 (3), 165 (6), 121 (3), 77 (2). HRMS (EI, 70 eV): calcd for 
C44H28S (M+): 588.1906; found 588.1901.  
  
8.3.3.General procedure for synthesis of 3,4-dibromo-2,5-diarylthiophenes (3a-f): To 
a toluene solution (4 mL) of 1 (0.400 g, 1.0 mmol) was added Pd(PPh3)4 (0.070 g, 6 mol-
%) at 20 °C. After stirring for 30 min, the arylboronic acid (2.2 mmol), K3PO4 (4.0 
mmol) and water (1.0 mL) were added. The mixture was stirred at 90 °C for 12 h. After 
cooling to ambient temperature, the mixture was diluted with EtOAc, dried (Na2SO4), 
and filtered through a short Celite pad. The solution was concentrated in vacuo and the 
residue was purified by flash column chromatography (fine flash silica gel, n-heptane). 
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Synthesis of 3,4-dibromo-2,5-diphenylthiophene (3a). Starting with 1 (0.400 g, 1.0 
mmol) and phenylboronic acid (2.2 mmol), 3a was isolated (0.125 g, 32%) as a 
colourless solid; mp 150−151 oC. 1H NMR (300 MHz, CDCl3):  = 7.35 (m, 2×3H, Ar), 
7.61 (m, 2×2H, Ar). 13C NMR (75 MHz, CDCl3):  = 112.2 (2C, CBr), 128.4, 128.7, 
128.8 (2×5CH, Ar), 132.8, 138.1 (2×2C, ArC); IR (KBr, cm−1):  =  3051 (w), 2924 (w), 
2853 (w), 1477 (m), 1268 (m), 1028 (w), 749 (s), 699 (s), 628 (w), 584 (w). MS (EI, 70 
eV): m/z (%) = 396 (M+, [81Br,81Br], 55), 394 (M+, [81Br,79Br], 100), 392 (M+, [79Br,79Br], 
53), 314 (3), 234 (48), 202 (8), 197 (7), 189 (22), 117 (12), 95 (6), 77 (5). HRMS (EI, 70 
eV): calcd for C16H10Br2S (M+, [79Br,79Br]): 391.8864; found 391.8861. 
Synthesis of 3,4-dibromo-2,5-di(4-methoxy)thiophene (3c). Starting with 1 (0.400 g, 
1.0 mmol) and 4-methoxyphenylboronic acid (2.2 mmol), 3c was isolated (0.194 g, 43%) 
as a colourless solid; mp 171−173 oC. 1H NMR (300 MHz, CDCl3):  = 3.78 (s, 6 H, 
2OCH3), 6.93 (d, 3J = 8.2 Hz, 4 H, Ar), 7.54 (d, 3J = 8.2 Hz, 4 H, Ar). 13C NMR (75 
MHz, CDCl3):  = 55.6 (2C, OCH3), 111.4 (2C, CBr), 114.0, 129.9 (2×4CH, Ar), 126.2, 
137.3, 159.9 (2×3C, ArC); IR (KBr, cm−1);  =  3442 (br, w), 2959 (w), 2923 (w), 2835 
(w), 1598 (w), 1579 (w), 1482 (s),  1252 (s), 1179 (w), 1117 (m), 1024 (s), 796 (m), 751 
(s); MS (EI, 70 eV): m/z (%) = 456 (M+, [81Br,81Br], 48), 454 (M+, [81Br,79Br], 100), 452 
(M+, [79Br,79Br], 43), 476 (13), 474 (12),  279 (10), 208 (12), 136 (11), 121 (19), 119 
(17), 105 (16), 77 (11), 69 (3). HRMS (EI, 70 eV): calcd for C18H14Br2O2S (M+, 
[79Br,79Br]): 451.9076; found: 451.9073. 
Synthesis of 3,4-dibromo-2,5-di(2-methoxy)thiophene (3d). Starting with 1 (0.400 g, 
1.0 mmol) and 2-methoxyphenylboronic acid (2.2 mmol), 3d was isolated (0.159 g, 35%) 
as a colourless solid; mp 120−122 oC. A small amount of impurity could not be removed.
1H NMR (300 MHz, CDCl3):  = 3.78 (s, 6 H, 2OCH3), 6.93 (m, 2×2 H, Ar), 7.34 (m, 4 
H, Ar). 13C NMR (75 MHz, CDCl3):  = 55.6 (2C, OCH3), 111.2, 120.4, 130.5, 132.2 
(2×4CH, Ar), 112.6, 121.7, 134.9, 157.0 (2×4C, ArC); IR (KBr, cm−1):  = 3432 (br, w), 
2995 (w), 2961 (w), 2835 (w), 1608 (s), 1534 (s), 1491 (s), 1299 (w), 1253 (s), 1180 (s), 
1040 (s), 828 (s), 805 (m), 754 (w), 578 (w), 514 (w); MS (EI, 70 eV): m/z (%) = 456 
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(M+, [81Br,81Br], 47), 454 (M+, [81Br,79Br], 100), 452 (M+, [79Br,79Br], 43), 376 (56), 374 
(53),  279 (22), 264 (37), 237 (16),  208 (9), 149 (7), 147 (7), 131 (5), 104 (6), 71 (16), 57 
(25). HRMS (EI, 70 eV): calcd for C18H14Br2O2S (M+, [79Br, 79Br]): 451.9070; found: 
451.9069. 
Synthesis of 3,4-dibromo-2,5-di(3,5-dimethylphenyl)thiophene (3e). Starting with 1
(0.400 g, 1.0 mmol) and 3,5-dimethylphenylboronic acid (2.2 mmol), 3e was isolated 
(0.242 g, 54%) as a colourless solid; mp 120−121 oC. A small amount of impurity could 
not be separated.  1H NMR (300 MHz, CDCl3):  = 2.26 (s, 12 H, 4CH3), 6.93 (s, 2 H, 
Ar), 7.21 (s, 4 H, Ar). 13C NMR (75 MHz, CDCl3):  = 21.6 (2C, CH3), 111.8 (2C, CBr), 
126.2, 129.9 (2×4CH, Ar), 123.3, 138.1, 141.4 (2×3C, ArC); IR (KBr, cm	−1):  = 3436 (br, 
w), 2997 (w), 2917 (m), 1598 (s), 1457 (m), 1298 (w), 1257 (w), 1039 (w), 896 (w),  852 
(s), 828 (s), 707 (m), 689 (m); MS (EI, 70 eV): m/z (%) = 452 (M+, [81Br,81Br], 50), 450 
(M+, [81Br,79Br], 100), 448 (M+, [79Br,79Br], 45), 372 (17), 370 (16),  290 (19), 225 (5), 
210 (48), 195 (15), 149 (8), 97 (7), 69 (16). HRMS (EI, 70 eV): calcd for C20H18Br2S 
(M+, [79Br,79Br]): 447.9491; found: 447.9492. 
Synthesis of 3,4-dibromo-2,5-di(thien-2-yl)thiophene (3f). Starting with 1 (0.400 g, 
1.0 mmol) and 2-thiopheneboronic acid (0.299 g, 2.2 mmol), 3f was isolated (0.194 g, 
48%) as a colourless solid; 89−91 oC. 1H NMR (300 MHz, CDCl3):  = 7.05 (t, 3J = 3.7 
Hz, 2×1H, thiophene), 7.28 (d, 3J = 4.1 Hz, 2×1H, thiophene), 7.41 (m, 2×1H, thiophene). 
13C NMR (75 MHz, CDCl3):  = 112.4 (2C, CBr), 126.8,  127.1, 127.4 (2×3CH, 
thiophene), 132.0, 135.1 (2×2C, ArC); IR (KBr, cm−1):  = 3094 (w), 2960 (w), 2923 (w), 
1484 (w), 1418 (w), 1261 (w), 1221 (w), 1060 (w), 844 (m), 815 (m), 699 (m), 686 (s). 
MS (EI, 70 eV): m/z (%) = 408 (M+, [81Br,81Br], 55), 406 (M+, [81Br,79Br], 100), 404 (M+, 
[79Br,79Br], 47), 328 (16), 326 (17), 246 (52), 202 (11), 149 (7), 127 (10), 112 (5), 95 (9), 
84 (17). HRMS (EI, 70 eV): calcd for C12H6Br2S3 (M+, [79Br,79Br]): 403.7993; found: 
403.7986. 
Synthesis of 3,4-diphenyl-2,5-di(4-tolyl)thiophene (4b). Starting with 3b (1.0 mmol) 
and phenylboronic acid (3.0 mmol), 4b was isolated (0.212 g, 51%) as a colourless solid; 
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mp 154−155 oC. 1H NMR (300 MHz, CDCl3):  = 2.22 (s, 3×2H, CH3), 6.87 (d, 3J = 8.2 
Hz, 4 H, 2CH, Ar), 6.91 (d, 3J = 8.2 Hz, 4 H, 2CH, Ar),  7.08 (m, 10 H, Ar). 13C NMR 
(75 MHz, CDCl3):  = 21.0 (2C, CH3), 126.3, 127.6, 128.8, 128.9, 130.7 (2×10CH, Ar),  
136.7, 136.8, 138.3, 139.4 (2×4C, ArC); IR (KBr, cm	−1):  =  3052 (w), 2918 (w), 1544 
(w), 1502 (m), 1439 (m), 1021 (w), 836 (w), 817 (m), 771 (s), 703 (s), 523 (w), 510 (w); 
MS (EI, 70 eV): m/z (%) = 416 (M+, 100), 324 (4), 281 (6), 183 (4), 165 (6), 149 (7), 112 
(13), 97 (15), 83 (19), 57 (32). HRMS (EI, 70 eV): calcd for C30H24S (M+): 416.1593; 
found: 416.1591.  
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General Introduction 
The medicinal plants find application in pharmaceutical, cosmetic, agricultural and food 
industry. The use of the medicinal herbs for curing disease has been documented in 
history of all civilizations. Man in the pre-historic era was probably not aware about the 
health hazards associated with irrational therapy. With the onset of research in medicine, 
it was concluded that plants contain active principles, which are responsible, for curative 
action of the herbs. 
Before onset of synthetic era, man was completely dependent on medicinal herbs for 
prevention and treatment of diseases. With introduction of scientific procedures the 
researchers, were able to understand about toxic principles present in the green flora. The 
scientists isolated active constituents of the medicinal herbs and after testing some were 
found to be therapeutically active. Aconitine, Atisine, Lobeline, Nicotine, Strychnine, 
Digoxin, Atropine, Morphine are some common examples. 
The efficacy of some herbal products is beyond doubt, the most recent examples being 
Silybum marianum (silymarin), Artemisia annua (artemesinin) and Taxus baccata (taxol). 
On the other hand, randomized, controlled trials have proved the efficacy of some 
established remedies, for instance, Ginkgo biloba for tinnitus, Hypericum perforatum is a 
reputed remedy for depression. In Hypericum some researchers are of the view that 
hypericin is the active principle of the herb and some believe that hyperforin is 
responsible for antidepressant action of the herb. 
Recently research has supported biological activities of some medicinal herbs. Cancer is 
such a segment where researchers are expecting new molecules from herbs that can 
provide us with tools for fighting this dreaded disease. Allamanda cathratica 
[allamandin], Elephatopus elatus [elephantpoin], Helenium autmnale [helenalin] 
Vernonia hymenlepis, Heliotropium indicum [Indicine-N-oxide], Daphne mezereum 
(mezerien) and Stereospermum suaveolans [laphacol] are medicinal plants that have 
shown significant tumor inhibiting effect. 
Diabetes mellitus is another area where a lot of research is going on. Ajuga reptens (the 
active principle is said to potentiate effects of insulin), Galagea officinalis (galagine), 
Bougainvillea spectabilis (pinitol), Momordica charantia (chirantin), Gymnema sylvestre 
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(gymnemic acid) are some medicinal herbs that have shown effectiveness in non-insulin 
dependent diabetes. Recently extract of Tecoma stans has shown potent anti diabetic 
activity. Alkaloid tecomonine is considered to be active principle of the herb.Arthritis is 
another potential disease where no satisfactory answer is present in modern medicine. 
Commiphora mukul (guggulsterones), Boswellia serrata [boswellic acid], Withania 
somnifera (withanolides), Ruscus acueleatus (ruscogenin), Harpagophytum procumbens 
(harpagoside) are prominent plants with anti- arthritic activity. Harpagoside is a precious 
constituent as it has anti rheumatoid activity. Rest of all natural products has anti-
inflammatory activityChrysanthemum parthenium traditionally known as feverfew has 
shown promising results in migraine, a disease that has eluded the researchers from 
centuries. The herb contains sesquiterpenes lactones called parthenolides, which are the 
active principles of the herb. Hepatoprotective action of certain botanicals deserves 
attention. Sedum sarmentosum [sarmentosin], Schisandra chinensis [waweizichun and 
schisantherin] have shown their ability to lower raised liver enzymes in viral hepatitis. 
Croton sublyratus [plaunotol] has potent and wide spectrum anti peptic ulcer action. A 
number of plant derivatives have shown anti-Aids activity. Ancistrocladus korupensis 
[michellamine-b], Caulophyllum langigerum [calanolide-a], Caulophyllum teymani 
[costatolide-a], Homalanthus nutans [prostratin], Conospermum sp [concurvone] are the 
medicinal herbs from African countries that are being employed in research for finding a 
suitable cure for Aids. 
The concept of antioxidants is fastly catching up and latest research has shown that a 
number of herbal derivatives have excellent antioxidant action. Bacopa monnieri contains 
bacosides A and B and bacoside A is a strong antioxidant, which reduces several steps of 
free radical damage. Coleus forskohlii [forskolin], Grape seed [proanthocyanidins], 
Camellia sinensis [polyphenols], Huperzia serrata [huperzine], Pinus maritima 
[Pycnogenol], Borago officinalis [gamma linoleic acid] and Vinca minor [Vinpocetine] 
are potential antioxidantsThe plant is a biosynthetic laboratory, not only for chemical 
compounds, but also a multitude of compounds like glycosides, alkaloids etc. These exert 
physiological and therapeutic effect. The compounds that are responsible for medicinal 
property of the drug are usually secondary metabolites. A systematic study of a crude 
drug embraces through consideration of primary and secondary metabolites derived as a 
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result of plant metabolism. The plant material is subjected to phytochemical screening for 
the detection of various plant constituents.[12] 
The genus Pulicaria Gaertn. of the family Compositae (Asteraceae) consists of 100 
species and this genus has been the subject of several chemical investigations, giving rise 
to the isolation of flavonoids, sesquiterpenes, diterpenes, triterpenes, caryophyllenes and 
caryophyllane derivatives [13,14]. Several species of this genus have been used as insect 
repellents and in the treatment of dysentery [15]. The genus  is placed in the 
tribe Inuleae s. str. [16]. Chemically this genus is not homogeneous. As pointedout 
previously [17] some species contain diterpenes,others caryophyllene derivatives and 
those now placed inthe genus 	
 contain sesquiterpene lactones. Pulicaria 
undulata L. which is a synonym of Pulicaria crispa Forssk. and Francoeuria crispa
Forssk. [18] Is an annual wooly herb which can cover whole desert wadis with its bright 
yellow flowers and fills the air with a rich perfume. Most plants appear with only a few 
flower-bearing branches but, under good conditions, they can grow into a splendid bush. 
One of its local names "Shai-el-Gebel which gives the secret away that this plant is used 
as an herbal tea and as a medicinal plant. The Bedouin's or vernacular name for Pulicaria 
crispa is Dethdath and Desdas. The Arabic names include: Arfeg; Feliet el-Hami; El 
Attasa, El Eteytesa; Sabad, Gettiat, Zibl el Far, Ghobbeira and Khanouf.The Berber name 
are: Timetfest.This plant is used medicinally as a remedy for breathing problems. One 
small spoon of the herb can be boiled in a glass of water as needed. The flower branches 
areused for preparing a powerful sneezing powder. 
A. Mey. Has 
been studied previously, but only thymol derivatives and flavones sesquiterpenes, 
diterpenes [19,20] have been reported.  
Botanical description of the plant Pulicaria undulata 
Family of Pulicaria 
“Asteraceae (compositae) is also called sunflower family Herbs, shrubs and even trees 
are in the Sunflower Family.  What seems to be a single flower is really a group of many 
flowers of two kinds.  The strap-shaped forms on the outer edge that look like petals are 
each a complete flower and are called ray florets.  The tightly packed tubular forms in the 
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centre are also complete flowers and are known as disk florets.  Some members of the 
Sunflower Family have only ray flowers.  Dandelions and chicory are examples.  Other 
members of the family have only disk florets.  Thistles are an example of this.  Ray and 
disk flowers are connected to a structure called the receptacle and underneath the 
receptacle are a number of bracts known as the involucres.  The largest family of vascular 
plants, with possibly 950 genera and 20,000 species, chiefly herbaceous and world-wide 
in distribution:” [Cited from ref.Munz, Flora So. Calif.95] 
“The composite or aster family (Asteraceae) is one of the largest families of plants, 
containing about 20,000 species, distributed among more than 1,000 genera, and 
occurring widely on all continents, except Antarctica. This family is commonly regarded 
by modern botanists as the most advanced of the plant families, because of the complex, 
highly evolved structure of its multi-flowered, composite reproductive structures. The 
members of the composite family display a remarkable range of growth forms, ranging 
from tiny, herbaceous annual plants, to vine-like lianas, and tall, tree-like perennials. For 
example, some species in the genus Senecio are small, annual plants, such as the 
widespread common groundsel (Senecio vulgaris). In contrast, the giant senecio (S. 
adnivalis) species found on a mountain in Uganda, is a perennial plant that grows as tall 
as 26 ft (8 m). The most species-rich genera in the aster family are Senecio (about 1,500 
species), Vernonia (900 species), Hieracium (800 species), and Eupatorium (600 
species). Various members of the aster family are familiar species in natural habitats, 
while others are cultivated plants in gardens, and some are grown as foods. Some species 
in the aster family are considered to have negative values as weeds of agriculture or 
lawns. Members of the Asteraceae are most readily characterized by their unique floral 
structure. The flowers of members of this family are aggregated within a composite 
grouping known as an inflorescence, which in this family is known as a head. In the head, 
the small, individual flowers, called florets, are attached to a basal structure known as a 
receptacle. The latter is surrounded by one or more rows of bracts that make up the 
involucre Artichokes in Salinas.” [Cited from ref. California. 1983 Lawrence Midgale, 
National Audubon Society Collection/Photo Researchers, Inc.].  
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Genus Pulicaria 
Pulicaria is a genus of flowering plant in the Asteraceae family. It contains the following 
species: 
• Pulicaria aromatica
• Pulicaria dioscorides
•   Pulicaria diversifolia
• Pulicaria elegans
• Pulicaria lanata
• Pulicaria stephanocarpa
• Pulicaria vieraeoides
  
Medicinal importance of the Pulicaria undulata
Pulicaria undulata L. which is a synonym of Pulicaria crispa Forssk. and Francoeuria 
crispa Forssk. is used to treat inflammation and a potential cancer chemopreventive agent 
“axillarin” has also been isolated from its aerial parts [20]. It is also used as a tonic, tea 
substitute, and antispasmodic, hypoglycemic and for the preparation of perfumes. The 
essential oil obtained from its aerial parts exhibited insecticidal and antibacterial 
activities [21, 22]. 
General Experimental Conditions 
Physical Constants 
Optical rotations were measured on JASCO DIP-360 digital polarimeter. All the 
compounds were oily or gummy solids due to which their melting points were not 
determined. 
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Spectroscopy 
Ultraviolet (UV) spectra were recorded in methanol on Hitachi U-3200 
spectrophotometer. Infrared (IR) spectra were scanned on JASCO 302-A Infrared 
Spectrometer.  
Proton magnetic resonance (1H NMR) spectra were recorded at 300, 400 and 500 MHz 
on Bruker AM-300, AM-400 or AMX-500 nuclear magnetic resonance spectrometers 
using TMS as an internal reference. The 13C NMR spectra were scanned with the same 
instruments at 75, 100 and 125 MHz respectively. 
The heteronuclear 2D 1H-13C chemical shift correlation experiments were carried out at 
500 MHz with a sweep width of 12820 Hz (2k data points) in ω2 and 1024 Hz (256 t1
values zero-filled to 2K) in ω 1. In both 2D experiments, a sec. relaxation delay was used 
and 16 transients were performed for each t1 value.  
For NOE difference measurements, the sample was frozen under liquid nitrogen and 
degassed. A lower decoupler power of 0.2 watt with 35 attenuation in dbs was used. The 
pre-irradiation time was 11 sec; which is the sum of three delays as used in the NOE 
difference programme of Bruker. The impulse lengths of 100 microseconds were 
maintained to avoid saturation. 
Low-resolution electron impact mass spectra were recorded on a Finnigan MAT 311 and 
MAT 311 spectrometers, coupled with PDP 11/34 computer system. Peak matching, field 
desorption (FD) and field ionization (FI) were performed on the Finnigan MAT 312 mass 
spectrometer. High resolution mass measurements and fast atom bombardment (FAB) 
mass measurement were carried out on Jeol JMS HX 110 mass spectrometer. FAB source 
using glycerol or thioglycol as the matrix and cesium iodide (CsI) as an internal standard 
was used for accurate mass measurements. 
Chromatography 
Column chromatography was performed on silica gel (Si 60, 70-230 mesh, E. Merck), 
vacuum liquid chromatography (VLC) was performed on silica gel (Si 60, F254, E. 
Merck). 
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Flash column chromatography was performed on Eyela Flash Chromatography model 
EF-10, using silica gel (Si 60, 230-400 mesh, E. Merck) as an absorbent. 
Precoated silica gel GF-254 preparative plates (20×20, 0.5 mm thick) (E. Merck) were 
used for preparative thick layer chromatography. The purity of the samples were also 
checked on TLC and HPTLC plates. 
Spray reagent 
Ceric sulphate was used for the detection of compounds. 
Ceric sulphate
Ceric sulphate (0.1 g) and trichloroacetic acid (1 g) were dissolved in 4 ml distill water. 
The solution was boiled and conc. H2SO4 was added drop wise until the disappearance of 
turbidity.  
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Chapter 9 
  16b,17-Dihydroxy-ent-kauran-19-oic acid from Pulicaria undulata 
                                                                              Acta Cryst. (2005). E61, o3053–o3055 
The title compound, C20H32O4, was isolated from Pulicariaunduleta. It has an ent-kaurane 
diterpeniod ring system. In the crystal structure, the molecules are linked via O—H-----O 
hydrogen bonds into a ribbon structure.
9.1. Comment 
Pulicaria unduleta is a herbaceous plant belonging to the family Asteracea (Compsitae), 
the largest family of the flowering plants. It comprises about 10,100 genera and 
20,000species, commonly found in frigid, temperate, subtropical andtropical regions of 
Asia and Africa (Nasir & Ali, 1972). The genus Pulicaria has 11 species distributed in 
tropical and temperate regions in Pakistan (Ayoub & Elassam, 1981).Plants of this genus 
are known to contain flavones, alkaloids,monoterpenes, sesquiterpenes, sesquiterpene 
lactones (Bohlmannet al., 1979), diterpenoids, polyacetylene and thymolderivatives 
(Metwally et al., 1986). Ent Kauranoic acid is foundto exhibit significant activity against 
HIV replication in H9lymphocyte cells, with an EC50 value of 0.8 mg ml_1 with 
therapeutic index >5 (Wu et al., 1996). The title compound, (I),has been isolated from 
Helianthus petioaries (Herz & Kulanthaivel,1984) and Annona squamasa (Wu et al., 
1996). We have undertaken the X-ray crystal-structure determination of(I) isolated from 
Pulicaria unduleta in order to establish its 
Molecular conformation and relative stereochemistry. 
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The bond lengths in (I) show normal values (Allen et al.,1987). The C—C bond lengths 
lie in the range 1.514 (3)–1.574 (2) A °. All the ring junctions in the ent-kaurane 
diterpenoidring system are trans-fused. Rings A and B adopt chair conformations and 
ring C is in a distorted chair conformation,with puckering amplitude Q = 0.625 (2)_, _ = 
27.3 (2)_ and ’ =294.6 (4)_ (Cremer & Pople, 1975). The distortion may beattributed to 
the narrowing of the C13—C14—C8 bond angleto 101.95 (14)_. The five-membered 
ring D adopts an envelope conformation with atom C14 displaced from the 
C8/C15/C16/C13 plane by 0.707 (3) A ° . The C2—C3—C4—C20 torsion 
           
Figure 1 
The molecular structure of (I), showing 50% probability displacementellipsoids and the 
atom-numbering scheme. Dashed lines indicate theintramolecular hydrogen bonds 
angle of _71.0 (2)_ describes the _-orientation of the carboxylic acid group with respect 
to the ent-kaurane nucleus, whereas the hydroxymethylene group at atom C16 is _-
oriented, the C15—C16—C17—O2 torsion angle being175.67 (17)_. Intermolecular 
O2—H1O2---O3 and C2—H2C_ _ _O4 hydrogen bonds generate rings of graph-set 
motifR11(5) and R11(6), respectively (Bernstein et al., 1995).The crystal structure is 
stabilized by O—H_ _ _O hydrogen bonds (Table 1). These hydrogen bonds link the 
molecules into a ribbon-like structure (Fig. 2). 
160
9.2.Experimental 
The dry plant material was chopped and soaked in methanol for a period of 30 d. The 
combined methanolic extract was evaporated under vacuum to yield a crude methanolic 
extract. The methanol extract (253 g) was then fractionated with petroleum ether 
(161.5g), chloroform (32.5 g), ethyl acetate (10.0 g) and butanol (50.5 g). The 
chloroform-soluble fraction was subjected to column chromatography using silica-gel 
absorbent, eluted with petroleum ether, and the polarity was gradually increased with 
chloroform and methanol. Various subtractions with the same constituents were 
combined and further purified using flash column chromatography (Si gel) and eluted 
with increasing polarities of petroleum ether and ethyl acetate to afford the title 
compound, (I). An RF value of 0.67 was noted on thin-layer chromatography (0.5% 
methanol–95.5% chloroform) and the compound was recrystallized from chloroform 
(m.p. 571–573 K).
                      
                             Figure 2 
                            The crystal packing of (I), viewed down the axis. Dashed Lines indicate 
                             hydrogen bonds. 
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Chapter 10
            Antioxidant Flavonoids from Pulicaria undulata 
                                                                          Polish Journal of Chemistry 2006, 745-751  
10.1. Introduction: 
The genus Pulicaria Gaertn. of the family Compositae (Asteraceae) consists of 100 
species and this genus has been the subject of several chemical investigations, giving rise 
to the isolation of flavonoids, sesquiterpenes, diterpenes, triterpenes, caryophyllenes and 
caryophyllane derivatives [1,2]. Several species of this genus have been used as insect 
repellents and in the treatment of dysentery [2]. The constituents of P. paludosa Link., a 
Spanish endemic species, are used in an ointment for skin disorders [3]. Pulicaria 
undulata L. which is a synonym of Pulicaria crispa Forssk. and Francoeuria crispa
Forssk. [4] is used to treat inflammation and a potential cancer chemopreventive agent 
“axillarin” has also been isolated from its aerial parts [5]. It is also used as a tonic, tea 
substitute, antispasmodic, hypoglycemic and for the preparation of perfumes. The 
essential oil obtained from its aerial parts exhibited insecticidal and antibacterial 
activities [6,7]. 
The superoxide anion, O2-, is formed in almost all aerobic cells and is a major agent in 
the mechanism of oxygen toxicity [8,9]. It is closely related to the biological course of 
apolexis, tumor, and inflammation etc. Compared with other oxygen radicals, superoxide 
anion has a longer life-time, can move to an aim at a longer distance, and thus has more 
dangerous. O2- is considered to be generated primarily by mitochondria in various cells, 
and by phagocytes such as granulocytes and monocytes/macrophages [10]. Under 
physiologic conditions, O2- is converted to H2O2 in hydrophilic solvents such as water by 
a disproportion reaction [11]. In addition, O2- can react with nitric oxide (NO) and 
generate highly toxic ROS including ONOO- and nitrogen oxides (NOx) [12]. Thus, 
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elimination of O2- is an important biologic need. Therefore, it is very important to study 
the scavenging of superoxideanion
10.2. Results and Discussion 
The ethylacetate soluble fraction of the whole plant of Pulicaria undulata L. (syn. 
Pulicaria crispa Forssk.) led to the isolation two new flavonoid glycosides (1 and 6) and 
their structures were deduced by a detailed analysis of their spectral data and by the 
comparison with the published data of the closely resembling compounds.  
Pulicaroside (1) was isolated as an amorphous solid. Its molecular formula C28H32O7 was 
established through the HRFAB-MS (+) showing a quasi-molecular ion [M+H]+ peak at 
m/z 641.5447 (cald. 641.5432), which indicated 13 degrees of unsaturation. The UV 
spectrum of 1 with AlCl3-HCl showed a 10 nm bathochromic shift in band I relative to 
MeOH spectrum indicating a 6-OR group in the molecule [13]. Its IR spectrum exhibited 
absorptions for hydroxyl groups (3418-3295 cm-1), methine (2923 cm-1), conjugated 
carbonyl group (1601 cm-1), aromatic unsaturation (1506-1451 cm-1), ether linkage (1285 
cm-1) while the broad C-O stretching bands in the region of 1137-1031 cm-1  suggested its 
glycosidic nature. Its EI-MS spectrum exhibited an ion at m/z 316 [M – (2 x glucose]+
and the other characteristic fragments were observed m/z 168 [C6H(OH)3OCO]+ and at
m/z 148 [C6H4(OH)CCOMe]+ which were accounted for the trihydroxyl substituted A 
ring and a monohydroxyl substituted B ring respectively. Its 1H-NMR spectrum revealed 
two ortho-coupled doublets at δ 8.01 (2H, J = 8.4) and δ 6.85 (2H, J = 8.4) for a para-
disubstituted B ring, a singlet at δ 3.82 (3H) for a 3-O-methoxyl group, another singlet at 
δ 6.42 (1H) for H-8, similar to those of 2 [experimental part], however the presence of 
two anomeric doublets centered at δ 5.15 (1H, J = 7.4) and δ 4.92 (1H, J = 7.6) 
respectively, indicated that the structure of 1 was exactly similar to that of 2, except for 
the presence of an additional -glucose moiety and its presence was further confirmed by 
its 13C-NMR spectrum which corroborated the characteristic signals for two glucose units 
along with the signals for a similar aglycone moiety like that of 2. The position of the 
additional glucose unit was deduced through the downfield shift of C-6 (66.8) as 
compared to the respective signal of 2 and HMBC correlations of H-1 with C-6 and H-
164
6 with C-1. Important HMBC correlations are shown in fig. 1. Since only D-glucose is 
known in nature [14], therefore, based upon the above cumulative evidences, 1 was 
identified as 6-hydroxykaempferol 3-methyl ether 6-O-[O-β-D-glucuronopyranosyl 
(1→6)] β-D-glucopyranoside. 
Undulatoside (6) was obtained also as an amorphous solid. It was assigned a molecular 
formula C22H24O12 on the basis of HRFAB-MS (+) (m/z 481.4217 [M+H]+, cald. 
481.4195), showing 11 degrees of unsaturation. Its UV spectrum showed absorption 
maxima at 324.6 nm (sh, band I) and 288.3 nm (band II) which are specific for the 
dihydroflavonol skeleton. Its IR spectrum revealed the absorptions for the hydroxyl 
groups (3540-3285 cm-1) and a chelated carbonyl group (1626 cm-1). Bands of aromatic 
ring (1578-1504 cm-1) and of the glycosidic linkage (3233-1064 cm-1) were also present. 
The EI-MS spectrum exhibited an ion at m/z 318 [M – glucose]+ followed by the loss of a 
fragment with m/z 136 [C6H4(OH)CHCHOH]+ and thus the methoxyl group was assigned 
on the ring A on the basis of a fragment ion at m/z 182 [C6H(OH)2(OMe)OCO]+. Its 1H-
NMR spectrum revealed two sets of symmetric doublets, one at δ 7.69 (2H, J = 8.4) and 
δ 6.84 (2H, J = 8.4) for a para-disubstituted B ring while another at δ 5.40 (1H, J = 11.6) 
and δ 4.72 (1H, J = 11.6) for H-2 and H-3 respectively. It also showed two singlets at 
δ 6.48 (1H) and δ 3.86 (3H), for H-8 and a 6-O-methoxyl group respectively, similar to 
those of reported for (2R:3R)-dihydro-5, 7, 4-trihydroxy-6-methoxyflavonol [15], and an 
additional doublet at δ 4.99 (1H, J = 7.8) was assignable to an anomeric proton, thus 
showing the presence of β-glucose moiety in this molecule. The 2R:3R configuration was 
assigned based on the large coupling coupling constant (J2, 3 = 11.6 Hz) and positive 
optical rotation sign (+ 24.8) in accordance with the literature report [15]. However, the 
absolute stereochemistry of the two optically active carbons could not be determined due 
to the small amount of the substance. The site of linkage of the glucose unit was 
identified through the downfield shift of C-3 (δ 77.6) and upfield shifts of C-4 (δ 196.4) 
and C-2 (δ 82.1) [16] as compared to those of reported for (2R:3R)-dihydro-5, 7, 4-
trihydroxy-6-methoxyflavonol [15]. The long range HMBC correlations of H-1 with C-3 
and H-3 with C-1 further confirmed this assignment. Since only D-glucose is known in 
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nature [14], hence on the basis of above cumulative evidences, the structure of 6 was 
established as (2R:3R)-dihydro-5,7,4-trihydroxy-6-methoxyflavonol-3-O-β-D- glucopyr-
anoside. 
From our investigated source, four other known flavonones; 6-hydroxykaempferol 3-
methyl ether 6-O-β-D-glucopyranoside (2) [13], 6-methoxykaempferol 3-O-β-D-
glucopyranoside (3) [17], 6-methoxykaempferol (4) [18] and quercetagetin 3,6-dimethyl 
ether (axillarin) (5) [5] were also isolated and all these flavonoids (1-6) showed 
superoxide anion scavenging activity and the results are shown in table 2. As far 
structure-activity relationship is concerned, the presence of an additional glucose unit in 
1, in comparison with 2, results in a slight decrease of its scavenging potential. Similarly, 
the mutual exchange in the positions of –OMe and –Oglc. in 3, relative to 2,  also 
decreases its scavenging activity. However, when 4 was compared 3, a free hydroxyl 
group at C-3 in 4 enhanced its scavenging ability as compared to that of 3. In 5, the 
presence of two adjacent hydroxyl groups in ring B unexpectedly resulted in a decrease 
of its scavenging activity relative to that of 4. In 6 although the only difference with 3
was the absence of a double bond between C-2 and C-3, yet the great scavenging 
potential of this molecule can be rationalized for the axial and equatorial orientation of 
the substituents at C-2 and C-3 respectively. 
10.3. Experimental Section. 
General experimental procedures. For column chromatography (CC), silica gel (70-230 
mesh) and for flash chromatography (FC), silica gel (230-400 mesh) was used. TLC was 
performed on pre-coated silica gel G-25-UV254 plates. Detection was carried out at 254 
nm, and by ceric sulphate reagent. Purity was checked on TLC with different solvent 
systems using methanol, acetic acid, water and CHCL3 giving single spot. The optical 
rotations were measured on a Jasco-DIP-360 digital polarimeter. The UV and IR spectra 
were recorded on Hitachi-UV-3200 and Jasco-320-A spectrophotometer, respectively. 
1H-NMR, 13C-NMR, COSY, HMQC and HMBC Spectra were run on Bruker 
spectrometers operating at 500, 400 and 300 MHz. The chemical shifts are given in δ in 
ppm and coupling constants in Hz. EI-MS and FAB_MS spectra were recorded on a   
JMS-HX-110 spectrometer, with a data system.
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Plant material. The plant Pulicaria undulata L. (Asteraceae) was collected from Loralai, 
Blalochistan, and identified by Dr. Rasool Bakhsh Tareen (Taxonomist), Department of 
Botany, Balochistan University, Quetta, Pakistan. A voucher specimen (no. 1437a) has 
been deposited at the herbarium of the Botany Department of the same university.
Extraction and purification. The shade-dried ground plant material (whole plant) (30 kg) 
was exhaustively extracted with methanol at room temperature. The extract was 
evaporated to yield the residue (753 g). The whole residue was dissolved in water and 
partitioned with hexane, chloroform, ethyl acetate and n-butanol. The ethyl acetate 
soluble extract (182.4 g) was subjected to CC over silica gel column using hexane with 
gradient of CHCl3 up to 100 % and then the polarity was increased with methanol in a 
similar fashion. Fifteen fractions (Fr 1-15) were collected. The Fr. 5 was submitted to 
repeated FC (230-400 mesh) and eluted with MeOH: CHCl3 (4:96) to get two sub-
fractions (Frsb. 5.1 and Frsb.5.2). The Frsb.5.1 was then flash choromatographed eluting 
with MeOH: CHCl3 (3.8:96.2) to get purified 4 (25.3 mg). The Frsb.5.2 was then 
subjected to flash choromatography, eluting with MeOH: CHCl3 (4:96) to purify 5 (17.6 
mg). Similarly, the Fr. 9 was subjected to FC and eluted with MeOH: CHCl3 (12:88) to 
get three sub-fractions (Frsb. 9.1, Frsb.9.2, and Frsb.9.3). These three sub-fractions were 
again loaded on flash silica gel separately and eluted with MeOH: CHCl3 (11:89, 
11.5:88.5 and 12:88 respectively) to afford purified 2 (22.1 mg), 3 (17.9 mg) and 6 (10.2 
mg) respecively. Likewise, the Fr. 13 was subjected to repeated FC and eluted with 
MeOH: CHCl3 (17:83) which yielded the purified 1 (11.7 mg). 
Pulicaroside (= 6-hydroxykaempferol 3-methyl ether 6-O-[O-β-D-glucuronopyr-anosyl 
(1→6)] β-D-glucopyranoside; 1): Amorphous powder (11.7 mg): C28H32O7; [α]23D + 22.3 
(c = 0.029, MeOH); UV λmax nm (log ε) (MeOH): 337.1 (1.94), 286.3 (4.26); UV λmax
nm (log ε) (AlCl3/HCl): 347.1 (2.10), 299.2 (4.29);  IR νmax (KBr): 3418-3295 (OH), 
2923 (C-H), 1601 (C=O),  1506-1451 (C=C, Ar), 1285 (C-O-C), 1137-1031 (C-O) cm-1; 
1H and 13C NMR: Table 1; HRFAB-MS (+): m/z 641.5447 [M+H]+, cald. 641.5432; 
FAB-MS (Pos. ion mode) m/z 641 [M+H]+; FAB-MS (Neg. ion mode) m/z 639 [M-H]-; 
EIMS: m/z (rel. int.): 316 [M – (2 x glucose)]+ (100), 273 [M – (2 x glucose) - COMe]+
(44), 168 [C6H(OH)3OCO]+ (41), 148 [C6H4(OH)CCOMe]+ (32). 
167
 6-Hydroxykaempferol 3-methyl ether 6-O-β-D-glucopyranoside (2): 1H-NMR (500 
MHz, MeOD): 8.10 (2H, d, J = 8.6, H-2′, H-6′), 6.87 (2H, d, J = 8.6, H-3′, H-5′), 6.41 
(1H, s, H-8), 5.14 (1H, d, J = 7.3, H-1′′), 3.80 (3H, s, 3-OMe); 13C-NMR (125 MHz, 
MeOD): 178.8 (C-4), 161.6 (C-4′), 158.6 (C-7), 158.2 (C-2), 154.9 (C-9), 153.1 (C-5), 
135.0 (C-3), 134.7 (C-6), 132.1 (C-2′, 6′), 123.0 (C-1′), 116.1 (C-3′, 5′), 104.9 (C-1′′), 
103.8 (C-10), 96.8 (C-8), 78.3 (C-3′′), 78.1 (C-5′′), 75.7 (C-2′′), 71.2 (C-4′′), 62.6 (C-6′′), 
60.6 (3-OMe). 
6-Methoxykaempferol 3-O-β-D-glucopyranoside (3): 1H-NMR (500 MHz, MeOD): 
8.04 (2H, d, J = 8.2, H-2′, H-6′), 6.87 (2H, d, J = 8.2, H-3′, H-5′), 6.51 (1H, s, H-8), 5.23 
(1H, d, J = 6.9, H-1′′), 3.87 (3H, s, 6-OMe); 13C-NMR (125 MHz, MeOD): 179.8 (C-4), 
161.6 (C-4′), 159.3 (C-7), 158.7 (C-2), 153.7 (C-9), 153.5 (C-5), 135.2 (C-3), 132.7 (C-
6), 132.3 (C-2′, 6′), 122.8 (C-1′), 116.1 (C-3′, 5′), 106.2 (C-10), 104.3 (C-1′′), 95.0 (C-8), 
78.4 (C-3′′), 78.0 (C-5′′), 75.7 (C-2′′), 71.4 (C-4′′), 62.7 (C-6′′), 60.9 (6-OMe). 
6-Methoxykaempferol (4): 1H-NMR (500 MHz, MeOD): 8.09 (2H, d, J = 8.9, H-2′, H-
6′), 6.90 (2H, d, J = 8.2, H-3′, H-5′), 6.50 (1H, s, H-8), 3.87 (3H, s, 6-OMe); 13C-NMR 
(125 MHz, MeOD): 175.9 (C-4), 160.5 (C-4′), 158.9 (C-2), 158.7 (C-7), 153.5 (C-9), 
153.3 (C-5), 136.5 (C-3), 132.7 (C-6), 131.9 (C-2′, C-6′), 122.2 (C-1′), 116.0 (C-3′, C-5′), 
105.2 (C-10), 95.0 (C-8), 60.9 (6-OMe). 
Axillarin (= quercetagetin 3,6-dimethyl ether; 5): 1H-NMR (500 MHz, MeOD): 7.62 
(1H, d, J = 2.1, H-2′), 7.53 (1H, dd, J = 8.5, 2.1, H-6′), 6.90 (1H, d, J = 8.5, H-5′), 6.50 
(1H, s, H-8), 3.87 (3H, s, 6-OMe), 3. 78 (3H, s, 3-OMe);  13C-NMR (125 MHz, MeOD): 
180.3 (C-4), 158.8 (C-7), 158.1 (C-2), 153.8 (C-9), 153.7 (C-5), 150.0 (C-4′), 146.5 (C-
3′), 139.2 (C-3), 132.6 (C-6), 123.0 (C-1′), 122.3 (C-6′), 116.5 (C-2′), 116.4 (C-5′),  
106.3 (C-10), 95.0 (C-8), 60.9 (6-OMe), 60.5 (3-OMe). 
Undulatoside {= (2R:3R)-dihydro-5,7,4-trihydroxy-6-methoxyflavonol-3-O-β-D- gluco-
pyranoside; 6}: Amorphous powder (10.2 mg): C22H24O12; [α]23D + 24.8 (c = 0.01, 
MeOH); UV λmax nm (log ε) (MeOH): 324.6 (2.6), 288.3 (3.9); UV λmax nm (log ε) 
(AlCl3/HCl): 379.1 (2.7), 308.7 (4.1);  IR νmax (KBr): 3450-3285 (OH), 2936 (C-H), 1626 
(C=O),  1578-1504 (C=C, Ar), 1280 (C-O-C), 1156-1064 (C-O) cm-1; 1H and 13C NMR: 
Table 1; HRFAB-MS (+): m/z 481.4217 [M+H]+, cald. 481.4195; FAB-MS (Pos. ion 
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mode) m/z 481 [M+H]+; FAB-MS (Neg. ion mode) m/z 479 [M-H]-; EIMS: m/z (rel. int.): 
318 [M – glucose]+ (100), 182 [C6H(OH)2(OMe)OCO]+ (86), 136 
[C6H4(OH)CHCHOH]+  (59). 
10.4.Superoxide Anion Scavenging Assay: The reaction mixture contained 280 
μΜ β−nicotinamide adenine dinucleotide reduced form (NADH), 80 μΜ nitroble 
tetrazolium (NBT) , 8 μΜ phenazine methosulphate (PMS) and various concentrations of 
test samples in 200 μL of 0.1 M phosphate buffer (pH 7.5). The NBT, NADH and PMS 
were prepared in the same buffer. Test samples were dissolved in DMSO. The reaction 
was performed in 96-well microtitre plates (Molecular Devices, Spectramax 340) at room 
temperature and absorbance was measured at 560 nm [19].  
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Table 1. NMR Data (MeOD) of Compounds 1 and 6, δ in ppm, J in  Ηz 
                           1 a                6 a
No.                   δ (H)               
             δ(C)b
              δ (H)                          δ(C)b
2 - 158.3 5.40 (d, J = 11.6) 82.1 
3 - 135.2 4.72 (d, J = 11.6) 77.6 
4 - 178.8 - 196.4 
5 - 153.4 - 157.5 
6 - 134.9 - 132.2 
7 - 158.8 - 159.4 
8 6.42 s 154.8 6.48 s 95.5 
9 - 131.3 - 156.2 
10 - 104.1 - 102.1 
1′ - 123.4 - 128.3 
2′, 6′ 8.01  (d, J = 8.4) 132.0 7.69  (d, J = 8.4) 131.4 
3′, 5′ 6.85 (d, J = 8.4) 116.2 6.84  (d, J = 8.4) 116.1 
4′ - 161.5 - 160.9 
3-
OMe 
3.82 s 60.6 - - 
6-
OMe 
- - 3.86 s 60.9 
1′′ 5.15 (d, J = 7.4) 104.2 4.99 (d, J = 7.8) 104.8 
2′′ 3.45 (br t, J = 7.8) 75.6 3.46 (br t, J = 7.7) 75.5 
3′′ 3.49 m 78.3 3.51 (br t, J = 7.9) 78.2 
4′′ 3.41 m 72.0 3.42 (br t, J = 7.8) 71.8 
5′′ 3.86 m 77.1 3.84  (ddd, J =1.9, 8.2, 
11.3) 
77.9 
6′′ 4.40 (dd, J = 7.7, 
11.6) 
4.49 (dd, J = 1.9, 
66.8 4.35 (dd, J = 7.4, 11.8) 
4.43 (dd, J = 2.0, 11.8) 
61.8 
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11.6) 
1′′′ 4.92 (d, J = 7.6) 104.0 - - 
2′′′ 3.47 (br t, J = 7.7) 75.7 - - 
3′′′ 3.52 m 78.1 - - 
4′′′ 3.43 m 72.4 - - 
5′′′ 3.86 m 77.9 - - 
6′′′ 4.32 (dd, J = 7.8, 
11.9) 
4.41 (dd, J = 1.8, 
11.9) 
62.0 - - 
a All spectra were recorded at 500 MHz (1H) and 125 MHz (13C); assignment were aided 
by 2D-NMR  
COSY, HMQC and HMBC experiments, b   13C NMR multiplicities were determined by 
DEPT 135°. 
Table 2. Antioxidant Activities of the Flavonoids 1-6 as Compared with the     
Standard Inhibitors 
Substance 
Super oxide 
Anion Scavenging 
Activity (%)  
AT 1000 µM
1 42.9 
2 39.5 
3 92.4 
4  75.3  
5 80.5 
6 24.8 
Propyl gallate a) 92.00 
3-t-Butyl-4-hydr-
oxy anisole a)
91.25 
                         a) Standard antioxidants 
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                                                                                                                      Chapter 11
           New ent–kaurane type Diterpene Glycoside Pulicaroside-B 
            From Pulicaria undulata 
                                                                        Natural Product Communications, accepted 
11.1. Introduction 
Pulicaria undulata L.  Belongs to the family Asteraceae (Compositae),one of  the largest 
family of flowering plants, which comprises of about 1,100 genera and 20,000 species. 
Plants of this family are found in temperate and subtropical regions of the world [1]. The 
genus Pulicaria has eleven species, distributed in tropical and temperate regions of 
Pakistan [2]. The plants of this genus are used in traditional medicine as tonic, a 
substitute for tea, and an antispasmodic and anti-hypoglycemic drug and as ingredients of 
perfume [3]. Aerial parts of Pulicaria undulata are used for antibacterial agent [4]. 
Literature survey showed some reports on essential oils [5–6], terpenoids [7–8] and 
flavonoids [9-10] of Pulicaria undulata. 
11.2. Results and Discussion 
The n-butanol soluble fraction of the whole plant of Pulicaria undulata L. (syn. Pulicaria 
crispa Forssk.) yielded a new diterpene glycoside, pulicaroside-B (1), along with three 
known compounds paniculosides-IV (2) , roseoside (3) and corchoionol C (4). Their 
structures were deduced by detailed analysis of their spectral data and comparison of 
their spectral data with those of the closely related compounds [11-15]. Pulicaroside-B 1
was isolated as colourless solid. Its molecular formula (C45H68O16) was established by the 
positive ion HRFABMS, showing a quasi-molecular ion [M+H]+ peak at m/z 865.4480 
which indicated 12 degrees of unsaturation. The absorption bands in the IR spectrum 
appeared at 3408 (OH), 1723 cm–1, and 1653cm–1. The intense IR absorption band at 
1723 cm-1 revealed the presence of ester functionality. The intense absorption at 1653cm–
1 indicated the presence of conjugated carbonyl functionality in the molecule. The 
complete hydrolysis of 1 yielded glucose as the only sugar (see experimental). This was 
also supported by fragment ions in the positive ion FABMS at m/z 703 [M – hexose]+ and 
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m/z 541   [M –2 hexose]+. 1H-NMR and 13C-NMR data (Table 1) showed that the 
aglycone basic skeleton was similar to that of reported Ent-kaurene [16] and this 
assignment was thoroughly supported by its EIMS spectrum which exhibited an ion peak 
at m/z 334 [M –2hexose – corchoionol moiety]+. In 1H-NMR spectrum signals (H-1’’) 
and (H-1’’’) belonged to two sugar moieties anomeric proton doublets at δ 4.26 (J= 7.78 
Hz) and δ 5.40 (J= 8.13 Hz). The evidence for the β-configuration of these sugars was 
drawn from the large coupling constants value of anomeric proton.  
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The HMBC correlation between anomeric proton H-1’’’ (δ 5.40) and carbonyl carbon 
(δ 178.3) showed that one glucose was connected to aglycone through ester functionality. 
The HMBC correlation between anomeric proton H-1’’ (δ 4.26) and carbon (δ 75.3) 
showed that the 2nd glucose was connected to aglycone through ether linkage. The signals 
for hexose were consistent with –D–glucose [16]. Three singlets were present at δ  0.99, 
1.20, and 1.34 in the 1H–NMR spectrum for three tert–methyls. Their associated carbon 
signals in the HMQC spectrum were at δ 18.5, 29.0, and 23.4. Among other four methyl 
signals, three were singlets, and one narrow doublet, present at δ  1.01, 1.03, 1.28 and 
1.93(d) in the 1H–NMR spectrum. Their associated carbon signals in the HMQC 
spectrum at δ 24.7, 23.5, 22.2, and 19.6, respectively, revealed the presence of four 
methyls, which were related to the skeleton of corchoionol C glycoside (corchoionoside 
C) [14] moiety. The linkage between diterpene and the derivative of -ionol glycoside 
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moiety was established by 13C–NMR spectrum and HMBC correlations. The downfield 
shift of carbon at δ  83.2, instead of 80.0, in 4 [14] indicated that C-6’ οf corchoionol 
moiety  is not free.   The HMBC correlation between H-7 (δ 3.45), C-7 (δ 74.9) of 
diterpene and carbon C-6’ (δ 83.2) of -ionol moiety showed that the diterpene was 
connected to -ionol glycoside moiety through ether linkage between C-7 of diterpene 
and C-6’ of -ionol glycoside moiety. After assigning the proton and carbon chemical 
shifts (table 1) with the help of HMQC, HMBC, and COSY spectra (fig. 1), the structure 
of pulicarioside-B (1) was elucidated as ent-11α,16α-epoxy-16(R)-7-O [3-oxo-α-ionol 9-
O{β-D-glucopyranosyl}]19-O[β-D-glucopyranosyl] kauranoate. 
Compound 2, 3 and 4 were isolated for the first time from this plant [11-14]. 
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Table 1. NMR data (CD3OD) of compound 1 δ in ppm, J in  Ηz 
No.  δ (H)  δ(C) HMBC H1-H1
COSY 
1 1.17,1.83 42.5   
2 1.37,1.63 20.1   
3 1.13,2.23 38.9   
4 - 44.5   
5 1.80 49.3   
6 1.94,2.16 30.2   
7 3.47 75.3 C4’ 0.99, 1.80 
8 - 50.5   
9 1.78 54.4   
10 - 38.1   
11 4.33bs 78.0  1.78 
12 2.14 41.7   
13 2.25 46.7  1.91 
14 1.91 43.7   
15 1.88 53.0   
16 - 87.0   
17 1.34s 23.4 C13, C15, C16 2.25 
18 1.20s 29.0 C3, C4, C5, C19 1.80 
19 - 178.0   
20 0.99s 18.5 C5, C9, C10 1.78 
1′ - 42.1   
2′ 2.16,2.6 (dd, J=16.90,16.93) 50.7   
3′ - 201.3   
4′ 5.86s 127.0   
5′ - 167.1   
6′ - 83.1   
7′ 5.96 (d, J=15.52) 133.8 C4’, C8’  
8′ 5.70,5.73 (dd, J=7.25,7.25) 133.7 C7’, C9’ 5.96 
9′ 4.56 (q, J=6.57) 75   
10′ 1.28 (d, J=6.36) 22.2 C8’, C9’  
11′ 1.03s 23.5   
12′ 1.01s 24.7   
13′ 1.93 (d, J=1.25) 19.6  5.86 
9’-O-β-D-glucoside    
1 4.26 (d, J=7.78) 101.2 C9’  
2 - 74.6   
3 - 78.7   
4 - 71.1   
5 - 78.4   
6 3.65 (dd, J=6,11.9 ) 3.85 (dd, 
J=2.22,11.94) 
62.4   
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19-O-β-D-glucoside ester    
1 5.4d, J=8.13 95.7 C19  
2 - 74.1   
3 - 78.5   
4 - 71.6   
5 - 78.2   
6 3.56 (dd, J=5.6,11.9) 3.78 (dd, 
J=2.2,11.8) 
62.3   
11.3. Experimental Section. 
General: The IR spectra were recorded on Jasco-320-A spectrophotometer. The optical 
rotation was measured on a Jasco-DIP-360 digital polarimeter. EI-MS and FAB_MS 
spectra were recorded on a   JMS-HX-110 spectrometer. 1H-NMR, 13C-NMR, COSY, 
NOESY, HMQC and HMBC spectra were run on Bruker spectrometers operating at 500, 
400, and 300 MHz. For column chromatography, silica gel (70-230 mesh) and for flash 
chromatography, silica gel (230-400 mesh) was used. TLC was performed on pre-coated 
silica gel G-25-UV254 plates. Detection was carried out at 254 nm, and by spraying with 
ceric sulphate and aniline phthalate reagents. For recycling HPLC (LC 908 W) a semi-
preparative (M-80) reverse phase column was used. Purity was checked on TLC with 
different solvent systems using methanol, acetic acid, water, and CHCl3, giving single 
spot.  
11.3.1. Plant material: The plant Pulicaria undulata L. (Asteraceae) was collected in 
August 2002 from Loralai, Balochistan, and identified by one of us (R.B.T.). A voucher 
specimen (no. 1437a) has been deposited at the herbarium of the Botany Department of 
the same University.
11.3.2.Extraction and isolation: The shade–dried ground plant material (whole plant, 30 
kg) was exhaustively extracted with methanol at room temperature. The extract was 
evaporated to yield the residue (753 g). The whole residue was dissolved in water and 
partitioned with n-hexane, chloroform, ethyl acetate, and n-butanol. The n-butanol-
soluble fraction (112 g) was subjected to column chromatography (silica gel, n-Hexane-
CHCl3 mixtures of increasing polarity, CHCl3, CHCl3-MeOH mixtures of increasing 
polarity) and fifteen fractions (1–15) were collected. Fraction 2 was subjected to repeated 
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flash chromatography (230-400 mesh) and eluted with MeOH-CHCl3 (2:98) yielding 
pure 4 (18.3 mg). Fraction 5 was subjected to repeated fraction chromatography (230-400 
mesh) and eluted with MeOH-CHCl3 (5:95) furnishing pure 3 (22.9 mg). Fraction 7 was 
subjected to repeated fraction chromatography (230-400 mesh) and eluted with MeOH-
CHCl3 (10:90) which yielded pure 2 (29.5 mg). Fraction 9 was loaded on flash silica gel 
and eluted with MeOH-CHCl3 (15:85) to get two sub-fractions (Frsb. 9.1 and Frsb.9.2). 
Fraction 9.2 was then submitted to Sephadex LH-20 and eluted with pure water, and 
finally purified on recycling HPLC (LC 908 W) using a reverse phase semi preparative 
(M-80) column. Elution was carried out at a flow rate of 4 ml/ min under isocratic 
conditions with MeOH-H2O (1: 1). The peaks were detected by UV and RI detectors. The 
eluate of the peak at a retention time of 46 min furnished pure 1 (12.9mg).   
11.3.3 Acid hydrolysis of 1 and 3: A solution of 1 and 3 separately, (3mg each) in 
MeOH (5 ml) containing 2 N HCl (4 ml) was refluxed for 4h, concentrated under reduced 
pressure, and diluted with H2O (8ml). It was extracted with EtOAc and the residue 
obtained from the organic phase was found to be a mixture of products. . The aqueous 
phase was neutralized with Ag2CO3, filtered and evaporated under reduced pressure. The 
obtained residue showed the presence of glucose in 1 and 3, when compared with the 
authentic sample on TLC (EtOAc-MeOH-AcOH-H2O = 11: 2: 2: 2) . The spots were 
visualized  by spraying with aniline phthalate reagent.  
Some coupling constants are not given in table because peaks are mixed in 1H-NMR 
spectra. The absolute configuration at C-7 and C-6’ is not defined because of the overlap 
of peaks  in 1H-NMR and NOESY spectra. 
Pulicarioside-B (1) ent-11α,16α-epoxy-16(R)-7-O[6’S,9’S-3’-oxo-α-ionol 9’-O{β-D-
glucopyranosyl}] 19-O[β-D-glucopyranosyl] kauranoate. 
Transparent solid 
[]D: +26.3 
IR (KBr) νmax: 3408, 2928, 1723, 1653, 1280, 1071 
1H NMR (CD3OD): Table 1. 
13C NMR (CD3OD): Table 1. 
HMBC (CD3OD): fig. 2  
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HRFABMS (+) m/z: 865.4480 [M+H]+ (calc. for C45H69O16, 865.4586). 
FABMS (+) m/z: 865 [M+H]+, 703 [M – hexose]+, 541 [M –2 hexose]+, 335 [M –2 
hexose – (corchoionol)]+
 FABMS (-) m/z: 863 [M-H]-, 701 [M – hexose]-, 539 [M –2 hexose]-, 333 [M –2 hexose 
– (corchoionol)]-;  
EIMS m/z (rel. int.): 334 [M –2hexose – corchoionol]- 
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                                                                                                                      Chapter 12 
A  New Flavonoid from Pulicaria undulata 
                                                                                                   Manuscript in preparation 
  
 12.1. Result and discussion  
The ethyl acetate soluble fraction of the whole plant of Pulicaria undulata L. (syn. 
Pulicaria crispa Forssk.) led to the isolation of a new flavonoid Undulol (1) and its 
structure was deduced by detailed analysis of spectral data and comparison of its spectral 
data with those of the closely related compounds [8-10]. 
Undulol (1) was isolated as an amorphous solid. Its molecular formula C23H18O8 was 
established by the positive ion HRFAB MS  showing molecular ion [M+H]+ peak at m/z
423.0002 (cald. 423.10017), which indicated 15 degrees of unsaturation. Its IR      
spectrum exhibited absorption bands for hydroxyl groups (3418-3295 cm-1), methyl 
(2923 cm-1), conjugated carbonyl group (1601 cm-1), and aromatic unsaturation (1506-
1451 cm-1). Its     EI-MS spectrum exhibited an ion at m/z 330 [M –(p-hydoxy phenyl)]+. 
Its 1H-NMR spectrum revealed two sets of ortho-coupled doublets for ring B and for 7-
O-(p-hydroxy) phenyl ring. Ortho-coupled doublets at δ 7.84 (2H, J = 8.68) and δ 6.89 
(2H, J = 8.86) for ortho, meta and para substituted ring B, two singlet at δ 3.87 (3H) and 
3.85 (3H) for two methoxy group at C2’ and C3’ positions of ring B. Ortho-coupled 
doublets at δ 8.08 (1H, J = 8.78) and δ 6.93 (1H, J = 8.77) for para hydroxyl substituted 
phenyl ring. This assignment was further confirmed by its 13C-NMR and HMBC 
spectrum. Important HMBC correlations are shown in fig. 1. Based upon the above 
cumulative evidences, 1 was identified as 7-O-p-hydroxy phenyl 2’, 3’-
dimethoxyapigenin
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Structure of Compound 1 and HMBC correlations
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                 Table 1. NMR data for compound 1 in D3OD (δ in ppm, J in  Ηz) 
No.                   δH                            δCb
2 - 166.4 
3 6.59 s 103.4 
4 -  184.3 
5 - 154.7 
6 6.55 s 95.3 
7 - 177.3 
8 6.49 s 94.8 
9 - 158.6 
10 - 112.6 
1′ - 105.0 
2′,  - 148.4 
3′  - 136.9 
4′ - 162.8 
5′ 6.90  (d, J = 8.86) 116.3 
6′ 7.84  (d, J = 8.68) 129.4 
2′-
OMe 
3.87s 60.97 
3′-
OMe 
3.85s 60.94 
1′′ - 153.7 
2′′,6′′ 8.08  (d, J = 8.78) 130.7 
3′′,5′′ 6.93  (d, J = 8.77) 117.0 
4′′ - 160.6 
    
a   All spectra were recorded at 500 MHz (1H) and 125 MHz (13C); assignment were aided 
by 2D-NMR  
COSY, HMQC and HMBC experiments, b   13C NMR multiplicities were determined by 
DEPT 135°. 
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12.2. General experimental procedures
The IR spectra were recorded on Hitachi-UV-3200 and JASCO-320-A 
spectrophotometer, respectively. 1H-NMR, 13C-NMR, COSY, HMQC and HMBC 
spectra were run on Bruker spectrometers operating at 500, 400 and 300 MHz. The 
chemical shifts were recorded as δ in ppm and coupling constants in Hz. EI-MS and 
FAB_MS spectra were recorded on a   JMS-HX-110 spectrometer. For column 
chromatography, silica gel (70-230 mesh) and for flash chromatography, silica gel (230-
400 mesh) was used. TLC was performed on pre-coated silica gel G-25-UV254 plates. 
Detection was carried out at 254 nm, and by ceric sulphate reagent. Purity was checked 
on TLC with different solvent systems using methanol, acetic acid and CHCl3 giving 
single spot.  
12.3. Extraction and purification 
The shade-dried ground plant material (whole plant) (30 kg) was exhaustively extracted 
with methanol at room temperature. The extract was evaporated to yield the residue (753 
g). The whole residue was dissolved in water and partitioned with n-hexane, chloroform, 
ethyl acetate and n-butanol. The ethyl acetate soluble extract (182.4 g) was subjected to 
column chromatography over silica gel using n-hexane with gradient of CHCl3 up to 100 
% and then the polarity was increased with methanol in a similar fashion. Fifteen 
fractions were collected. The fraction 5 was submitted to repeated flash chromatography 
(230-400 mesh) and eluted with MeOH: CHCl3 (4:96) to get two sub-fractions 5.1 and 
5.2. The sub-fractions 5.1 was then flash choromatographed eluting with MeOH: CHCl3
(3.8:96.2) to get purified 1 (11.7mg).  
12.3.1. Undulol (1). Amorphous powder; C23H18O8; IR(KBr) νmax 3418-3295 (OH), 2923 
(C-H), 1601 (C=O),  1506-1451 (C=C, Ar) cm-1; 1H and 13C NMR, table 1; HRFAB-MS 
(+): m/z 423.00020 [M+H]+, cald. 423.10017; FAB-MS (Pos. ion mode) m/z 423 
[M+H]+; FAB-MS (Neg. ion mode) m/z 421 [M-H]-; EIMS: m/z (rel. int.): 330 [M – (p-
hydroxy-phenyl)]+ (100).
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Zusammanfassung 
Teil A: Spirocyclische Cyclopropane wurden durch Umsetzung von Ketosulfon- und 
Cyanoaceton-Dianionen hergestellt und durch Behandlung mit 
Tetraalkylammoniumhalogeniden in funktionaliserte Arene überführt. Durch 
Cyclisierung des Dianions von Aceton und eines 3-Oxophosphonates konnten 
regioisomere Spirocyclopropane hergestellt und durch anschließende Umsetzung mit   
Tetraalkylammoniumhalogeniden in funktionaliserte Arene überführt werden. Es wurden 
Beiträge zur Synthese von Diarylethern, Biarylen und 1-Azaxanthonen geliefert. Teil B: 
Weiterhin wurden Ergebnisse auf dem Gebiet der regioselektiven Synthese von 
Thiophenen durch Suzuki-Reaktionen von Tetrabromthiophen geliefert. Teil C: 
Schließlich wurden neue  Naturstoffe isoliert und charakterisiert.  
Part A: Spirocyclic cyclopropanes were made by reaction of ketosulfone and ketonitrile 
dianions. This was futher transformed to fuctionalized   Arenes in the presence of 
tetraalkyl ammonium halides.By cyclization of the dianions from Acetone and 3-
Oxophosphates it was possible to obtain regioisomeric spirocyclopropanes which were 
futher reacted with tetraalkyl ammoniun halides to obtain fuctionalized Arenes.  
Contributions were also made in the area of the Diarylether Biaryles and 1-Azaxanthones 
synthesis. Part B: Futher more contributions wre made in the area of regioselective 
synthesis of the Thiophenes by Suzuki reactions of tetrabromothiophene. Part C: Natural 
products were isolated and characterized.
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Ambident dianions are organic substrates containing two delocalized negative charges.1 
The generation of dianions requires strong bases such as lithium diisopropylamide (LDA) 
or n-butyllithium (n-BuLi). 1,3-Dicarbonyl compounds can be metallated twice by the 
action of two equivalents of LDA or by the use of NaH/n-BuLi.2 The terminal carbon 
atom of the dianion can be regioselectively coupled with one equivalent of an 
electrophile to give a monoanion which is subsequently trapped by addition of a second 
electrophile. Monoanions may be alkylated twice by a double deprotonation-alkylation 
sequence. However, the regioselectivities of reactions of monoanions and dianions 
generally differ greatly. For example, 1,3-dicarbonyl monoanions are generally alkylated 
at the central carbon or at the oxygen atom whereas the formation of dianions allows for 
the functionalization of the terminal carbon atom. An exception is reactions of highly 
stabilized 1,3,5-tricarbonyl compounds, which contain two (rather than only one) highly 
CH acidic groups. The product obtained by sequential alkylation of a stabilized 
carbanion can be identical to that prepared from the respective dianion.  
 
Most work in dianion chemistry has been concentrated so far on condensation reactions 
with monofunctional electrophiles and subsequent addition of water to give open-chained 
products.2 Despite their simplicity and synthetic usefulness, cyclization reactions of 
dianions with dielectrophiles are relatively rare.3-5 The use of 1,2-dielectrophiles is 
particularly problematic, since both dianions and 1,2-dielectrophiles represent highly 
reactive compounds (low reactivity matching). In addition, 1,2-dielectrophiles are often 
rather labile and reactions with nucleophiles can result in polymerisation, decomposition, 
formation of open-chained products, elimination or SET-processes. Two ways to 
overcome these intrinsic limitations are viable: a) a proper tuning of the reactivity of 
dianion and dielectrophile and b) the use of electroneutral dianion equivalents (masked 
dianions) in Lewis acid catalyzed reactions. 
 
Two general mechanistic pathways can be discussed for cyclization reactions of dianions 
(Scheme 1): firstly, the dianion can react with a monofunctional electrophile with 
transposition of a negative charge from the dianion to the electrophile. This carbanion 
attacks an electrophilic center of the former dianion moiety (e. g. the ester group) to give 
 2
a monoanion which is subsequently quenched with water (mechanism type A). Secondly, 
the dianion can react as a dinucleophile with a dielectrophile (mechanism type B).  
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                                           Scheme 1 
 
The Lewis acid mediated domino “[3+3]-cyclization-homo-Michael” reaction of 1,3-
bis(silyl enol ethers) with 1,1-diacylcyclopropanes allows an efficient one-pot synthesis 
of functionalized salicylates containing a halogenated side-chain (see Scheme 2).6 Two 
mechanisms can be discussed.  
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Scheme 2. Possible mechanisms of the cyclization of 1,3-bis(silyl enol ethers) with 1,1-
diacetylcyclopropane 
 
Path A: the TiCl4-mediated ring-opening of 1,1-diacetylcyclopropane results in the 
formation of the titanium enolate A which subsequently undergoes a cyclization with the 
 4
1,3-bissilyl enol ethers. Alternatively, the cyclization may precede by formation of the 
spirocyclic intermediate C and subsequent TiCl4-mediated ring cleavage (homo-Michael 
reaction) via intermediate D. The isolation of the spirocyclopropane intermediate proved 
to be possible when the reaction was carried out in the presence of 0.3 equiv. of TiCl4 
(vide infra). Therefore, the cyclization of 1,3-bis(silyl enol ethers) with 1,1-
diacylcyclopropanes presumably proceeds by mechanism type B.  
 
The cyclization of 1,3-dicarbonyl dianions with 1,1-diacylcyclopropanes allowed the 
synthesis of 1-hydroxyspiro[2.5]cyclooct-4-en-3-ones in good yields (Scheme 3). The 
reaction of 1,3-bis(silyl enol ethers) with 1,1-diacylcyclopropanes, in the presence of 0.3 
equiv. of TiCl4, also afforded 1-hydroxyspiro[5.2]cyclooct-4-en-3-ones.7 The use of more 
than 0.5 equiv. of TiCl4 resulted in cleavage of the cyclopropane moiety and 
aromatisation (Scheme 3). 1-Hydroxyspiro[5.2]cyclooct-4-en-3-ones represent analogues 
of the illudines.  
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Scheme 3. Synthesis of 1-hydroxyspiro[2.5]cyclooct-4-en-3-ones (4); i, 1) LDA (2.3 
equiv.), dicarbonyl compound (1.2 equiv.), THF, 1 h, 0 °C, 2) 1,1-diacetylcyclopropane 
(1.0 equiv.), 78 °C, 1 h, 7820 oC, 14 h; ii, TiCl4 (0.3 equiv.), CH2Cl2, 7820 oC, 
12 h. 
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1-Hydroxyspiro[5.2]cyclooct-4-en-3-ones 4 represent highly reactive electrophiles and 
strong alkylating agents.29, 30 Treatment of 1-hydroxyspiro[5.2]cyclooct-4-en-3-ones 4
with titanium tetrahalides (method A) or tetraalkylammonium halides, in the presence of 
boron trifluoride (method B), resulted in the formation of 4-(2-haloethyl)salicylates 5 
(Scheme 4).  
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Scheme 4. Reaction of 1-hydroxyspiro[5.2]cyclooct-4-en-3-ones (4) with TiX4 (method 
A) and NBu4X (method B) 
 6
In my thesis, I adopted the above-mentioned methodology to the synthesis and reactions 
of novel spirocyclopropanes based on cyclizations of -ketosulfone, -ketonitrile 6 and -
ketophosphonate dianions with 1,1-diacetylcyclopropane. These reactions afford 1-
hydroxyspiro[5.2]cyclooct-4-en-3-ones 7 which were transformed, by reaction with 
tetrabutylammonium halides, into functionalized phenols 8 as shown in Scheme 5.
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Scheme 5. Synthesis of 8; i: 1) LDA (2.0 equiv), 1 (1.0 equiv), THF, 1 h, 0 °C, 2) 2 (1.0 
equiv), 78  20 °C, 14 h; ii: nBu4NX (1.0 equiv), BF3OEt2 (0.5 equiv.), –78  20 °C, 
12 h 
The regioselective alkylation of the dianions of simple -ketoesters with alkyl iodides 
provides a convenient access to a variety of higher homologues8. These include branched, 
non-branched and -chloroalkyl-substituted derivatives. The one-pot cyclization of the 
dianions9 of 1,3-dicarbonyl compounds with 1-bromo-2-chloroethane10,11 afforded a 
variety of 2-alkylidenetetrahydrofurans 8,12  in good yields with very good regio- and E/Z-
diastereoselectivity  (cyclization type A, Scheme 6)13,14. Notably, the synthesis of 2-
alkylidenetetrahydrofurans containing a remote chloro group proceeded with very good 
chemoselectivity. In fact, the chloro group proved to be compatible with the LDA-
mediated generation of the dianions and the LDA-mediated cyclization.8 Lindqvist et al. 
 7
earlier reported base-mediated intramolecular cyclizations of -halo--keto esters to give 
cyclic ethers or ketones13a. The one-pot cyclization of dilithiated ethyl 4-
chloroacetoacetate with 1-bromo-2-chloroethane afforded, albeit in low yield, 3-chloro-2-
alkylidenetetrahydrofuran as a separable mixture of E/Z-isomers (Scheme 6).  
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Scheme 6. Cyclization of 1,3-dicarbonyl dianions with 1-bromo-2-chloroethane; i: (1) 
LDA (2.3 equiv.), THF, 0 °C, 1 h, (2) R3I, –78  20 ºC, 14 h, (3) 20 ºC, 2 h; ii: (1) LDA 
(2.3 equiv.), THF, 0 °C, 1 h, (2) BrCH2CH2Cl, –78  20 ºC, 14 h, (3) 20 ºC, 24 h or 68 
°C, 9 h. 
 
The one-pot cyclization of dilithiated 1,3-dicarbonyl compounds with 1,4-dibromo-2-
butene15 provides a convenient approach to 2-alkylidene-5-vinyltetrahydrofurans (13)  
(Scheme 7)12. The formation of products can be explained by a domino SN/SN' reaction. 
The products are formed as separable mixtures of E/Z isomers. The ratio strongly 
depends on the reaction time and on the substituents. The exocyclic double bond is 
initially formed with Z-configuration. By stirring of the reaction mixture at room 
temperature, an isomerization of the exocyclic double bond to the thermodynamically 
more stable E-configuration is observed. However, the isomerization could not be 
efficiently carried out after isolation of the Z-isomer, since the rearrangement was 
accompanied by decomposition. Weiler et al. reported that the reaction of 1,3-dicarbonyl 
 8
dianions with 1,4-dichloro-2-butene (rather than 1,4-dibromo-2-butene) resulted in the 
formation of mixtures of open-chain products in low yields15a. Elegant and efficient 
cyclizations of 1,4-dibromo-2-butene with the stabilized carbanions of dimethyl acetone-
1,3-dicarboxylate and of various other 1,3,5-tricarbonyl compounds has been reported by 
Rodriguez.15c. 
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Scheme 7. Synthesis of 2-alkylidene-5-vinyltetrahydrofurans 13: i: (1) LDA (2.3 equiv.), 
THF, 0 °C, 1 h, (2) 1,4-dibromobut-2-ene, –78  20 ºC, 14 h, (3) 20 ºC, 24 h. 
 
We used the above mention methodologies to chemo- and regioselective synthesis of  -
bromo-3-ketosulfones, -bromo-3-ketonitriles and various functionalized 2-(-
bromoalkyl)benzofurans by application of a ring-closing/ring-opening strategy. The 
cyclization of 3-ketosulfone and 3-ketonitrile dianions with 1-bromo-2-chloroethane or 
1,4-dibromobut-2-ene afforded functionalized 2-alkylidenetetrahydrofurans (16), which 
were subsequently cleaved by reaction with boron tribromide or boron trichloride as 
shown in Scheme 8. 
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Scheme 8. Synthesis of benzofurans 17, i: 1) 2.5 equiv. LDA, THF, 0 °C, 45 min, 2) acid 
chloride, 78  20 °C, 14 h; ii: 2.5 equiv. LDA, THF, 0 °C, 1 h, 2) Br(CH2)2Cl, 78  
20 °C, 14 h; then reflux, 14 h; iii: 1) 5.0 equiv. BBr3, CH2Cl2, 0  20 °C, 12 h, 20 °C, 12 
h; 2) H2O 
 
In 1980, Chan and coworkers reported the first example of a new synthetic approach to 
salicylates based on cyclization reactions of 1,3-bis(silyl enol ethers).16 These 
transformations, which can be formally regarded as [3+3] cyclizations, provide a 
convenient approach to a variety of functionalized arenes which are often not readily 
available by more classic methods. 1,3-Bis(silyl enol ethers) can be regarded as 
electroneutral equivalents of 1,3-dicarbonyl dianions (masked dianions) and generally 
attack electrophiles with their terminal carbon atom (as is the case for dianions). The 
chemistry of silyl enol ethers17 and 1,3-bis(silyl enol ethers)18 has been reviewed. 
 
OMe
OSiMe3Me3SiO
 _ _ _  
                         Figure 1. Reactivity of 1,3-bis(silyl enol ethers) in [3+3] cyclizations 
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Chan and coworkers reported the TiCl4 mediated synthesis of methyl salicylate  by [3+3] 
cyclization of 1,3-bis(silyl enol ether) 19  with 1,1,3,3-tetramethoxypropane 18  (Scheme 
9)16. This transformation proceeds by Lewis acid mediated attack of the terminal carbon 
atom of the 1,3-bis(silyl enol ether) onto the 1,1,3,3-tetramethoxypropane, cyclization 
and subsequent aromatization by double elimination of methanol. 
 
MeO OMe
OMeOMe OMe
OSiMe3Me3SiO
OH
OMe
O
i
19
18 20  
Scheme 9. Cyclization of a 1,3-bis(silyl enol ether) with 1,1,3,3-tetramethoxypropane, i:
TiCl4, CH2Cl2, –78  20 °C 
 
Chan and coworker were the first to report the synthesis of salicylates by [3+3] 
cyclization of 1,3-bis(silyl enol ethers) with 3-silyloxyalk-2-en-1-ones (Scheme 10)19,20.  
These cyclizations generally proceed by TiCl4 mediated conjugate addition of the 
terminal carbon atom of the bis-silyl enol ether onto the 3-silyloxyalk-2-en-1-one, 
cyclization, extrusion of siloxane and aromatization. 
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Scheme 10. Mechanism of the cyclization of 1,3-bis(silyl enol ethers) with 3-silyloxyalk-2-
en-1-ones; i: TiCl4, CH2Cl2, –7820 °C 
 
In my thesis, I have adopted this methodology of formal [3+3] cyclizations of 1,3-
bis(silyl enol ethers) with 1,3-dielectrophiles, such as 1,1,3,3-tetramethoxypropane, 18 3-
(silyloxy)alk-2-en-1-ones, 21 for the synthesis of 4-aryloxy-1,3-bis(trimethylsilyloxy)-
1,3-dienes 22 and 4-aryl-1,3-bis(trimethylsilyloxy)-1,3-dienes 26 and their application to 
the synthesis of diaryl ethers. Noteworthy, these reactions allow a convenient and 
regioselective synthesis of sterically encumbered and functionalized diaryl ethers 23 and 
biaryls 27 (Schemes 11 and 12), which are not readily available by other methods. 
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Scheme 11. Synthesis of 23, i: TiCl4, CH2Cl2, –78  20 °C, 20 h. 
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Scheme 12. Synthesis of 27; i:   Me3SiCl, NEt3, C6H6, 20 °C, 72 h; ii: LDA, THF, –78  
20 °C; iii: Me3SiOTf (0.1 equiv.), CH2Cl2, –78  20 °C, 20 h 
 
Ghosh and coworkers21 were the first to report condensation reactions of 4-oxo-4H-[1] 
benzopyran-3-carbonitriles (henceforth called chromone-3-nitriles) with sodium azide to 
form 3-(1H-tetrazol-5-yl)chromones. They also investigated the reaction with hydrazine, 
phenylhydrazine, hydroxylamine, and some reactive methylene compounds, such as 
acetylacetone, ethyl acetoacetate,diethyl malonate, and ethyl cyanoacetate. The formal 
[4+2]-cycloaddition of 1,3-butadienes with 4-(trimethylsilyloxy)benzopyrylium triflates 
 13
was first reported by Akiba and coworkers22 . They have developed a facile and useful 
method for the regioselective introduction of carbon nucleophiles into pyrones via 
pyrylium cations by means of tert-butyldimethylsilyl triflate. It was observed that the 
generation of siloxypyrylium salts was one of the most effective methods for activation 
of the pyrone ring in the absence of other activating groups as shown in Scheme 13. 
Moreover, a synthetic advantage of this method is the tandem introduction of two kinds 
of substituents successively at C2 and C3 of the pyrones. These authors have further 
investigated reactions of chromones with various types of nucleophiles for preparation of 
2-substituted chromone and xanthone derivatives. 
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Scheme 13 
 
In the light of the above described methodology, the Langer group developed new 
domino reactions of 4-(silyloxy)benzopyryliumtriflates. For example, the TMSOTf-
mediated reaction of 3-cyanochromones 30 with 1,3-bis(trimethylsilyloxy)-1,3-
 14
butadienes 31 provides functionalized 1-azaxanthones 33 as shown in Scheme 14. The 
products are not readily available by other methods. 
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Scheme 14. Synthesis of 1-azaxanthones 33: i: 1) 1, Me3SiOTf, 1 h, 20 °C, 2) 2, CH2Cl2, 
0  20 °C, 12 h, 3) HCl (10%); ii: 1) NEt3, EtOH, 20 °C, 12 h, 2) HCl (1 M) 
The chemistry of 1-silyloxy-1-methoxy-3-phenylthio-1,3-butadiene has been described 
by Chan and co-workers23 in 1986. They have described the regioselectivity of the 
reaction of 3 with electrophiles. The reactions with unsaturated ketones and simple silyl 
enol ethers have been reported (Schemes 15 and 16). 
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In my thesis, I have adopted this methodology to the synthesis of 3- and 5-
thioaryloxysalicylates based on exploratory work of Chan et al. (Schemes 15 and 16). I 
synthesized 2-(thioaryloxy)benzoates and thioxanthones based on formal [3+3] 
cyclizations of 1-methoxy-1-trimethylsilyloxy-3-thioaryloxy-1,3-butadienes 40 with 3-
silyloxy-2-en-1-ones 39 and 1,1,3,3-tetramethoxypropane. The sterically encumbered and 
functionalized products reported are again not readily available by other methods 
(Scheme 17). 
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                                                   Scheme 17 
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The palladium-catalysed Suzuki cross-coupling reaction of organoboron compounds with 
organic halides or pseudo-halides is a remarkably useful tool in organic synthesis. During 
the past decade, this reaction has been used for various carbon-carbon bond formations, 
which proceed under mild conditions. The reaction is largely unaffected by the presence 
of water, tolerates a broad range of functionalities and by-products are not toxic. The 
reaction has largely been employed in academic laboratories as well as in pharmaceutical 
and fine chemical industries to synthesise a large variety of organic molecules. For 
example, it has been applied industrially to the production of Losartan (1), which is a 
Merck antihypertensive drug, and has been used for the large scale synthesis of 
compound 2, which is a key intermediate for the synthesis of SB-245570 (3), a compound 
useful for the treatment of depression, and as a key step in a convergent multikilogram 
synthesis of CI-1034 (4) (Figure 2), a potent endothelian receptor antagonist24. 
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                                                           Figure 2
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Thiophenes are present in pharmacologically relevant natural products. This includes, for 
example, dibenzothiophenes, 4,6-diethyldibenzothiophenes possessing estrogenic activity 
(44, Scheme 18),25 [2,2';5',2''] terthiophenes,26 (Scheme 19) and thienyl-diynes.27 2,3-
Dibromothiophene has been functionalized by regioselective Sonogashira couplings of 
carbon atom C-2 ( Scheme 20).28 A very good C-2 regioselectivity was observed also for 
the Kumada cross coupling of 2,3- and 2,4-dibromothiophene.29 In my thesis, I have 
studied the synthesis of various tetraarylthiophenes based on Suzuki reactions  of 
tetrabromothiophenes as shown in Scheme 21. 
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Scheme 18. Synthesis of 4,6-dimethyldibenzothiophene (44), i: KOH, NMP, 170 °C, 
85%; ii: Pd/C, MeOH, H2, 1 atm, RT, 90%; iii: H2SO4 ,NaNO2, NaBF4, 0° C; iv: Cu, 
DMSO, RT, 25%. 
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Scheme 19. Synthesis of of [2,2'; 5’, 2’’] terthiophenes (47) ( i) NIS. DMF. Overnight, 
20 °C, (ii) PdCl2 ppf, basic alumina /KF, 	 5 min, max temp 80 °C.  
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Scheme 20. Synthesis of 49, 50 ( i) Pd(PPh3)2Cl,  CuI, (i-Pr) NH, 	 5 min, temp 50 
°C.and 	 20 min, temp 100 °C. 
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51 52
Scheme 21. Synthesis of tetraarylthiophene (52) Conditions: i, 1 (1.0 equiv.), ArB(OH)2 
(5.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (8.0 equiv.), Toulene/H2O = 4:1  
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The genus Pulicaria Gaertn. of the family Compositae (Asteraceae) consists of 100 
species and this genus has been the subject of several chemical investigations, giving rise 
to the isolation of flavonoids, sesquiterpenes, diterpenes, triterpenes, caryophyllenes and 
caryophyllane derivatives30,31 Several species of this genus have been used as insect 
repellents and in the treatment of dysentery32. The genus Pulicaria is placed in the tribe 
Inuleae s. str.33 Chemically this genus is not homogeneous. As pointed out previously 
some species34 contain diterpenes,others caryophyllene derivatives and those now placed 
inthe genus Francoeuria contain sesquiterpene lactones. Pulicaria undulata L. which is a 
synonym of Pulicaria crispa Forssk. and Francoeuria crispa Forssk.35 Is an annual 
wooly herb which can cover whole desert wadis with its bright yellow flowers and fills 
the air with a rich perfume. Most plants appear with only a few flower-bearing branches 
but, under good conditions, they can grow into a splendid bush. One of its local names 
"Shai-el-Gebel which gives the secret away that this plant is used as an herbal tea and as 
a medicinal plant. The Bedouin's or vernacular name for Pulicaria crispa is Dethdath and 
Desdas. The Arabic names include: Arfeg; Feliet el-Hami; El Attasa, El Eteytesa; Sabad, 
Gettiat, Zibl el Far, Ghobbeira and Khanouf. This plant is used medicinally as a remedy 
for breathing problems. One small spoon of the herb can be boiled in a glass of water as 
needed. The flower branches are used for preparing a powerful sneezing 
powder. Pulicaria undulata, C. A. Mey. has been studied previously, but only thymol 
derivatives and flavones sesquiterpenes, diterpenes36, 37,38 have been reported as shown in 
Figure 3. 
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Figure 3 
 
My own studies were focused on the isolation and characterization of new chemical 
constituents from Pulicaria undulata. This work was carried out at the H. E. J. research 
institute (Karachi, pakistan) under the guidance of Professor Dr. Viqar Uddin Ahmad. 
During these studies I have isolated and structurally elucidated different chemical 
constituents that belong to flavonoid and ent-kaurane-type diterpenes, to two new 
flavonoid glycosides, pulicaroside, undulatoside and one new flavonoid undulol. In 
addition, four known flavonones – one new ent-kaurane-type diterpene glycoside, 
pulicaroside-B together with three known compounds paniculosides-IV, roseoside and 
corchionol C  which  are derivatives of -ionol – were isolated. The structures of the new 
and known compounds were elucidated by 1D- and 2D-NMR techniques, along with 
other spectral evidences and comparison of the spectral data with those of closely related 
compounds. All the flavonoids that are discussed in chapter 11 exibited superoxide anion 
scavenging activity. 
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        Description of my own contributions to the scientific publications 
 
The coauthors of the scientific publications are given below. My own contributions to 
these publications can be easily recognized by the fact that I only included those 
compounds in the experimental section of the paper which I prepared myself. This 
means that the compounds given in the experimental section of my thesis are those 
compounds which I prepared without the help of others. In the following, my own 
contributions are described in great detail. 
 
Chapter 1 
The Langer group has previously reported the cyclization of the dianion of alkyl 
acetoacetate with 1,1-diacetylcyclopropane to give 1-hydroxyspiro[5.2]cyclooct-4-en-2-
ones. I used other types of 1,3-dianions, such as 
-ketosulfone, -cyanoacetone, and 
diethyl 2-oxopropylphosphonate dianions and synthesized the corresponding 
functionalized  spirocyclopropanes 3a,b (see Scheme 1, Table 1). These products were 
transformed into stable aromatic phenols upon cleavage of the cyclopropane moiety by 
treatment with tetraalkylammonium halides in the presence of boron trifluoride to give 
products 4a-f (see Scheme 2, Table 2). The novel spirocyclopropane 6 was synthesized 
by cyclization of 1,1-diacetylcyclopropane with the dianion of -cyanoacetone, generated 
by treatment of 5-methylisoxazole with LDA (Scheme 3, Chapter 1). The BF3OEt2-
mediated reaction of 6 with tetrabutylammonium halides gave the 2-cyanophenols 7a-c 
containing a remote halide group (Scheme 3, Table 3). The cyclization of 1,1-
diacetylcyclopropane with the dianion of diethyl 2-oxopropylphosphonate (8), generated 
by means of LDA, afforded the novel unsubstituted 1-hydroxyspiro[5.2]cyclooct-4-en-3-
one 9 (Scheme 4). The formation of 9 can be explained by cyclization (intermediate C), 
elimination of lithium diethyl phosphate (intermediate D) and subsequent protonation 
upon addition of water. Alternatively, the reaction can be regarded as a domino aldol / 
Horner-Wadsworth-Emmons (HWE) reaction. The BF3OEt2-mediated reaction of 9 with 
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tetrabutylammonium halides afforded the functionalized phenols 10a-c (Scheme 5, Table 
4). I synthesized all the above mentioned compounds myself without the help of others. 
The contribution of the other co-authors involves their help during chromatographic 
problems, spectroscopic analysis and X-ray analysis. 
 
Chapter 2
In my thesis I studied for the first time in our group the use of acetone as a dianion in the 
reaction with 1,1-diacetylcyclopropane. In this chapter, my research work is mainly 
focussed on studies related to the dianion chemistry of acetone as well as 2-
oxopropylphosphonate. I concentrated on the cyclization of the dianion of diethyl 2-
oxopropylphosphonate (1), generated by means of LDA, with 1-acetyl-1-
benzoylcyclopropane to afford the novel 1-hydroxyspiro[5.2]cyclooct-4-en-3-ones 3 
(Scheme1). The BF3OEt2-mediated reaction of 3 with tetrabutylammonium halides 
afforded the phenols 4a-c (Scheme 2, Table 1) containing a halogenated side chain. The 
cyclization of 1,1-diacylcyclopropanes 2a-c with the dianion of acetone, generated by 
menas of a THF-suspension of potassium hydride and subsequent addition of TMEDA 
and nBuLi, afforded the 1-hydroxyspiro[5.2]cyclooct-3-en-5-ones 6a-c (Scheme 3, Table 
2). The BF3OEt2-mediated reaction of 6a-c with tetrabutylammonium halides afforded 
the phenols 7a-h and the halogen-free 10-membered cyclic diethers 8a-c (Scheme 4, 
Table 3 in chapter). I synthesized all the above mentioned compounds myself, except for 
6d, 7i,j, and 8d. The other co-authors synthesized 6d, 7i,j, and 8d and solved other 
scientific problems, such as chromatography, spectroscopic analysis and X-ray analysis. 
 
Chapter 3
The Langer group previously reported the synthesis of 6-bromo-3-oxoalkanoates and 
benzofuran-3-carboxylic esters containing a remote bromide groups by reaction of BBr3 
with 2-alkylidenetetrahydrofurans. My work focussed on the synthesis of novel 
benzofurans based on reactions of 3-ketosulfones and 3-ketonitriles. The reaction of the 
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dianion of 3-ketosulfone 1b with 1-bromo-2-chloroethane gave the 2-
(sulfonylmethylidene)-tetrahydrofuran 2b (Scheme 1, Table 1). I futher synthesized the 
2-(sulfonylmethylidene)-5-vinyltetrahydrofuran 4b by cyclization of dilithiated 3-
ketosulfones 1b with 1,4-dibromobut-2-ene (Scheme 2, Table 2). The reaction of 4b with 
BBr3 afforded the -bromo-3-ketosulfones 5b. In addition 3-ketosulfones 7a,b,d were 
prepared by acylation of aryl-[(2-methoxyphenyl)methyl]-sulfones 6a,c. The cyclization 
of the dianions of 7a,c,d with 1-bromo-2-chloroethane afforded the 2-
alkylidenetetrahydrofurans 8a,c,d. Treatment of 8a,c,d with BBr3 afforded the 2-(-
bromoalkyl)-3-sulfonylbenzofurans 9a,c,d (Scheme 3, Table 3). The reaction of 8a,c,d 
with BCl3 gave 2-(-hydroxypropyl)-3-sulfonylbenzofuran 9e,g. I studied the cyclization 
of the dianion of -ketonitrile with 1-bromo-2-chloroethane and 1,4-dibromobut-2-ene to 
give 2-alkylidenetetrahydrofuran 16 and 2-alkylidene-5-vinyltetrahydrofuran 18.  
Treatment of the latter with BBr3 and subsequently with HBr (62%) afforded the 2-(-
bromoalkyl)-3-carboxybenzofuran 17 (Scheme 6) and the 2-(-bromoalkyl)-3-
carboxybenzofuran 19 (Scheme 7). I synthesized all the above mentioned compounds 
without the help of others. The contribution of the other co-authors is related to solve 
other scientific problem, such as chromatography, spectroscopic analysis and X-rays 
analysis. 
 
Chapter 4 
The Langer group earlier reported the synthesis of 5-aryloxysalicylates and 5-
thioaryloxysalicylates based on reactions of 2-aryloxy- and 2-thioaryloxy-3-
trimethylsilyloxy-2-en-1-ones, respectively. In my thesis, I synthesized for the first time 
4-aryloxy-1,3-bis(trimethylsilyloxy)-1,3-dienes and studied their application to the 
synthesis of diaryl ethers. I focussed mainly on domino 	[3+3]-cyclization-homo-Michael	 
reactions in this chapter. The TiCl4- and TiBr4-mediated reaction of 1,3-bis(silyloxy)-1,3-
diene 4a with 1,1-diacetylcyclopropane (8) afforded the 3-phenoxysalicylates 9a,b 
containing a remote halide function (Scheme 4, Table 3). I synthesized all the above 
mentioned compounds without the help of others. The contribution of the other co-
authors is related to chromatography, spectroscopic analysis and X-ray analysis. 
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 Chapter 5 
The TMSOTf-mediated [4+2]-cycloaddition of 1,3-butadienes with 3-cyanochromone, 
via its 4-(trimethylsilyloxy)benzopyrylium triflate, has been previously reported by our 
group. In the light of this reaction, I studied the development of new applications of 4-
(silyloxy)benzopyrylium triflates. The TMSOTf-mediated reaction of 3-cyanochromones 
with 1,3-bis(trimethylsilyloxy)-1,3-butadienes allows a convenient synthesis of 
functionalized 1-azaxanthones. In my thesis, I used cyanochromone, 6-
chlorocyanochromone, 6-methylcyanochromone, 6,7-dimethylcyanochromone and 1,3-
bis(silyl enol ethers) 2e, 2f,2s, 2t and prepared the substituted azaxanthones 4,l,n,o,af,ag
(Scheme 2, Table 1) The other co-authors synthesized all other compounds. 
 
Chapter 6
  The Langer group has developed a convenient approach to salicylates by formal [3+3] 
cyclizations of 1,3-bis(trimethylsilyloxy)-1,3-dienes with 3-trimethylsilyloxy-2-en-1-
ones. For the first time, I synthesized 4-aryl-1,3-bis(trimethylsilyloxy)-1,3-butadienes and 
applied them to the synthesis of functionalized biaryls. I carried out the TiCl4-mediated 
reaction of 1,3-bis(silyloxy)-1,3-dienes 4a and 4d with 1,1-diacetylcyclopropane (8) to 
give the 3-arylsalicylates 9a and 9b, respectively (Scheme 3). The other co-authors 
synthesized all compounds except from the above mentioned compounds. 
 
Chapter 7 
Based on initial studies of Chan et al., I developed a new methodology for the synthesis 
of 2-(thioaryloxy)benzoates and thioxanthones based on formal [3+3] cyclizations of 1-
methoxy-1-trimethylsilyloxy-3-thioaryloxy-1,3-butadienes with 3-silyloxy-2-en-1-ones 
and 1,1,3,3-tetramethoxypropane. This is related to the formal [3+3] cyclization of 1,3-
bis(silyloxy)-1,3-butadienes with 3-siloxy-2-en-1-ones which has been reported in our 
group before. First, I synthesized the 1-methoxy-1-trimethylsilyloxy-3-thioaryloxy-1,3-
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butadienes 3a-c (Scheme 1, Table 1). Their reaction with 3-silyloxy-2-en-1-ones 4a-e 
afforded the 2-(thioaryloxy) benzoates 5e,f,g,h,i,j (Scheme 3, Table 2). The cyclization of 
dienes 3a,c with 1,1,3,3-tetramethoxypropane (6), in the presence of catalytic amounts of 
trimethylsilyl-trifluoromethanesulfonate (Me3SiOTf, 0.1 equiv.), afforded the 2-
(thioaryloxy)benzoates 7a (Scheme 3). I treated the 2-(thioaryloxy)benzoates 5,e,f,h,i
with concentrated sulfuric acid to give the thioxanthones 8d,e,f,g (Scheme 4, Table 2).  
The other co-authors synthesized the remaining compounds (except from the above 
mentioned ones). 
 
Chapter 8
In collaboration with another Ph.D student of the Langer group, I synthesized 
tetraarylthiophenes by regioselective Suzuki reactions of tetrabromothiophene. 
Tetrabromothiophene (1) was prepared by bromination of thiophene (following a 
modified literature procedure). The tetraarylthiophenes 2a,b,c,d, containing four identical 
aryl groups, were successfully prepared by Suzuki reaction of 1 (1.0 equiv.) with 5.0 
equiv. of various boronic acids (Scheme 1, Table 1 in chapter 8). The reaction of 1 (1.0 
equiv.) with 2.2 equiv. of boronic acids allowed the regioselective synthesis of the 2,5-
diaryl-3,4-dibromothiophenes 3a,c-f (Scheme 2, Table 2). Product 3a (1.0 equiv.) could 
be further functionalized by Suzuki-reaction using 3.0 equiv. of various arylboronic acids 
to give the tetraarylthiophene 4b which contains two different types of aryl groups 
(Scheme 2, Table 3). I synthesized the above mentioned compounds. The contribution of 
the other co-authors is based on the synthesis of the other products, chromatography, 
spectroscopic analysis and X-ray analysis. 
Chapters 9-12 
Chapters 9 and 10 deal with the phytochemical  investigation of pulicaria undualta. I 
selected this plant, due to the reason that it has a valuable medicinal importance. The 
plant Pulicaria undulata L. (Asteraceae) was collected from Loralai, Blalochistan, and 
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identified by Dr. Rasool Bakhsh Tareen (Taxonomist), Department of Botany, 
Balochistan University, Quetta, Pakistan. I chopped and soaked dry plant material in 
methanol for a period of 30 days. The combined methanolic extract was evaporated under 
vacuum to yield a crude methanolic extract. The methanol extract was then fractionated 
with petroleum ether, chloroform, ethyl acetate and butanol. In chapter 9, the chloroform-
soluble fraction was subjected to column chromatography using silica-gel, eluted with 
petroleum ether, and the polarity was gradually increased with chloroform and methanol 
to afford 16b, 17-dihydroxy-ent-kauran-19-oic acid.  
In chapter 10, the ethyl acetate soluble extract was subjected to CC over silica gel, using 
hexane with a gradient of CHCl3 up to 100% and then the polarity was increased with 
methanol in a similar fashion. Fifteen fractions (Fr 1-15) were collected. The Fr 5 and Fr 
9 were then subjected to flash chromatography eluting with MeOH/CHCl3 to give 
purified compounds 1-6: 6-hydroxykaempferol 3-methyl ether, 6-O-
-D-glucopyranoside 
(2), 6-methoxykaempferol 3-O-
-D-glucopyranoside (3), 6-methoxykaempferol (4) and 
quercetagetin 3,6-dimethyl ether (axillarin) (5) were known flavonones. Pulicaroside (1) 
and undulatoside (6) were isolated as new compounds in pulicaria undulata.  
In chapter 11, the n-butanol soluble fraction of the whole plant of Pulicaria undulata L. 
(syn. Pulicaria crispa Forssk.) yielded a new diterpene glycoside, pulicaroside-B (1), 
along with three known compounds, paniculosides-IV (2), roseoside (3) and corchoionol 
C (4). Their structures were deduced by detailed analysis of their spectral data and 
comparison of their spectral data with those of closely related compounds. I used the 
recycling HPLC (LC 908 W), a semi-preparative (M-80) reverse phase column for 
further purification and the purity was checked by TLC with different solvent systems 
using methanol, acetic acid, water, and CHCl3, giving a single spot.
In chapter 12, I used the ethyl acetate soluble fraction of the whole plant of Pulicaria 
undulata L. (syn. Pulicaria crispa Forssk.) which led to the isolation of the new 
flavonoid Undulol (1). Its structure was deduced by detailed analysis of the spectral data 
and comparison of its spectral data with those of the closely related compounds. All 
experimental portions of chapters 9 to 12 described above I have been done myself 
without the help of others. Other co-authors solved other scientific problems, such as 
spectroscopic analysis, X-ray analysis and the superoxide anion scavenging assay. 
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